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ABSTRACT 
 
Background 
 
Despite public health campaigns and improvements in healthcare, socioeconomic gradients 
in health and life expectancy persist, and in many cases are becoming more marked – the 
gradient in coronary heart disease being a prime example. Classic cardiovascular risk 
factors (e.g. smoking, cholesterol and blood pressure) only partially explain the deprivation 
effect, and attempts to narrow the health gap by focussing on such risk factors do not 
appear to be succeeding. There also appear to be socioeconomic differences in uptake of 
healthy lifestyle advice. The work described in this thesis aimed to expand current 
understanding of the deprivation-based gap in health and life expectancy, focussing 
particularly on the socioeconomic gradient in cardiovascular risk.  
 
Methods 
 
Using a cross-sectional, population-based study design based in the Greater Glasgow area,  
666 participants were selected on the basis of area-level social deprivation (Scottish Index 
for Multiple Deprivation ranking). The study was designed to include approximately equal 
numbers from most deprived and least deprived areas; equal numbers of male and female 
participants and equal numbers of participants from each age group studied (35-44; 45-54 
and 55-64 years). Participants completed an extensive questionnaire on health, lifestyle and 
early life experiences. Anthropometric measures (height, leg length, weight, waist, hip and 
thigh circumferences) were recorded. Blood pressure, heart rate and parameters of lung 
function (Forced Expiratory Volume in 1 second [FEV1] and Forced Vital Capacity 
[FVC]) were recorded. Psychological assessments (General Health Questionnaire-28, 
Generalised Self-Efficacy Scale, Sense of Coherence Scale, Beck Hopelessness Scale, 
Eysenck Personality Scale and Rosenberg Self-Esteem Scale) and assessments of cognitive 
function (Auditory Verbal Learning Test, Choice Reaction Time and Stroop Test) were 
undertaken. Fasting blood samples were obtained for classic and emerging cardiovascular 
risk factors including lipid profile, glucose, insulin, leptin, adiponectin, C-reactive protein, 
interleukin-6, soluble intercellular adhesion molecule-1, von Willebrand Factor, 
fibrinogen, D-dimer and tissue plasminogen activator antigen. Carotid ultrasound 
assessment of intima-media thickness (cIMT), plaque score and arterial stiffness was 
performed.  
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Results  
 
Total and low density lipoprotein cholesterol were significantly higher in the least deprived 
group (both p<0.0001). Triglycerides were higher and high density lipoprotein cholesterol 
lower in the most deprived group (both p<0.0001). Fasting glucose, insulin and leptin were 
higher in the most deprived group. C-reactive protein, interleukin-6 and soluble 
intercellular adhesion molecule-1 were higher in the most deprived group (all p<0.0001). 
Von Willebrand factor, fibrinogen and D-dimer were higher in the most deprived group. 
Age- and sex-adjusted cIMT was significantly higher in the most deprived group, but on 
subgroup analysis this difference was only apparent in the highest age tertile in males 
(>56.3 years). Plaque score showed a much more highly significant deprivation difference 
in the group as a whole (p<0.0001). No differences in parameters of arterial stiffness were 
found between the most deprived and least deprived groups. Neither adjustment for classic 
nor emerging cardiovascular risk factors, either alone or in combination, abolished the 
area-level deprivation-based difference in plaque presence or cIMT. Adjustment for early 
life markers of socioeconomic status in addition to classic cardiovascular risk factors 
abolished the deprivation-based difference in plaque presence. Further associations 
between early life factors and health outcomes were noted: lung function (FEV1) and 
cognitive performance appeared to be influenced by father’s occupation, whether the 
parents/guardians were owner-occupiers or tenants, and by degree of overcrowding; cIMT 
was modestly related to father’s occupation and carotid plaque was related strongly to 
father’s occupation and parental home status. Socioeconomic differences were noted in the 
impact of personality in determining mental wellbeing, and also in relation to the health 
behaviours of fruit and vegetable consumption and smoking cessation. 
 
Conclusions 
 
The relationship between social deprivation and health is complex and multifactorial and 
appears to involve the interplay of early life factors, biological mediators, psychological 
parameters such as personality and cognitive function, health behaviours and outcomes 
such as atherosclerosis. Approaches aiming to narrow the deprivation gap in health will 
need to be designed to take into account this complexity, addressing factors such as early 
life experiences and personality, as well as the more classically recognised factors such as 
smoking, cholesterol and blood pressure, if they are to have a chance of succeeding in 
improving the health of those most in need. 
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CHAPTER 1 – INTRODUCTION 
 
1.1 Introduction – the relationship between social deprivation and ill health 
 
1.1.1 The relationship between social deprivation and life expectancy 
– a historical perspective 
 
The inverse relationship between social deprivation and life expectancy has long been 
recognised. A paper published in the Lancet in 1843 observed that there was a strong 
association between occupation and life expectancy (Table 1.1). The paper concluded by 
calling for legislation to, “compel the corporations and ground-landlords to make 
alterations for the comfort and health of those comparatively helpless classes of the 
community, the artisans and labourers.”1 In more recent times, Watt in 1992 compared 
mortality in Glasgow with that in Edinburgh. He predicted that in 1989-93 Glasgow men 
would have a mortality rate equivalent to that of Edinburgh men who were 5.1 years older, 
with the figure for women being 3.9 years. Commenting that it was unlikely that 
differences in smoking and diet explained all of these differences, he suggested that the 
explanation was likely to lie in differences in levels of socioeconomic deprivation between 
Glasgow and Edinburgh.2 
 
1.1.2 The Greater Glasgow story 
 
The relationship between social deprivation and life expectancy is most strikingly 
demonstrated in the Greater Glasgow area of Scotland. At a community level (average 
population of 70 000 people) male life expectancy at birth varies from 63.5 to 78.7 years. 
When these areas are further broken down to postcode level areas (average population of 
3000 to 5000 people) these differences become even more marked, with male life 
expectancy varying across Greater Glasgow from 53.9 to 82.6 years (Figure 1.1).3 Female 
life expectancy shows similar trends, although with less extreme absolute differences 
between areas, with life expectancy at birth varying at community level from 74.1 to 82.2 
years, and at postcode sector level from 68.8 to 84.4 years.3 
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Table 1.1 Life expectancy by occupation in selected districts and towns, 
1843 
 
Districts and towns Gentry/professional Farmers/tradesmen Labourers/artisans 
1. Rural and 
suburban districts 
   
Rutland 52 41 38 
Wiltshire 50 48 33 
Kendal Union 45 39 34 
Kensington Union 44 29 26 
2. Towns    
Bath 55 37 25 
Truro 41 33 28 
Leeds 44 27 19 
Bethnal Green 
(London) 
45 26 16 
Manchester 38 20 17 
Liverpool 35 22 15 
 
Life expectancy is given in years. Table reconstructed with data from reference 1. 
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Figure 1.1 Male life expectancy at birth, 1998-2002. Comparison of 10 
postcode sectors with highest life expectancy with those with lowest life 
expectancy in the West of Scotland and Greater Glasgow 
 
Life expectancy is given in years. Areas in dark red are within Greater Glasgow; areas in 
light blue are other West of Scotland council areas.  
From reference 3, reproduced by kind permission of Glasgow Centre for Population Health. 
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1.1.3 Trends with time 
 
An examination of trends in life expectancy over recent years gives further cause for 
concern. In Scotland as a whole, from 1981 to 2002 male life expectancy increased from 
69.4 years to 73.3 years. However, when the most and least deprived communities in 
Greater Glasgow (as defined by the Carstairs score)4 are examined, it can be seen that 
while male life expectancy in the least deprived areas of Greater Glasgow has been 
consistently above the Scottish average, and has risen in parallel with the Scottish average, 
life expectancy in the most deprived areas has fallen over this time period. This has 
resulted in a significant widening of the difference in life expectancy between most and 
least deprived areas from 6.9 to 11.8 years (Figure 1.2).3 A similar, though less 
pronounced, pattern is seen in females, with the gap in life expectancy having risen from 
5.4 to 7.5 years.3 
 
1.1.4 Cardiovascular disease as a major cause of death, and its 
associations with social deprivation 
 
While in Victorian times, epidemics of infectious disease were a common cause of death,5 
in Scotland in 2008 the three most common causes of death were cancer (27% of all 
deaths), ischaemic (coronary) heart disease (16%) and cerebrovascular disease (stroke) 
(10%).6 Although death rates from ischaemic heart disease and stroke have fallen in recent 
years,6 cardiovascular disease remains a significant cause of mortality and morbidity. 
Figure 1.3 demonstrates that although mortality from heart disease has decreased across 
all Greater Glasgow communities, there remains significant variation in heart disease 
mortality across the Greater Glasgow area, with the difference between the highest and 
lowest death rates (Bridgeton/Dennistoun, areas of high social deprivation versus 
Anniesland/Bearsden/Milngavie, areas of low deprivation) having increased slightly over 
the past ten years.3  
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Figure 1.2 Male life expectancy in the least deprived and most deprived 
quintiles in Greater Glasgow from 1981 to 2002 
 
 
Life expectancy is given in years.  
GROS – General Register Office for Scotland 
From reference 3. Reproduced by kind permission of Glasgow Centre for Population 
Health. 
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Figure 1.3 Heart disease: average annual age-standardised death rates, 
Greater Glasgow communities, 1991/93 – 2000/02 
 
 
The highest death rate from heart disease in Greater Glasgow is seen in Bridgeton and 
Dennistoun, areas of high social deprivation. Anniesland, Bearsden and Milngavie (areas 
of low social deprivation) have the lowest heart disease death rates.  
NHSHS – National Health Service Health Scotland 
GRO(S) – General Register Office for Scotland 
From reference 3. Reproduced by kind permission of Glasgow Centre for Population 
Health. 
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The association between social deprivation and coronary heart disease has been well 
documented.7 The Whitehall study, which studied 17 530 male civil servants aged between 
40 and 64 years, reported in 1981 a rate of angina that was 53% higher in the lowest 
employment grade compared with the highest. This difference was only partly explained 
by currently recognised cardiovascular risk factors.8 Furthermore, the British Women’s 
Heart and Health Study found, in a study involving individuals living in 23 different 
British towns, an increasing prevalence of coronary heart disease with increasing 
socioeconomic deprivation, based on the Carstairs score of area-level deprivation. This 
association between area-level deprivation and coronary heart disease persisted after 
adjustment for ten indicators of individual life-course socioeconomic status.9  
 
Given the socioeconomic gradient in prevalence of coronary heart disease, and the 
widening gap in life expectancy between those at the two extremes of the deprivation 
continuum, the next logical question to ask is to what extent coronary heart disease 
contributes to the deprivation gap in life expectancy. In Scotland as a whole, the three most 
common causes of “premature death” (death before the age of 65 years) between 2001 and 
2003 were acute myocardial infarction (8.5% of all deaths before the age of 65 years), 
malignant neoplasm of bronchus or lung (7.9%) and chronic ischaemic heart disease 
(6.6%). In Greater Glasgow, however, alcoholic liver disease was the commonest cause of 
premature death (9.0%), followed by malignant neoplasm of bronchus or lung (8.1%). 
Acute myocardial infarction (7.8%) and chronic ischaemic heart disease (6.9%) were the 
third and fourth most common causes. In Bridgeton and Dennistoun (areas of high social 
deprivation within Greater Glasgow), alcoholic liver disease was clearly the most common 
cause of death (13.6%), followed by acute myocardial infarction (7.7%) and chronic 
ischaemic heart disease (7.1%). These figures indicate the emerging importance of alcohol 
(and in particular alcoholic liver disease) as a cause of premature death, especially in more 
deprived areas, and, therefore, as a likely contributor to the widening socioeconomic gap in 
life expectancy. However, even in Bridgeton and Dennistoun (where alcoholic liver 
disease made a particularly marked contribution to premature mortality), coronary heart 
disease caused 14.8% of premature deaths (the combined total of deaths from acute 
myocardial infarction and chronic ischaemic heart disease)3 so it appears highly likely that 
coronary heart disease is a significant (although by no means unique) contributor to the 
socioeconomic gradient in life expectancy. 
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1.2 Cardiovascular risk factors 
 
The currently recognised classic cardiovascular risk factors include the nonmodifiable risk 
factors of age and male sex and the modifiable risk factors of lipids (especially low density 
lipoprotein cholesterol), cigarette smoking, hypertension, diabetes mellitus, obesity and 
physical inactivity.10 In recent years, additional possible risk factors have been identified; 
these “emerging” risk factors include markers of insulin resistance, inflammation, 
endothelial dysfunction and haemostasis.10  
 
1.2.1 Smoking 
 
1.2.1.1 Association of smoking with cardiovascular risk 
 
Ever since Doll’s observations on mortality in British doctors in relation to smoking,11 the 
associations of cigarette smoking with cardiovascular risk have been well documented. The 
relationship between cigarette smoking and ischaemic heart disease is dose dependent,11 is 
demonstrable in both males and females12 and has been confirmed in subsequent studies, 
including the Framingham study13 and the Multiple Risk Factor Intervention Trial 
(MRFIT).14  
   
1.2.1.2 Association of smoking with social deprivation 
 
The association of cigarette smoking with social deprivation is now well recognised. 
Lyratzopoulos and co-workers studied cigarette smoking in a UK context in a primary 
care-based cardiovascular risk factor screening programme involving 33 977 men and     
37 161 women aged between 35 and 60 years. Social deprivation was assessed using the 
Townsend deprivation score, which determines area-level deprivation based on 
unemployment, overcrowding, non-car ownership and non-home ownership. They found 
that for any ordinal increase in deprivation group, odds ratio for current smoking increased 
by 1.24 (95% CI 1.22 to 1.26) in men and 1.26 (95% CI 1.24 to 1.28) in women. At the 
start of their study in 1989, current smoking in the most affluent group was 43.0% for men, 
falling to 24.7% in 1999, a fall of 42.6%. By contrast, in the most deprived group, smoking 
prevalence fell from 65.8% to 59.7% over the same time period, a fall of 9.3%. Similar 
trends were seen in women, with a fall of 60.8% in the most affluent group and 15.6% in 
the most deprived group. Thus, although percentage of current smokers is decreasing 
generally with time, the gap between most and least deprived areas is also widening.15 
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Similar associations between social deprivation and cigarette smoking have been observed 
when individual markers of socioeconomic status such as education,16 occupation17 or 
income18 are used.  
 
In Greater Glasgow, a similar picture is seen, with smoking prevalence in 2001 varying 
from 16% in areas of low social deprivation to 63% in areas of high social deprivation.3 
Subsequent to this, in March 2006 a ban on smoking in enclosed public places was 
introduced in Scotland.19 In an analysis of the ongoing Aspirin for Asymptomatic 
Atherosclerosis (AAA) Trial, an increase was noted in the proportion of smokers stopping 
smoking in the three months prior to the introduction of this legislation. In this study, no 
association was noted between area-level social deprivation and likelihood of stopping 
smoking,20 although it remains to be seen whether a socioeconomic differential in 
likelihood of smoking cessation at the time of introduction of the legislation will be seen 
when statistics from the wider population are analysed.  
 
1.2.2 Lipids 
 
1.2.2.1 Association of lipids with cardiovascular risk 
 
The relationship between serum cholesterol concentration and risk of coronary heart 
disease is well documented. The Multiple Risk Factor Intervention Trial (MRFIT) 
demonstrated, in 356 222 men aged between 35 and 57 years, a continuous and graded 
relationship between serum cholesterol concentration and risk of death from coronary heart 
disease.21 This finding was consistent with findings from the Framingham study, in which 
total22 and low density lipoprotein (LDL)23 cholesterol were found to be associated with 
risk of coronary heart disease. The inverse relationship between high density lipoprotein 
(HDL) cholesterol and coronary heart disease risk is also well documented, with an 
analysis of four prospective studies (Framingham Heart Study, Lipid Research Clinics 
Prevalence Mortality Follow-up Study, Coronary Primary Prevention Trial and Multiple 
Risk Factor Intervention Trial) finding that an increase in HDL cholesterol of 
0.026mmol/L was associated with a 2% decrease in coronary heart disease risk in men and 
3% in women.24 
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1.2.2.2 Association of lipids with social deprivation 
 
Previous studies examining the relationship between total cholesterol and social 
deprivation have yielded varied results. The Whitehall II study, which studied 10 308 civil 
servants (6895 male and 3413 female) between the ages of 35 and 55 years at baseline, 
found no association between socioeconomic status (assessed by occupation) and 
percentage of subjects having serum cholesterol concentration >6.2mmol/L.25 Similarly, 
the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) 
study, which included 22 478 (10 150 male and 12 328 female) participants aged 39 to 79 
years, found no consistent associations between occupational social class (Registrar 
General’s classification) and total serum cholesterol.26 Contrasting findings were reported 
in a study of 2063 individuals aged 23 to 25 years in Brazil, in which lower total and LDL 
cholesterol concentrations were found in more deprived individuals.27 
 
Given the recognised associations between social deprivation and both diabetes mellitus 
(discussed in section 1.2.5) and insulin resistance (see section 1.3.1.1) it would not be 
unexpected for higher concentrations of triglycerides and lower concentrations of high 
density lipoprotein (HDL) cholesterol (both characteristic of insulin resistance) to be found 
in more deprived populations. The English Longitudinal Study of Ageing examined 
concentrations of HDL cholesterol and triglycerides in 4774 participants age 50 years and 
over living in England, relating these to area-level social deprivation. In 52-65 year old 
participants, no associations were observed between deprivation and HDL cholesterol 
concentration, but a significant gradient (p=0.01) was noted in triglyceride concentration, 
with higher concentrations in more deprived groups. In participants over 65 years of age, 
significant associations (both p<0.001) were evident for HDL cholesterol (lower in more 
deprived participants) and triglycerides (higher in more deprived groups). All of the above 
significant associations persisted after additional adjustment for the individual 
socioeconomic indicators of occupational social class, educational attainment and wealth.28 
These findings were broadly consistent with previous findings from the Whitehall II study 
of civil servants, in which significant associations (p=0.0001for the trend in both cases) 
were found between employment grade and both HDL cholesterol (higher concentrations 
in participants of higher employment grade) and triglycerides (higher concentrations in 
participants of lower employment grade). Consistent with these findings, there was a 
strong inverse relationship between employment grade and prevalence of metabolic 
syndrome (defined in this study as having three or more of the following variables in the 
top quintile: 2 hour glucose in oral glucose tolerance test, systolic blood pressure, fasting 
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triglyceride concentration, HDL cholesterol [lowest quintile] and waist: hip ratio).29 The 
findings of the Whitehall II study were, in turn, consistent with earlier findings from the 
Lipid Research Clinics Program, in which HDL cholesterol concentrations were measured 
in 2182 white females and 2368 white males aged 20 to 59 years in nine North American 
populations. When examining HDL cholesterol concentration in relation to educational 
attainment as an individual-level marker of socioeconomic status, HDL cholesterol 
concentration was positively associated with educational attainment in both males and 
females. When genders were analysed separately, the association between educational 
attainment and HDL cholesterol was stronger in females than in males.30 The published 
literature is, therefore, generally consistent in reporting higher triglyceride concentrations 
and lower HDL cholesterol concentrations in more deprived populations. 
 
1.2.3 Physical activity  
 
1.2.3.1 Association of physical activity with cardiovascular risk 
 
It is widely accepted that physical inactivity increases risk of coronary heart disease and 
that, conversely, regular physical activity reduces coronary heart disease risk.10 It is likely 
that this effect is mediated through several mechanisms, with beneficial effects of regular 
physical activity having been demonstrated on HDL cholesterol,31 reduction of insulin 
resistance and risk of developing type 2 diabetes mellitus,32 and lowering of blood 
pressure.33 
 
1.2.3.2 Association of physical activity with social deprivation 
 
An analysis of the 2003 Scottish Health Survey, involving 2346 men and 2941 women 
aged 25 to 64 years, studied the association between lifecourse socioeconomic status 
(indicated by parental occupational social class, participant’s education and occupational 
social class and housing tenure) and physical activity (indicated by occupational activity, 
walking, sport and exercise, housework and manual leisure). In both males and females, a 
significantly higher percentage of most deprived participants were classed as having low or 
no physical activity, compared to least deprived participants.34 These findings are in 
contrast to those reported in the 2002 NHS Greater Glasgow Health/Well-Being Survey, in 
which 53% of least deprived subjects were found to take at least 20 minutes of vigorous 
exercise at least 3 times per week or 30 minutes of moderate exercise at least 5 times per 
week, compared with 59% of most deprived subjects.3 However, this survey mainly 
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focused on leisure time physical activity, and it is known that there are significant 
associations between balance of work and leisure time physical activity and socioeconomic 
status.35 It is likely, therefore, that an assessment which includes work and leisure physical 
activity will give a fuller picture of physical activity than one which assesses only leisure 
time physical activity. 
 
1.2.4 Hypertension  
 
1.2.4.1 Association of blood pressure with cardiovascular risk 
 
Epidemiological studies have consistently shown a continuous association between blood 
pressure and risk of coronary heart disease, with no lower threshold level below which the 
relationship does not hold.36 This association exists in men and women,37 and has been 
demonstrated to exist in various different parts of the world.38 
 
1.2.4.2 Association of blood pressure with social deprivation 
 
Studies examining the relationship between social deprivation and blood pressure have 
yielded fairly consistent results. The Scottish Heart Health study, involving 5123 men and 
5236 women aged between 40 and 59 years, found associations in men between diastolic 
blood pressure and both housing tenure and employment status, and in women with 
occupational social class, housing tenure and level of education.39 Similarly, the Stockport 
Cardiovascular Disease Risk Factor Screening Programme, which studied 33 977 men and 
37 161 women aged between 35 to 60 years, found that for every incremental increase in 
the Townsend area-level deprivation score, systolic blood pressure increased by 0.47 
mmHg in men and 0.56 mmHg in women, and diastolic blood pressure increased by 0.33 
mmHg in men and 0.37 mmHg in women (all p <0.001).15 Consistent with this, an analysis 
of the Whitehall II prospective cohort study, involving 5363 male civil servants aged 40 to 
62 years at baseline, found a significantly higher prevalence of hypertension in men of low 
socioeconomic status, compared with those of intermediate or high socioeconomic status, 
with hypertension being defined as >140/90 mmHg or on antihypertensive medication, and 
socioeconomic status classified according to employment grade.25  
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1.2.5 Association of diabetes mellitus with social deprivation 
 
The relationship between diabetes mellitus and risk of coronary heart disease or stroke has 
been well recognised for many years.40 41 The association between social deprivation and 
diabetes mellitus is also well recognised. Within Greater Glasgow, diabetes prevalence 
rates show significant geographical variation.3 Consistent with this, annual age 
standardised hospitalisation rates for diabetes vary from around 260 per 100 000 
population in the more affluent Anniesland/Bearsden/Milngavie area to 1150 per 100 000 
population in the more deprived Maryhill/Woodside and North Glasgow areas.3 An 
examination of Figure 1.4 also reveals that although hospitalisation rates for diabetes have 
risen in all areas over the period from 1991 to 2002, the rates have risen fastest and to the 
greatest degree in the most deprived areas, leading to a significant widening of the gap 
between the Maryhill/Woodside/North Glasgow and Anniesland/Bearsden/Milngavie 
areas.  
 
Findings from other geographical areas have been consistent with the findings in Greater 
Glasgow. The Whitehall II study found an incidence of diabetes of 6% in participants with 
a high occupational socioeconomic status; 7% in those of intermediate socioeconomic 
status and 11% in those of low socioeconomic status (although diabetes was diagnosed for 
the purposes of this study as fasting glucose >6.1 mmol/L or taking antidiabetic 
medication,25 thus including those who, by World Health Organisation diagnostic criteria, 
had either diabetes or impaired fasting glycaemia).42 Similar findings emerged from a 
study of 13 European countries, with significant inverse associations being found between 
educational attainment and both prevalence of diabetes mellitus and diabetes-related 
mortality.43 Consistent with this, low childhood socioeconomic status has been shown to be 
associated with risk of developing type 2 diabetes in adulthood, especially in females.44 
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Figure 1.4 Average annual age-standardised hospitalisation rates for 
diabetes mellitus in Greater Glasgow from 1991 to 2002 
 
 
 
Maryhill, Woodside and North Glasgow, with the highest hospitalisation rate for diabetes 
mellitus, are areas of relatively high social deprivation; Anniesland, Bearsden and 
Milngavie, with the lowest hospitalisation rate, are areas of low social deprivation.  
NHSHS – National Health Service Health Scotland 
ISD Scotland – Information Services Division Scotland 
From reference 3. Reproduced by kind permission of Glasgow Centre for Population 
Health. 
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1.2.6 Anthropometry  
 
1.2.6.1 Weight / Body Mass Index (BMI) 
 
Body mass index (defined as weight [kg] divided by the square of height [m]) has, for 
many years, been the recognised way of relating an individual’s weight to healthy target 
values.10 The associations of obesity with coronary heart disease and associated factors 
such as dyslipidaemia, hypertension, insulin resistance, endothelial dysfunction, 
inflammation and a prothrombotic state are well recognised.45  
 
1.2.6.2 Waist circumference and waist / hip ratio 
 
It has been recognised for some time that distribution of body fat is associated with 
coronary heart disease risk, with visceral adiposity being particularly indicative of an 
unfavourable risk profile. Insulin resistance, hypertension and dyslipidaemia have all been 
implicated as potential mechanistic links between abdominal obesity and increased 
cardiovascular risk.46 The European Prospective Investigation into Cancer and Nutrition in 
Norfolk (EPIC-Norfolk) cohort study, which included 24 508 participants aged 45 to 79 
years who were followed up for over 9 years, found that in a multivariate model adjusted 
for age, waist circumference, hip circumference and body mass index, a 1SD increase in 
waist circumference or body mass index was associated with an increased risk of coronary 
heart disease, while a 1SD increase in hip circumference was inversely associated with 
coronary heart disease risk (Table 1.2).47 Consistent with this, after adjusting for BMI, age, 
systolic blood pressure, total cholesterol, cigarette smoking, physical activity and alcohol 
intake, it was found that the association with coronary heart disease risk was stronger for 
waist-hip ratio than for waist circumference alone. Men in the top fifth of waist-hip 
distribution had 50% excess risk compared to those in the bottom fifth, compared to 20% 
for waist circumference alone. Women in the top fifth of waist-hip distribution had 90% 
excess coronary heart disease risk compared to those in the bottom fifth, compared to 80% 
for waist circumference.48 
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Table 1.2 Risk for coronary heart disease per 1 SD increase in waist and hip 
circumference and body mass index in men and women 45 to 79 years of 
age in the EPIC-Norfolk study 
 
Hazard ratio for CHD (95% CI) Parameter  
Males (n=11 117) Females (n=13 391) 
Waist circumference 1.21 (1.10 to 1.33)  1.41 (1.25 to 1.59) 
Hip circumference  0.78 (0.72 to 0.84) 0.74 (0.64 to 0.85) 
Body mass index 1.29 (1.18 to 1.42) 1.27 (1.09 to 1.48) 
 
CHD – Coronary heart disease 
Table adapted from reference 47. 
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Given the above evidence, it is logical that waist circumference and waist/hip ratio have 
been incorporated into relevant clinical guidelines. The National Institute for Health and 
Clinical Excellence (NICE) has advised that people with a waist circumference of >94cm 
(males) or >80cm (females) are at increased risk of health problems, and those with a waist 
circumference of >102cm (males) or >88cm (females) are at yet higher risk, even if body 
mass index is within the normal range of 18.5 to 25kg/m2. NICE further advises that 
waist/hip ratio is a useful measure of central adiposity in adults, but is more difficult to 
measure than waist circumference alone.49 Similarly, the National Cholesterol Education 
Program defines abdominal obesity as a waist circumference of greater than 102cm in men 
or 88cm in women.10 
 
1.2.6.3 Association between obesity and social deprivation 
 
The association between area-level social deprivation and obesity was examined in the 
Stockport Cardiovascular Disease Risk Factor Screening Programme. For every 
incremental increase in Townsend deprivation score, Body Mass Index (BMI) increased by 
0.11kg/m2 (95% CI 0.08 to 0.14) in men and by 0.39kg/m2 (95% CI 0.36 to 0.43) in 
women. Between 1989 and 1999, there was a slight reduction in the deprivation inequality 
in BMI in both men and women.15 
 
The finding of higher BMI in individuals from more deprived areas is broadly consistent 
with findings from the Scottish Heart Health Study which examined BMI in relation to 
various markers of individual-level socioeconomic status. Consistent inverse associations 
were noted between BMI and socioeconomic status using occupational, housing tenure or 
educational markers of social class.39 
 
1.2.7 To what extent do classic risk markers explain the deprivation 
gap in cardiovascular risk?  
 
Given the associations detailed above between socioeconomic status and many classic 
cardiovascular risk factors (in particular cigarette smoking, hypertension, diabetes mellitus, 
physical activity and obesity) the next logical question to address is whether these 
differences in risk factors explain the socioeconomic inequality in cardiovascular risk. This 
question was addressed in the EPIC-Norfolk cohort study. Occupational class was 
determined using Registrar General’s social class. When comparing those in the unskilled 
group with those in the professional group, age-adjusted relative risk for cardiovascular 
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disease hospital admissions in the 8902 men studied was 1.90 (95% CI 1.47 to 2.47; 
p<0.001). This relative risk fell to 1.76 (95% CI 1.35 to 2.28; p<0.001) on adjusting for 
smoking, but was essentially unchanged on adjusting in addition for the classic 
cardiovascular risk factors of BMI, systolic blood pressure, total cholesterol and history of 
diabetes (relative risk 1.75; 95% CI 1.34 to 2.27; p<0.001). Furthermore, additional 
adjustment for physical activity, weekly alcohol intake and plasma vitamin C concentration 
had no significant impact (relative risk 1.70; 95% CI 1.31 to 2.22; p<0.001). A similar 
pattern was seen in the 10 652 women studied.26 
 
The Whitehall II study reported similar findings. Assessing socioeconomic status by 
employment grade, the contribution of smoking, hypertension (blood pressure 
>140/90mmHg or on antihypertensive medication), hypercholesterolaemia (total 
cholesterol >6.2mmol/L) and diabetes (defined in this study as fasting glucose >6.1mmol/L 
or on antidiabetic medication) to the socioeconomic gradient in coronary heart disease 
incidence was studied. Compared to the high socioeconomic status group, the low 
socioeconomic status group had a relative risk for coronary heart disease of 1.66 (95% CI 
1.20 to 2.29). Smoking accounted for 18% of this excess risk; hypertension accounted for 
14%; hypercholesterolaemia contributed 3% and diabetes 6%. Taking all four risk factors 
together, only 38% of the excess coronary heart disease risk was explained.25 
 
Findings from the British Regional Heart Study were also similar. In this study of 5628 
British men between the ages of 40 and 59 years, the relative hazard for coronary heart 
disease for manual compared to non-manual occupational social class was 1.50 (95% CI 
1.25 to 1.79). Adjustment for cigarette smoking, systolic blood pressure, total cholesterol, 
BMI, physical activity, alcohol intake and Forced Expiratory Volume in 1 second (FEV1) 
explained 39% of this excess risk.50 Similarly, the US-based Cancer Prevention Studies I 
and II found that the inverse association between educational attainment and coronary 
heart disease risk was only partly explained by adjusting for smoking, BMI, diet, alcohol 
intake, hypertension and menopausal status in women.51 Similar findings had been 
previously reported in the Western Collaborative Group Study.52 
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1.3 Emerging cardiovascular risk markers 
 
Given the fact that classic cardiovascular risk factors only partially explain the 
socioeconomic inequality in cardiovascular risk, the search for explanatory risk factors 
then turns to the more recently identified emerging risk factors.10 Many of these can be 
classified as markers of insulin resistance/adiposity, inflammation, endothelial dysfunction 
or haemostasis. The associations of these emerging risk factors with cardiovascular disease 
and with social deprivation will now be examined. 
 
1.3.1 Markers of insulin resistance/adiposity 
 
The associations of type 2 diabetes mellitus (Section 1.2.5) and obesity (Section 1.2.6) 
with cardiovascular disease and with social deprivation are discussed above. Specific novel 
markers of insulin resistance and/or adiposity will now be examined. 
 
1.3.1.1 Insulin and Homeostasis Model Assessment –  
Insulin Resistance (HOMA-IR) 
 
The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) is calculated from 
fasting plasma glucose and insulin concentrations, using the formula: HOMA-IR = 
Glucose (mmol/L) x Insulin (mU/L) / 22.5, and has been shown to correlate well with 
assessment of insulin resistance by the euglycaemic clamp procedure.53 In view of the 
known associations between social deprivation and type 2 diabetes mellitus, it is not 
surprising that those studies which have specifically studied the association between 
indices of insulin resistance and social deprivation have also reported significant 
associations. 
 
The British Women’s Heart and Health Study examined 4286 women between the ages of 
60 and 79 years. After adjustment for age, HOMA-IR was found to increase by 3.75% per 
quintile increase in Carstairs area-level deprivation score. After additional adjustment for 
individual life-course socioeconomic status, this figure fell to 1.90%, remaining 
statistically significant.54 This study had previously reported associations between adverse 
social circumstances in childhood and later risk of insulin resistance.55  
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1.3.1.2 Adiponectin 
 
Adiponectin, a protein secreted exclusively by adipocytes, is known to have insulin-
sensitising, anti-inflammatory and anti-atherosclerotic effects. Several different multimeric 
forms exist, including homotrimers, hexamers and higher molecular weight forms. 
Adiponectin increases insulin-responsive glucose transport in adipocytes, thus enhancing 
insulin sensitivity. In addition, adiponectin inhibits secretion of several inflammatory 
mediators including interleukins-6 and -8. Low adiponectin concentrations are known to 
predict independently the development of insulin resistance and type 2 diabetes mellitus. 
Recently, evidence has emerged that it is the high molecular weight (HMW) multimeric 
forms of adiponectin that are specifically associated with favourable metabolic effects, 
with the ratio of HMW to total adiponectin correlating with insulin sensitivity in humans.56 
Although the associations between adiponectin and insulin resistance, dyslipidaemia and 
atherosclerosis have been previously studied,57 no studies have been identified that 
examined the association between socioeconomic status and the various forms of 
adiponectin. 
 
1.3.1.3 Leptin 
 
Leptin is a protein secreted by white adipose tissue, and circulating concentrations 
correlate with adiposity. Binding of leptin to its receptor in the hypothalamus activates 
pathways involved in regulation of energy homeostasis, glucose homeostasis and food 
intake. Rare cases of congenital leptin deficiency have been described in humans, with 
resulting marked hyperphagia and obesity, but the vast majority of obese humans have 
elevated leptin concentrations and are relatively resistant to leptin, with the result that 
administration of leptin in pharmacological doses to obese humans does not lead to 
significant weight loss.58 
 
Leptin concentrations were measured in the British Women’s Heart and Health Study and 
related to adult and childhood occupational social class. In this study (somewhat 
surprisingly in view of the known associations between social deprivation and obesity) no 
significant association was found between either childhood or adult social class and leptin 
concentration.59 
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1.3.2 Markers of inflammation  
 
1.3.2.1 C-reactive protein (CRP) 
 
It is now generally accepted that inflammatory pathways have a significant role in the 
process of atherogenesis.60 C-reactive protein, an acute-phase protein released by the liver 
in response to stimulation by interleukin-6 (IL-6), is an easily measured inflammatory 
marker. The Women’s Health Study of 27 939 American women measured both LDL 
cholesterol and CRP. For each increasing quintile of LDL cholesterol concentration, 
relative risks for first cardiovascular event (compared to those in the lowest quintile) were 
0.9, 1.1, 1.3 and 1.5 (p<0.001). However, the relative risks for each increasing quintile of 
CRP were 1.4, 1.6, 2.0 and 2.3 (p<0.001), suggesting that CRP is a stronger predictor of 
cardiovascular risk than LDL cholesterol.61 The Monitoring of Trends and Determinants in 
Cardiovascular Disease (MONICA) Augsburg study of men in southern Germany found 
that in men determined by the Framingham risk score to have a 10 year coronary event risk 
of between 10 and 20%, measurement of CRP improved risk prediction.62 Subsequently, 
the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating 
Rosuvastatin (JUPITER) study tested the hypothesis that people with elevated CRP but 
without elevated LDL cholesterol would benefit from statin treatment. JUPITER 
randomised 17 802 healthy men and women with LDL cholesterol concentrations of less 
than 3.4 mmol/L and CRP concentrations of >2.0 mg/L to either rosuvastatin 20mg daily 
or placebo. The trial was stopped early, with the hazard ratio for first major cardiovascular 
event in the rosuvastatin group being 0.56 compared to the placebo group (p<0.00001). 
 
The association of CRP with social deprivation has been studied in samples from the West 
of Scotland Coronary Prevention Study (WOSCOPS) and the Midspan family study. In 
both studies, a correlation was noted between Carstairs deprivation category and CRP 
concentration (p<0.0001). This association was independent of age, BMI, smoking status 
and prescriptions for angiotensin converting enzyme (ACE) inhibitors, statins and aspirin. 
In the WOSCOPS study, each unit increase in Carstairs deprivation category was 
associated with a 5.4% increase in CRP after adjustment for age, BMI, smoking and the 
above medications.63 
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1.3.2.2 Interleukin-6 (IL-6) 
 
As the main cytokine responsible for stimulating the hepatic acute phase response, the role 
of IL-6 in atherosclerosis is worthy of study. In the Iowa 65+ Rural Health Study, elevated 
IL-6 concentrations were more strongly associated with mortality than were elevated CRP 
concentrations, with the associations of IL-6 and CRP being additive.64 Several 
mechanisms have been suggested by which IL-6 may increase risk of atherosclerosis – 
these include effects on insulin sensitivity; release of adhesion molecules from endothelial 
cells; release of fibrinogen by the liver and procoagulant effects on platelets.65 
 
The association between IL-6 concentrations and social deprivation was studied in a US-
based study of 851 men and women between the ages of 30 and 54 years. Individual-level 
socioeconomic status (measured by income and educational attainment) was inversely 
associated with IL-6 concentrations, as was area-level socioeconomic status. After 
adjustment for lifestyle factors (smoking, alcohol consumption, sleep, exercise, BMI) and 
individual socioeconomic status, the inverse relationship between area-level 
socioeconomic status and IL-6 concentrations persisted. This suggests an effect of area-
level social deprivation on inflammation beyond that captured by the individual-level 
markers of income and educational attainment (although early life markers such as 
childhood overcrowding were not examined). However, the association between 
individual-level socioeconomic status and IL-6 was abolished after adjusting for lifestyle 
factors.66 Similarly, the British Regional Heart Study found a significant inverse 
relationship between occupational social class and IL-6 concentration, with this association 
being reduced (although still statistically significant) after adjusting for age, body mass 
index, smoking, alcohol consumption and physical activity.67 In the Whitehall II Study, the 
longitudinal association between occupational social class and IL-6 concentration was 
examined, with the conclusion that a steep socioeconomic gradient in IL-6 persisted over 
the 12 year study period, with no strong evidence of an interaction between socioeconomic 
status and rate of increase in IL-6 concentrations over this time period.68 
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1.3.3 Markers of endothelial dysfunction  
 
1.3.3.1 Soluble intercellular adhesion molecule-1 (sICAM-1) 
 
The role of endothelial dysfunction in atherosclerosis is now well recognised.69 Soluble 
intercellular adhesion molecule-1 (sICAM-1) is a circulating form of ICAM-1. ICAM-1 is 
present on endothelial cells, and is involved in facilitating leukocyte adhesion and 
migration across the endothelium. Release of sICAM-1 is stimulated by several mediators, 
including IL-6. sICAM-1 concentrations are elevated in association with hypertension, 
with insulin resistance and with cigarette smoking, and have been found to be higher in 
people with unstable angina pectoris when compared to people with stable angina and 
healthy controls. Furthermore, elevated sICAM-1 is predictive of risk of developing 
myocardial infarction, leading to recognition of sICAM-1 as an emerging cardiovascular 
risk factor.70 
 
The association between socioeconomic status and sICAM-1 concentration was examined 
in the US-based Women’s Health Study. In this study, sICAM-1 concentrations decreased 
progressively with increasing categories of education and income.71 Similarly, the 
Framingham Offspring Study found a significant inverse association between educational 
attainment and sICAM-1 concentration (p<0.0001), with the association persisting after 
adjusting for age, sex, smoking, blood pressure, total to high density lipoprotein cholesterol 
ratio, BMI, lipid-lowering and antihypertensive medication, prevalent cardiovascular 
disease and depression.72 
 
1.3.4 Markers of haemostasis  
 
1.3.4.1 Von Willebrand factor (vWF) 
 
Von Willebrand factor (vWF), produced by endothelial cells, has a role in platelet adhesion 
and aggregation, and also functions as a carrier protein and stabiliser for clotting factor 
VIII. Given its production by endothelial cells and its functions in haemostasis, it can 
legitimately be viewed as both a marker of endothelial dysfunction and of haemostasis. 
The ability of vWF concentrations to predict risk of future coronary heart disease has been 
examined in several studies, with odds ratio for coronary heart disease in highest versus 
lowest quartile of vWF ranging from 1.23 to 3. The consensus is that vWF is at best 
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weakly predictive of future coronary heart disease in initially healthy people, although it 
becomes a much stronger predictor in patients with existing vascular disease.73 
 
1.3.4.2 Fibrinogen 
 
Fibrinogen, the most abundant coagulation protein in blood, has major effects on 
coagulation, blood viscosity and platelet aggregation. A meta-analysis of 31 prospective 
studies involving 154 211 participants found an approximately log-linear association 
between fibrinogen concentration and coronary heart disease risk. Per 1g/L increase in 
fibrinogen concentration, age- and sex- adjusted hazard ratio for coronary heart disease 
was 2.42 (95% CI 2.24 to 2.60), falling to 1.93 (95% CI 1.79 to 2.08) after adjustment for 
smoking, total cholesterol, systolic blood pressure and BMI. In a subset of participants 
with available C-reactive protein results, further adjustment for C-reactive protein had no 
significant impact on the results.74 
 
1.3.4.3 Fibrin D-dimer 
 
Fibrin D-dimer is a marker of fibrin turnover, being present in several fibrin degradation 
products. The association between D-dimer concentrations and coronary heart disease risk 
was studied prospectively in the British Regional Heart Study. Men in the top third of D-
dimer concentrations had an odds ratio for coronary heart disease of 1.67 (95% CI 1.31 to 
2.13) after adjusting for age and town of residence. Further adjustment for smoking, blood 
pressure, total and HDL cholesterol, triglycerides, BMI and individual socioeconomic 
status had no significant impact (adjusted odds ratio 1.79 [95% CI 1.36 to 2.36]). A meta-
analysis of six previous population-based prospective studies yielded a very similar odds 
ratio of 1.7 (95% CI 1.3 to 2.2).75 
 
1.3.4.4 Tissue plasminogen activator (tPA) 
 
Tissue plasminogen activator (tPA) is responsible for activating clot dissolution, and is 
produced by vascular endothelial cells. tPA antigen is more easily measured in plasma than 
free active tPA, and is a marker of complex formation between tPA and its inhibitor, 
plasminogen activator inhibitor-1 (PAI-1). tPA antigen was measured in the British 
Regional Heart Study. The odds ratio for coronary heart disease in top versus bottom third 
of tPA antigen concentrations was 2.20 (95% CI 1.70 to 2.85) after adjusting for age and 
town of residence. After further adjustment for smoking, total and HDL cholesterol, 
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triglycerides, BMI, blood pressure and physical activity, this odds ratio fell to 1.60 (95% 
CI 1.20 to 2.13). A meta-analysis of 12 prospective studies revealed similar results, with an 
odds ratio of 2.18 (95% CI 1.77 to 2.69) after adjusting for age and sex, falling to 1.47 
(95% CI 1.19 to 1.81) after additional adjustment for classic cardiovascular risk factors.76 
 
1.3.4.5 Association of markers of haemostasis with socioeconomic 
status 
 
The associations between social deprivation and markers of haemostasis have previously 
been investigated. An analysis of the 1958 British Birth Cohort found higher 
concentrations of fibrinogen, von Willebrand factor antigen and tissue plasminogen 
activator antigen in individuals with higher cumulative lifecourse levels of social 
deprivation. After adjustment for body mass index, smoking and physical activity, the 
trend for fibrinogen remained significant.77 Similarly, the British Regional Heart Study 
found that in British men aged 60 to 79 years with no diagnosis of cardiovascular disease, 
diabetes or musculoskeletal disease requiring anti-inflammatory medication, occupational 
social class was inversely associated with fibrinogen, von Willebrand factor and fibrin D-
dimer, but not tPA antigen. The association with von Willebrand factor persisted after 
adjustment for age, BMI, smoking, alcohol consumption and physical activity.67 
 
1.3.5 To what extent do emerging risk markers explain the deprivation 
gap in cardiovascular risk?  
 
Given the associations between socioeconomic status and many emerging cardiovascular 
risk markers, and given the failure of differences in classic cardiovascular risk factors to 
explain the totality of the socioeconomic gradient in cardiovascular risk, it is logical to ask 
if these emerging risk markers can contribute anything to the explanation. This question 
was addressed to some extent in the US-based Women’s Health Study. Using the 
individual-level socioeconomic indicators of education and income, emerging biomarkers 
examined included C-reactive protein, sICAM-1 and fibrinogen. The primary outcome was 
a combined endpoint including non-fatal myocardial infarction, non-fatal ischaemic stroke, 
cardiovascular death and coronary revascularisation procedures. For increasing education 
categories, age- and ethnicity-adjusted relative risks for the primary cardiovascular 
endpoint were 1.0, 0.7, 0.5, 0.4 and 0.5. Adjusting for classical cardiovascular risk factors 
reduced the differences to some extent (without loss of statistical significance). Further 
adjustment for emerging risk markers had no significant impact. Use of household income 
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instead of education as the marker of socioeconomic status yielded very similar results 
(Table 1.3).71 This study indicates that CRP, sICAM-1 and fibrinogen – despite their 
associations with cardiovascular risk and with social deprivation – do not contribute 
significantly to the explanation of the socioeconomic gradient in cardiovascular risk. As 
discussed above, however, many other biomarkers have now emerged whose contribution 
to the explanation could be tested in a similar way. 
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Table 1.3 Contribution of classic and emerging cardiovascular risk factors to 
the socioeconomic gradient in cardiovascular risk 
 
Category n RR (age and ethnicity 
adjusted) 
RR (classic risk factor 
adjusted) 
RR (classic and 
emerging risk factor 
adjusted) 
Education     
<2 y health professional 
education 
2771 1.0 1.0 1.0 
2-<4 y health 
professional education 
9726 0.7 (0.5-0.8) 0.8 (0.7-1.0) 0.8 (0.7-1.0) 
Bachelor’s degree 5422 0.5 (0.4-0.7) 0.7 (0.5-0.9) 0.7 (0.5-0.9) 
Master’s degree 3502 0.4 (0.3-0.6) 0.6 (0.5-0.9) 0.6 (0.5-0.9) 
PhD/MD 1267 0.5 (0.3-0.7) 0.8 (0.5-1.2) 0.8 (0.5-1.2) 
P for trend  <0.001 0.006 0.006 
Annual household 
income (US $) 
    
<19 999 1143 1.0 1.0 1.0 
20 000-29 999 2184 1.0 (0.8-1.4) 1.2 (0.9-1.7) 1.2 (0.9-1.7) 
30 000-39 999 3139 0.9 (0.6-1.2) 1.1 (0.8-1.5) 1.1 (0.8-1.5) 
40 000-49 999 3753 0.7 (0.5-0.9) 0.9 (0.7-1.3) 0.9 (0.7-1.3) 
50 000-99 999 9426 0.7 (0.5-0.9) 1.0 (0.7-1.3) 1.0 (0.7-1.3) 
>100 000 3043 0.4 (0.3-0.7) 0.8 (0.5-1.2) 0.8 (0.5-1.2) 
P for trend  <0.001 0.09 0.08 
 
From reference 71.  
RR: relative risk (with 95% confidence intervals) 
Classic risk factor adjustment: adjusted for age, ethnicity, BMI, smoking, hypertension, diabetes, LDL and HDL cholesterol, 
triglycerides, hormone use, family history of myocardial infarction before 60 years of age, alcohol intake and physical activity 
Classic and emerging risk factor adjustment: as classic risk factor adjustment + CRP, sICAM-1, fibrinogen and homocysteine 
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1.4 Carotid ultrasound markers of atherosclerosis 
 
1.4.1 Carotid intima-media thickness (cIMT) – association with risk of 
MI/stroke 
 
In recent years, carotid ultrasound has emerged as an efficient and validated surrogate 
marker for assessing the degree of atherosclerosis in an individual. Measurement of the 
distal common carotid artery intima-media thickness (cIMT) is a commonly employed 
index (Figure 1.5). The American Society of Echocardiography (ASE) has recognised a 
clinical role for cIMT measurement and plaque detection in refining cardiovascular risk 
assessment in asymptomatic patients assessed as being at intermediate risk of coronary 
heart disease, defined as 6-20% 10 year risk of myocardial infarction or coronary heart 
disease death. The ASE recommendation is that people with carotid plaque, or with cIMT 
greater than or equal to the 75th centile for an age, sex and ethnicity matched population 
should be considered to be at increased risk, and may warrant more aggressive treatment of 
risk factors.78 
 
The utility of cIMT in predicting risk of myocardial infarction and stroke was assessed in a 
recent meta-analysis. Based on 8 prospective observational studies involving 37 197 
subjects with ages ranging from 19 to 90 years, the age-and-sex-adjusted relative risk for 
myocardial infarction was found to be 1.26 (95% confidence intervals 1.21 to 1.30) for 
every 1 standard deviation increase in cIMT and 1.15 (95% confidence intervals 1.12 to 
1.17) for every 0.10mm increase in cIMT. For stroke, the age-and-sex-adjusted relative 
risk was 1.32 (95% confidence intervals 1.27 to 1.38) per 1 standard deviation increase in 
cIMT and 1.18 (95% confidence intervals 1.16 to 1.21) for every 0.10mm increase in 
cIMT.79  
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Figure 1.5 Ultrasound assessment of common carotid intima-media 
thickness 
 
A. Schematic diagram of distal common carotid artery 
 
 
B. Ultrasound image of distal common carotid artery 
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1.4.2 Carotid plaque - association with risk of MI/stroke  
 
As well as allowing measurement of cIMT, carotid ultrasound can be used to identify 
carotid plaque80 – indeed given current understanding of the process of atherogenesis, 
plaque presence is a more mechanistically plausible marker of atherosclerosis than is 
cIMT. Plaque score has been shown to be associated with risk of myocardial infarction81-83 
and stroke.84 In the Rotterdam study, hazard ratio for myocardial infarction was 1.83 (95% 
confidence intervals 1.27 to 2.62) for plaque score of >3 versus 081 and age-and-sex-
adjusted relative risk for stroke was 1.61 (95% confidence interval 1.16–2.23) for highest 
to lowest tertile of plaque score.84  
 
Several studies have examined the comparative usefulness of cIMT and plaque score in 
predicting myocardial infarction and stroke. The Rotterdam study found carotid plaque 
score and cIMT to be equally strong predictors of myocardial infarction. The hazard ratio 
for myocardial infarction was 1.95 (95% CI 1.19 to 3.19) for highest to lowest quartile of 
cIMT and 1.83 (95% CI 1.27 to 2.62) for highest to lowest category of plaque score.81 
Interestingly, cIMT was a stronger predictor of stroke than was presence of plaque (age- 
and sex-adjusted relative risk of stroke for highest to lowest tertile of cIMT 2.23 [95% CI 
1.48 to 3.36]; for highest to lowest tertile of plaque score 1.61 [1.16 to 2.23]),84 although in 
elderly males, plaque burden has been found to be a more consistently strong predictor 
than cIMT of cardiovascular and all-cause mortality.85 Similarly, a study of 13 221 low 
risk, healthy individuals in Italy found plaque presence to be more strongly predictive than 
cIMT of future cardiovascular events.86 Plaque presence was also found in the Kuopio 
Ischaemic Heart Disease Risk Factor Study to be a stronger predictor than cIMT of acute 
myocardial infarction.87 Similarly, the Tromso Study found carotid plaque area to be a 
stronger predictor than cIMT of first myocardial infarction, particularly in women.82 
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1.4.3 Association between social deprivation and cIMT/carotid plaque  
 
Several studies have examined the relationship between socioeconomic status and 
ultrasound markers of atherosclerosis. Most have examined individual-level measures of 
socioeconomic position in relation to carotid intima-media thickness (cIMT). The 
Atherosclerosis Risk in Communities (ARIC) study found that cIMT fell significantly with 
increasing categories of income, educational attainment or occupation.88 Very similar 
results were obtained in the Kuopio Ischaemic Heart Disease study of Finnish men aged 42 
to 60 years,89 in which significant inverse differences in rate of progression of cIMT were 
also noted in relation to both income and educational attainment.90 The effect of childhood 
socioeconomic status (assessed by parental occupational social class) on cIMT was studied 
in the Young Finns study, with no association being found between childhood 
socioeconomic status and cIMT after adjusting for adult socioeconomic status.91 
 
Rosvall et al studied a population-based sample of 4033 individuals, finding significant 
associations between area-based indicators of social deprivation and carotid plaque score, 
with these associations only slightly reduced on adjusting for the individual level markers 
of education, employment status and occupational social class.92 Similarly, a study of 
untreated hypertensive men in Pittsburgh, USA, found inverse associations between 
community socioeconomic status and both cIMT and carotid plaque occurrence. The 
association with plaque occurrence persisted after adjusting for the individual-level 
markers of education and annual income.93 
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1.5 Carotid ultrasound markers of arterial stiffness 
 
Traditionally, systolic and diastolic blood pressure have been the main targets for blood 
pressure control in clinical practice. However, in an analysis of data from the Framingham 
Heart Study, pulse pressure was found, in subjects between 50 and 79 years of age, to be a 
stronger predictor of coronary heart disease than either systolic or diastolic blood 
pressure.94 The significance of this finding is that, in people within this age bracket and 
older, the major determinant of pulse pressure is large artery stiffness, suggesting possible 
benefit in measuring arterial stiffness.95 Several non-invasive methods of assessing arterial 
stiffness have been developed, of which the most commonly used are assessment of pulse 
wave velocity, M-mode ultrasound assessment of changes in artery diameter which can 
then be related to pulse pressure, and pulse waveform analysis. 
 
1.5.1 Pulse wave velocity 
 
Arterial pulse wave velocity (PWV) increases with increasing arterial stiffness, and is an 
independent predictor of cardiovascular events. PWV is measured by recording an arterial 
pulse wave at a proximal artery such as the common carotid, and at a more distal artery 
such as the femoral. The time delay between the arrival of a predefined part of the pulse 
wave at the two selected points is measured, and PWV is calculated as distance travelled / 
time.95 Raised PWV has been noted to be associated with a range of recognised 
cardiovascular risk factors96 including age,97 hypercholesterolaemia,98 type 2 diabetes 
mellitus99 and sedentary lifestyle.97 
 
1.5.2 M-mode ultrasound assessment  
 
Parameters of arterial stiffness can be assessed using measurements obtained by M- 
(movement) mode ultrasound. Changes in arterial wall diameter are related to pulse 
pressure, allowing calculation of a range of parameters of arterial stiffness, including 
compliance, distensibility, Petersen elasticity modulus and stiffness.95 In the Rotterdam 
Study, ultrasound was used to assess common carotid artery distensibility. An inverse 
association was found between distensibility and atherosclerosis as assessed by carotid 
intima-media thickness, severity of carotid artery plaques and severity of aortic plaques.100 
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1.5.3 Pulse waveform analysis 
 
Radial artery waveforms can be analysed non-invasively by applanation tonometry, with 
the waveform being calibrated to conventionally measured brachial blood pressure. Central 
aortic waveforms can be derived from the peripheral waveforms, and from the central 
aortic waveform an augmentation index can be calculated. The augmentation index is the 
proportion of central pulse pressure that results from arterial wave reflection, and gives a 
measure of arterial stiffness.95 The augmentation index has been found to increase with 
age101 and is also higher in patients with type 1 diabetes102 and in hypercholesterolaemia.103 
 
1.5.4 Associations between markers of arterial stiffness and risk of 
myocardial infarction (MI)/stroke 
 
The Rotterdam population-based study related carotid-femoral PWV and common carotid 
artery distensibility to ultrasound indicators of atherosclerosis (cIMT, carotid artery plaque 
and abdominal aorta calcified plaques). Significant increases in PWV were noted with 
increasing quartiles of cIMT and with increasing categories of carotid or aortic plaque. 
Similarly, common carotid distensibility decreased with increasing quartiles of cIMT and 
with increasing categories of carotid or aortic plaque. These associations persisted after 
adjustment for age, sex, mean arterial pressure, heart rate, total and HDL cholesterol, 
glucose, smoking, BMI and presence of diabetes mellitus. The authors suggested possible 
explanations for these associations, including the possibility that atherosclerosis leads to 
arterial stiffening, or that increased arterial stiffness leads to vessel wall damage and 
atherosclerosis, or indeed that arterial stiffness and atherosclerosis are independent 
processes that frequently occur at similar sites without a causal relationship existing 
between the two processes.100 The relationships between arterial stiffness and 
cardiovascular and all-cause mortality have also been investigated, with carotid-femoral 
PWV being an independent predictor of cardiovascular and all-cause mortality in 
hypertensive patients; aortic PWV and carotid artery stiffness being predictive of mortality 
in patients with end-stage renal failure and lower carotid artery distensibility being 
predictive of cardiovascular events after renal transplantation.95 
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1.5.5 Associations between social deprivation and markers of arterial 
stiffness 
 
The association between educational attainment and arterial stiffness (assessed by pulsatile 
arterial diameter change) was examined in 10 091 participants aged 45 to 64 years in the 
Atherosclerosis Risk in Communities study. A direct association was observed between 
educational attainment and arterial diameter change, i.e. lower educational attainment was 
associated with stiffer arteries. This association persisted after adjusting for age, height, 
diastolic diameter, systolic blood pressure, pulse pressure, ethnicity, gender and smoking 
status.104 More recently, a study of Japanese civil servants found significant inverse 
associations in men between brachial-ankle PWV and both educational attainment and 
employment grade, with these associations persisting after adjusting for age, BMI, 
smoking, alcohol consumption, exercise, medication for hypertension, hyperlipidaemia and 
diabetes, heart rate, systolic blood pressure, total and HDL cholesterol, triglycerides and 
CRP.105 Interestingly, a recently published study in adolescents living in the USA found 
associations between PWV and both parental educational attainment and family income, 
despite no associations being found between these markers of socioeconomic status and 
cIMT.106 It is clearly interesting to find differences in arterial stiffness emerging at such a 
young age (mean age was 17.8 years) and before differences can be identified in cIMT. 
This finding may lend support to the hypothesis that changes in arterial stiffness precede 
development of atherosclerosis in individuals. 
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1.6 Mental wellbeing, social deprivation and associations with 
cardiovascular risk  
 
The detrimental effects of social deprivation on physical health have been extensively 
described, with the discussion above focussing on the effects on cardiovascular disease. 
However, it is increasingly being recognised that deprivation has associations also with 
psychological wellbeing. If psychiatric hospital admission is taken as a crude indicator of 
lack of mental wellbeing, the relationship between social deprivation and psychiatric 
illness is demonstrated in Figure 1.6, which shows that the rate of first psychiatric hospital 
admissions in Maryhill/Woodside and North Glasgow is over three times that in Eastwood, 
both areas being part of the Greater Glasgow area.3 
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Figure 1.6 First psychiatric hospital admissions in relation to social 
deprivation in West of Scotland and Greater Glasgow communities 
 
 
 
Areas in dark red are within Greater Glasgow; areas in light blue are other West of 
Scotland council areas. Within Greater Glasgow, rate of first psychiatric hospital 
admissions is lowest in Eastwood (an area of low social deprivation) and highest in 
Maryhill, Woodside and North Glasgow (areas of high social deprivation).  
From reference 3, reproduced by kind permission of Glasgow Centre for Population Health. 
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1.6.1 Associations between psychological parameters, social 
deprivation and cardiovascular risk 
 
There are recognised associations between lower socioeconomic status and work stress, 
and between work stress and coronary heart disease, with the majority of studies in the 
field showing an independent association between work stress and coronary heart disease, 
suggesting the possibility of a causal relationship. Similarly, the majority of prospective 
studies have found an association between depression and risk of coronary heart disease, 
with depression overall conveying an approximately twofold increased risk of developing 
coronary heart disease, and a dose-effect relationship existing. Suggested mechanisms 
include depression promoting an inflammatory state, which in turn promotes 
atherosclerosis; both depression and coronary heart disease being products of widespread 
atherosclerosis; both depression and coronary heart disease arising from chronic 
environmental stress or depression leading to the adoption of harmful behaviours such as 
smoking, poor diet and lack of exercise, which in turn lead to atherosclerosis. Other 
potential mechanistic links between psychological parameters and coronary heart disease 
include: cortisol excess, which has been demonstrated in depression, work stress and 
hostility, and also in men of lower socioeconomic status; endothelial dysfunction, as 
brachial flow-mediated dilatation is impaired in depression, and sICAM-1 is higher; and 
platelet activation, which is increased in depression and in men of lower socioeconomic 
status. Hopelessness, anxiety and anger have also been linked to coronary heart disease.107 
 
The associations between these psychological parameters, deprivation and risk of coronary 
heart disease have potential implications for public health programmes aiming to narrow 
the deprivation gap in health and life expectancy. There is a clear socioeconomic 
differential in acceptance of many aspects of health promotion advice, with those in areas 
of high deprivation being less likely to accept such advice. It is quite plausible that features 
such as depression and hopelessness may affect an individual’s ability to respond to public 
health messages advising them to modify aspects of their lifestyle, which may partly 
explain why current attempts to narrow the deprivation gap are not being successful – in 
fact, as discussed above, the gap is widening. 
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1.6.2 Associations between cognitive function, social deprivation and 
cardiovascular risk 
 
The associations between socioeconomic status and cognitive function were investigated in 
10,308 civil servants aged 35 to 55 years in the Whitehall II study. Verbal memory, 
inductive reasoning, vocabulary and verbal fluency were assessed and related to lifecourse 
socioeconomic status. The findings suggested that while childhood socioeconomic status 
did not have a direct effect on cognitive function, there was evidence of a substantial 
indirect effect mediated through education and adult socioeconomic status.108  
 
Hart et al linked data from the Midspan studies with the Scottish Mental Survey and found 
that childhood intelligence quotient (IQ) was inversely associated with all-cause and 
coronary heart disease mortality, both with and without adjustment for area-level 
deprivation, with the association between childhood IQ and all-cause mortality also 
remaining after adjusting for occupational social class.109 The hypothesis that differences 
in IQ explain the deprivation gradient in ill health was further explored in the west of 
Scotland twenty-07 study. Coronary heart disease mortality was examined in relation to 
individual and area markers of social deprivation. Significant associations with coronary 
heart disease mortality were noted for childhood social class, income and Carstairs 
deprivation score. Adjustment for IQ reduced but did not abolish these associations, 
suggesting that IQ does not fully explain the socioeconomic gradient in coronary heart 
disease risk.110 
 
1.7 Methods of assessing social deprivation  
 
From the literature discussed above, it is clear that there are many different parameters by 
which social deprivation can be assessed and described. These parameters can be divided 
into area-based indicators of deprivation and individual-level indicators of socioeconomic 
status. These indicators will now be described in more detail. It is necessary first of all to 
define what is meant by deprivation. Townsend has defined deprivation as follows: 
“People are relatively deprived if they cannot obtain, at all or sufficiently, the 
conditions of life – that is, the diets, amenities, standards and services – which allow 
them to play the roles, participate in the relationships and follow the customary 
behaviour which is expected of them by virtue of their membership of society. If they 
lack or are denied resources to obtain access to these conditions of life and so fulfil 
membership of society, they may be said to be in poverty.”111 
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The emphasis of deprivation as a relative concept, in which individuals may be described 
as deprived if they lack the resources needed for them to function according to the norms 
of the society in which they live, is also a feature of the definition used in a report to the 
Scottish Executive by Bailey et al in 2003, in which the term ‘deprivation’ is noted for its 
focus on: 
“…the lack of goods, services or social relations or inadequate physical or social 
environment which results from a lack of financial resources. It is a relative measure 
where standards are defined in relation to social norms or expectations.”112 
 
1.7.1 Area-based measures of deprivation 
 
Area-level indicators of socioeconomic status generally take into account a variety of 
parameters by which the relative deprivation of a community can be described. The 
Scottish Index of Multiple Deprivation (SIMD) 2009 uses 38 indicators in seven domains: 
current income; employment; health; education, skills and training; geographic access to 
services; housing and crime.113 Areas are divided into data zones, which are small areas 
with a population of 500 to 1000 household residents. The data zones (6505 in total) are 
then ranked according to relative deprivation.114  
 
1.7.2 Individual-level measures of deprivation 
 
Individual measures of deprivation capture a range of information about each individual’s 
material and social circumstances – e.g. household income or occupational social class, 
with the information largely being derived from household surveys. The extent to which 
such measures can be obtained is, therefore, limited by the practicalities of surveying large 
numbers of people, a potentially time-consuming and labour-intensive process.112 
 
It is generally accepted that area-based and individual-level measures of deprivation serve 
different purposes, yielding different, but complementary, information. Individual-level 
measures provide a direct indication of the living standards experienced by each person 
living in an area, thus providing an indication of the number of people within an area who 
are living in conditions of deprivation. It is, therefore, possible to track changes in levels of 
deprivation over time. By contrast, area-based measures of deprivation give an indication 
of the characteristics of the area, and thus cannot be used to determine the number of 
individuals in a given area who are living in conditions of deprivation. Furthermore, as 
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area-based measures rank areas in terms of deprivation in relation to each other, it is not 
possible to use such measures to compare absolute changes in levels of deprivation over 
time.112 
 
1.8 Aims of thesis 
 
The overall aim of the work described in this thesis was to enhance current understanding 
of the factors underlying the socioeconomic gradient in ill health. In particular, this thesis 
focuses on the association between social deprivation and risk of coronary heart disease. 
Building on the observations that classic cardiovascular risk factors explain only part of the 
socioeconomic gradient in coronary heart disease risk, a key aim of the work described 
here was to determine the extent to which emerging cardiovascular risk factors contribute 
to the explanation of the socioeconomic gradient in coronary heart disease. Given the 
known involvement of inflammatory pathways in atherosclerosis and the known 
associations between deprivation and markers of inflammation, a prespecified hypothesis 
was that inflammation would explain the deprivation-based gap in coronary heart disease 
risk (as indicated by the surrogate ultrasound markers of intima-media thickness and 
plaque score). 
 
As discussed above, it is now being recognised that the effects of inflammation may extend 
to effects on cognition and personality, and that there are recognised associations between 
some of these psychological parameters and coronary heart disease risk. A further aim of 
this work was, therefore, to further understanding of the associations between social 
deprivation and markers of cognition and personality.  
 
In summary, therefore, the research questions addressed were: 
1) Do deprived sections of the community display increased prevalence of central obesity, 
insulin resistance and chronic inflammation compared to affluent sections? 
2) Is sub-clinical atherosclerosis (as detected by carotid ultrasound) more prevalent in 
deprived groups? To what extent is the prevalence explained by classic risk factors 
(smoking, blood pressure, cholesterol) and to what extent is it related to emerging risk 
factors? 
3) Do deprived groups differ from affluent ones in psychological profile (affective state 
and cognition)? What are the implications of any such differences for public health 
strategies aiming to narrow the deprivation gap in health? 
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CHAPTER 2 – METHODS 
 
2.1 Identification of potential participants 
 
Potential subjects for the Psychological, Social and Biological Determinants of Ill Health 
(pSoBid) study were identified on the basis of the Scottish Index for Multiple Deprivation 
(SIMD) 2004,115 which ranks small areas on the basis of multiple deprivation indicators. 
The six domains of multiple deprivation indicators used in SIMD 2004 were: income (e.g. 
number of adults and children in households receiving Income Support); employment (e.g. 
unemployment claimant count average over 12 months, number of working age Incapacity 
Benefit recipients); health (e.g. number of hospital episodes related to alcohol use and drug 
use, number of hospital emergency admissions); education, skills and training (e.g. number 
of working age people with no qualifications, number of school leavers age 16 years and 
over not in education); geographic access and telecommunications (e.g. drive time access 
to General Practitioner, supermarket and primary school) and housing (e.g. number of 
persons in households which are overcrowded, number of persons in households which are 
without central heating). Using SIMD 2004, the least and most deprived areas in the 
Greater Glasgow Health Board area were identified. At the start of the study, 31.4% of the 
Glasgow population were in the bottom 5% of the SIMD classification and 6% were in the 
top 20% of the SIMD classification. In order for the population composition of Greater 
Glasgow to be reflected in the study population, and to provide sufficient numbers of 
participants from each end of the deprivation continuum for valid comparisons to be made, 
the decision was made to study participants living in areas classified as being in the bottom 
5% (most deprived) of SIMD areas, and in the top 20% (least deprived). 
 
Five general practices with the highest percentage of patients aged 35-64 years living in 
areas classified as being in the bottom 5% of SIMD were approached and all agreed to 
participate in the recruitment process. A further five practices with the highest percentage 
of patients aged 35-64 years living in areas classified as being in the top 20% of SIMD also 
agreed to participate. The Health Information and Technology section of Greater Glasgow 
Health Board generated a target population of 21 672 people from the practice lists of these 
ten practices. From this target population, 12 groups of 300 participants were selected 
according to strata defined by the combination of home address SIMD classification, 
gender and age group (35 to 44, 45 to 54 and 55 to 64 years), giving a total sampling frame 
of 3600 subjects. As the sampling frame was constructed from general practice lists, this 
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included individuals regardless of whether or not they actually visited their general 
practitioner. 
 
2.2 Power calculation 
 
Sample size in the least deprived and most deprived groups was estimated on the 
assumption that 90% of participants would attend both study visits and have C-reactive 
protein measured and that a maximum of 10% would not have a carotid ultrasound scan of 
satisfactory quality for measurement of carotid intima-media thickness. The power 
calculations were based on perceived clinically meaningful differences and assumed a 
1.1mg/L standard deviation for the natural logarithm of C-reactive protein 
measurements116 and a 0.163mm standard deviation for carotid intima-media thickness.117 
Power calculations indicated that a sample size of 350 per group (most deprived and least 
deprived) would provide 84% power to detect a 30% difference in mean C-reactive protein 
concentration and 82% power to detect a 0.04mm difference in mean carotid intima-media 
thickness. 
 
2.3 Ethical approval 
 
The study was approved by the Glasgow Royal Infirmary Research Ethics committee. All 
participants gave written informed consent. 
 
2.4 Recruitment and response rates  
 
Letters inviting potential subjects to participate were sent in batches of 150 every two 
weeks. Accompanying the letter was a form for the subject to return (in a reply paid 
envelope) recording their contact details and indicating their willingness to consider 
participation. Subjects who agreed to receive further information about the study were sent 
the pSoBid participant information booklet (Appendix 1). If there was no response after 
two weeks, a reminder was sent. The Research Nurse contacted those who received the 
participant information booklet, and if after reading the information booklet they decided 
to participate in the study, they were invited to come for the first visit at their General 
Practitioner’s premises on a mutually agreed day and time. This process continued until 
approximately equal numbers for the 12 groups were recruited. 
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Figure 2.1 shows the recruitment flowchart for the study. Of the original sampling frame 
of 3600 potential subjects (1800 least deprived and 1800 most deprived), 1008 least 
deprived were invited to participate. (Not all of the 1800 subjects were contacted as 
recruitment targets had been met.) By contrast, 1704 most deprived subjects were invited 
to participate in order to meet recruitment targets. The only exclusion criteria for the study 
were having a terminal illness or an inability to understand the English language (due to 
the nature of the psychological questionnaires and cognitive assessments). General 
Practitioners were able to exclude subjects from the sample who were recently deceased or 
had a terminal illness. 
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Figure 2.1 Recruitment flowchart for the pSoBid study 
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Overall, 2712 invitations to participate were issued, with 700 participants completing study 
visit 1, giving an overall response rate of 25.8%. The response rates of different groups are 
shown in Table 2.1. This shows that the least deprived group (those who attended at least 
study visit 1) comprised 176 males and 178 females, while the most deprived group 
consisted of 165 males and 181 females. For the least deprived group as a whole, response 
rate was 35.1%, and for the most deprived group 20.3%. When examining each of the 12 
groups stratified by deprivation (most/least deprived), gender and age (35-44 years, 45-54 
years and 55-64 years), response rate varied from 14.1% in most deprived males age 35-44 
years, to 52.9% in least deprived males age 55-64 years. In general, response rates were 
higher in older age groups, and in the least deprived group. The vast majority of 
participants were born in the United Kingdom or Republic of Ireland, with only 19 
participants (2.7%) being born outside of these countries (14 from the least deprived group 
and 5 from the most deprived group). 
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Table 2.1 Response rates in the groups invited to participate in the pSoBid 
study 
 
 
 
 63 
2.5 Study protocol 
 
Participant visits were conducted between December 2005 and May 2007, with 
participants attending for two visits, generally around two weeks apart. In visit 1, subjects 
completed lifestyle and psychology questionnaires, and underwent measurement of blood 
pressure, heart rate, hip, waist and mid-thigh circumference and assessment of lung 
function (Forced Expiratory Volume in 1 second [FEV1] and Forced Vital Capacity 
[FVC]. For visit 2, participants attended fasting for blood to be taken for biochemical 
analyses. Height and weight were measured. After being provided with breakfast, subjects 
completed psychological and cognitive tests. Finally, carotid ultrasound assessment of 
cIMT, plaque score and arterial stiffness was performed.   
 
2.5.1 Lifestyle questionnaire  
 
At visit 1, participants completed an extensive lifestyle and health questionnaire, with a 
study nurse asking the questions and directly recording the participants’ answers onto an 
electronic proforma on a laptop. Questions addressed the following areas: 
• Residence (owner-occupier/tenant/living with parents/other) 
• Dependents; marital status 
• Self-rating of health (very good/good/fair/bad/very bad) 
• Past and present health 
• Prescribed and over-the-counter medication 
• Chest pain 
• Periodontal disease 
• Smoking 
• Alcohol consumption 
• Diet 
• Physical activity 
• Childhood circumstances 
• Birth weight and place of birth 
• Parental history 
• Education 
• Employment 
• Income 
Appendix 2 contains a paper version of the full lifestyle questionnaire. 
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2.5.2 Psychology questionnaires 
 
In order to assess psychological parameters in relation to social deprivation and 
cardiovascular risk, participants next completed a series of psychology questionnaires. In 
visit 1, the General Health Questionnaire-28 (GHQ-28) was used to detect psychological 
distress by assessing the participant’s current state and asking if it differed from their usual 
state.118 Self-efficacy was assessed by the Generalised Self-Efficacy Scale (GSS);119 sense 
of coherence by the Sense of Coherence Scale (SoC)120 and hopelessness by the Beck 
Hopelessness Scale (BHS).121 In visit 2, after being provided with breakfast, participants 
completed the Eysenck Personality Scale (EPR), which assesses the personality traits of 
neuroticism (the tendency to experience negative emotions including anxiety, anger and 
guilt), psychoticism (the predisposition to become sociopathic and tendency to be hostile, 
manipulative and impulsive) and extraversion (the tendency to enjoy positive events and 
human interaction).122 Self-esteem was then assessed using the Rosenberg Self-Esteem 
Scale (RSES).123 
 
2.5.3 Measurement of blood pressure and heart rate  
 
In visit 1, after completion of the lifestyle questionnaire, blood pressure and heart rate were 
measured. The Standard Operating Procedure for study visits stipulated that the participant 
should remain seated for at least 10 minutes prior to measurement of blood pressure and 
heart rate, although in practice participants were seated for much longer than this, as the 
lifestyle questionnaire took around an hour to complete. Blood pressure and heart rate were 
measured on the participant’s left arm using an Omron electronic sphygmomanometer 
(Omron Healthcare UK Ltd., Milton Keynes, United Kingdom). 
 
2.5.4 Anthropometric measurements 
 
In visit 1, after measurement of blood pressure and heart rate, participants’ waist, hip and 
mid-thigh circumferences were measured using a standardised protocol. Waist 
circumference was measured with the participant standing, with the measurement being 
made at the level of the highest point of the iliac crest. Hip circumference was measured 
with a measuring tape placed around the buttocks at the maximum extension of the 
buttocks, encircling the hips in a horizontal plane. Mid-thigh circumference was measured 
on the right leg, with the participant sitting with legs straight and feet resting flat on the 
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ground. The mid-thigh location was defined as the point midway between the outer edge of 
the inguinal crease and the mid-point of the patella. Height, sitting height (to allow 
calculation of leg length) and weight were measured in visit 2. 
 
2.5.5 Lung function 
 
Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC) were 
measured at the end of visit 1 using a Vitalograph compact II spirometer (CareFusion 232 
Ltd., Chatham Maritime, United Kingdom). 
 
2.5.6 Biochemical analysis 
 
Participants attended visit 2 having fasted for 12 hours in order for fasting blood samples 
to be taken for biochemical analysis of classic and emerging cardiovascular risk markers. 
All blood samples were separated and frozen at -80ºC within 1 hour of venepuncture, 
except for samples for cholesterol, triglycerides, Low Density Lipoprotein (LDL) 
cholesterol, High Density Lipoprotein (HDL) cholesterol, C-reactive protein (CRP) and 
glucose, which were analysed on fresh plasma.  
 
2.5.6.1 Classic risk factors 
 
Lipid profile: Cholesterol was determined by an enzymatic colorimetric assay on a Roche 
917 analyser (Roche Diagnostics Ltd., Burgess Hill, United Kingdom). Triglyceride was 
determined by an enzymatic colorimetric assay on a Roche 917 analyser (Roche 
Diagnostics Ltd., Burgess Hill, United Kingdom). Lipid fractions were measured using 
ultracentrifugation at 105 000g at 4ºC for 16 hours, producing an upper fraction containing 
Very Low Density Lipoprotein (VLDL) and a lower fraction containing HDL and LDL. 
The LDL component was precipitated using a solution of heparin and manganous chloride, 
leaving the HDL in solution.124 All of these lipid analyses had a between batch coefficient 
of variation (CV) of less than 3%. 
 
Glucose: Glucose was measured by hexokinase/glucose-6-phosphate dehydrogenase assay 
on an Abbott c8000 analyser (Abbott Diagnostics, Maidenhead, United Kingdom). 
Between batch CVs ranged (on the different Abbott c8000 analysers used) from 1.13 to 
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1.89% at a glucose concentration of 3.23mmol/L; from 1.10 to 1.45% at 6.42mmol/L and 
from 0.83 to 1.83% at 20.4mmol/L. 
 
 2.5.6.2 Emerging risk factors 
 
Insulin resistance/adiposity: Insulin was measured by a sandwich Enzyme-Linked 
Immunosorbent Assay (ELISA) (Mercodia AB, Uppsala, Sweden). Between batch 
analytical CV was 7.26% at 6.04mU/L and 7.85% at 11.2mU/L. Homeostasis Model 
Assessment – Insulin Resistance (HOMA-IR) was calculated as: Glucose (mmol/L) x 
Insulin (mU/L) / 22.5.53 Leptin was measured by an in-house radioimmunoassay validated 
against a commercially available assay.125 Between batch CVs for the leptin assay were 
8.5% at 33ng/mL, 4.4% at 11.7ng/mL and 5.7% at 1.4ng/mL. Adiponectin was measured 
by sandwich ELISA (ALPCO Diagnostics, Salem, USA), and had a between batch CV of 
8.9% for the total adiponectin assay and 15.1% for the high molecular weight assay. The 
higher CV for the high molecular weight assay was due to the fact that this assay has a 
number of pre-treatment steps before the samples are applied to the plate. 
 
Inflammation/endothelial dysfunction: C-reactive protein (CRP) was measured by an 
immunoturbidimetric assay (Roche Diagnostics Ltd., Burgess Hill, United Kingdom), and 
had a CV of less than 3%. Interleukin-6 (IL-6) and soluble Intercellular Adhesion 
Molecule-1 (sICAM-1) were measured by sandwich ELISA (R&D Systems Europe Ltd., 
Abingdon, United Kingdom). The between batch CV for IL-6 was 8.3% at a concentration 
of 2.84pg/mL and 10.0% at 5.38pg/mL. The between batch CV for sICAM-1 was 5.5% at 
an analyte concentration of 190ng/mL and 8.1% at 240ng/mL. 
 
Haemostasis: Von Willebrand Factor (vWF) was measured using an in-house ELISA, 
employing rabbit anti-human polyclonal antibodies (DAKO plc, High Wycombe, United 
Kingdom) and had a between batch CV of 3.4% at 128IU/dL. Fibrinogen was measured on 
an automated coagulometer (MDA-180, Organon Teknika, Cambridge, United Kingdom) 
with a between batch CV of 3.7% at a fibrinogen concentration of 2.89g/L. D-dimer and 
tissue Plasminogen Activator (tPA) antigen were measured by ELISA (Hyphen, Neuville-
sur-Oise, France). The between batch CV for D-dimer was 5.3% at a concentration of 
109ng/mL, and for tPA antigen was 6.5% at an analyte concentration of 4.42ng/mL. 
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2.5.7 Assessment of cognitive function 
 
In visit 2, after venepuncture, consumption of breakfast (or abstinence, according to each 
participant’s usual habit) and completion of the Eysenck Personality Scale and Rosenberg 
Self-Esteem Scale as detailed in Section 2.5.2, participants underwent a series of 
psychometric assessments of cognitive function. The test battery was designed to assess 
the principal cognitive domains of memory, reaction and decision processes and executive 
function. The number and duration of the tests was constrained by the time demands that 
might reasonably be made upon participants who were required to attend two separate 
study visits. Memory was assessed by the Auditory Verbal Learning Test, which assesses 
the rate of learning, recall and recognition performance.126 Five-choice reaction time was 
measured in milliseconds by the computerised system due to Hope et al127 and sensitive to 
a range of factors affecting motor and decision speed. Executive function was assessed by 
means of the Stroop test, which assesses the ability to inhibit dominant and over-learned 
responses.128 
 
2.5.8 Carotid ultrasound 
 
The last part of study visit 2 involved a carotid ultrasound assessment of intima-media 
thickness, plaque score and arterial stiffness. All scans were performed on a Siemens 
Acuson Sequoia 512 scanner with an L7 5-12MHz linear array broadband transducer 
(Siemens Medical Solutions, Erlangen, Germany). The majority of the scans were 
performed by the same research nurse, who had prior training in ultrasound techniques as 
detailed in Chapter 3.  
 
Carotid arteries were assessed bilaterally. The first stage of the protocol involved 
measuring Doppler velocity in the internal carotid artery to exclude significant internal 
carotid artery stenosis (Figure 2.2). A protocol for action to be taken on finding a raised 
internal carotid artery Doppler velocity had previously been agreed with the vascular 
surgeons of Glasgow Royal Infirmary. Briefly, this protocol involved no action being 
required in the case of asymptomatic participants with a Doppler velocity of less than 
1.2m/s. For asymptomatic individuals with a Doppler velocity of 1.2 to 2.3m/s 
(approximately corresponding to a 50-70% stenosis), the participant’s General Practitioner 
was advised to commence the individual on appropriate secondary cardiovascular 
prevention. Where the velocity was greater than 2.3m/s (corresponding to greater than 70% 
stenosis) a recommendation was made to the General Practitioner that secondary 
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cardiovascular prevention therapy be instituted, and in addition it was suggested that the 
General Practitioner discuss with the individual whether he or she would like to be referred 
to the vascular surgeons for discussion of the possibility of surgical treatment. For 
symptomatic individuals (i.e. those experiencing recurrent transient ischaemic attacks) 
referral to the Stroke Service was recommended. A Doppler trace from a participant found 
to have a 50-70% right carotid artery stenosis and an image of the underlying stenosing 
plaque are shown in Figure 2.3. 
 
B (brightness)-mode still images and dynamic clips were then recorded of the distal 1cm of 
the common carotid artery, the carotid bulb and the proximal internal carotid artery 
(Figure 2.4). Care was taken to keep the images horizontal, and to maximise the length of 
far arterial wall over which the double-line pattern representing the combined thickness of 
the tunica intima and tunica media was visualised. 
 
Finally, an M (movement)-mode image of the movement of the walls of the distal 1cm of 
the common carotid artery was recorded over at least two cardiac cycles, to allow 
assessment of parameters of arterial stiffness (Figure 2.5). Blood pressure was measured 
using an Omron electronic sphygmomanometer (Omron Healthcare UK Ltd., Milton 
Keynes, United Kingdom) immediately before and after capturing each M-mode image in 
order to allow the parameters of arterial stiffness to be calculated. 
 
Each scan was saved as a DICOM (Digital Imaging and Communications in Medicine) 
database.  
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Figure 2.2 Internal carotid artery Doppler trace 
 
 
Right internal carotid artery Doppler trace showing a Doppler velocity of 0.861m/s. 
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Figure 2.3 Internal carotid artery Doppler trace and B-mode ultrasound 
image from an individual with a 50-70% right carotid artery stenosis 
 
A. Doppler trace 
 
 
 
The right internal carotid artery Doppler velocity of 1.69m/s is consistent with a 50-70% 
carotid stenosis.
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B. B-mode image of right carotid bulb 
 
 
 
The plaque causing the 50-70% stenosis can be seen clearly on this B-mode ultrasound 
image.
plaque 
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Figure 2.4 B-mode still images of distal common carotid artery, carotid bulb 
and proximal internal carotid artery 
 
A. Common carotid artery 
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B. Carotid bulb 
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C. Internal carotid artery 
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Figure 2.5 M-mode image of right distal common carotid artery 
 
 
 
The small upper image shows a B-mode image of the distal common carotid artery, 
showing the region through which the cross-sectional M-mode image (lower image) was 
taken.
near wall 
lumen 
far wall 
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Scans were analysed using the eTrack software provided by the Department of Vascular 
Medicine and Physiology, Academic Medical Centre, Amsterdam, The Netherlands. All 
scans were analysed by myself, blinded to the identities of the participants. Carotid intima-
media thickness (cIMT) was measured on the far wall of each arterial segment, averaged 
along a 1cm length, or as much of this as was able to be read (Figure 2.6).  
 
Plaque score was also calculated.81 This was determined by counting the number of 
plaques, with plaque being defined as a focal structure encroaching into the arterial lumen 
of at least 0.5mm or 50% of the surrounding carotid intima-media thickness (cIMT) value, 
or demonstrating a thickness >1.5mm as measured from media-adventitia interface to 
intima-lumen interface.80 This plaque count was then converted to plaque score by dividing 
by the number of readable images present and multiplying by 6 (the maximum possible 
number of images per subject),81 thus adjusting for unreadable images. 
 
Calculation of parameters of arterial stiffness was also carried out using the eTrack 
software to analyse the M-mode images of right and left common carotid arteries as shown 
in Figure 2.7. The algorithms used to derive the parameters of arterial stiffness are as 
follows:129 
 
∆P = systolic blood pressure – diastolic blood pressure 
∆diameter = change in lumen diameter between systole and diastole 
strain = ∆diameter / diastolic diameter 
 
distensibility = 2 x strain / ∆P 
 
compliance = (∏ x diastolic diameter x ∆diameter) / (2 x ∆P) 
 
Petersen elasticity modulus = (∆P/strain) 
 
Stiffness(ß) = [ln(systolic blood pressure/diastolic blood pressure)] / Strain 
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Modified formulae according to Heijden-Spek130 were also used in order to account for 
non-negligible area changes over one heart beat in the large arteries: 
 
distensibility_Tf = (2 x ∆diameter x diastolic diameter + ∆diameter2) / (∆P x diastolic 
diameter2) 
 
compliance_Tf = (∏ x [2 x ∆diameter x diastolic diameter + ∆diameter2]) / (4 x ∆P) 
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Figure 2.6 Analysis of common carotid artery intima-media thickness 
A. Selection of region of interest (distal 1cm of far wall of common carotid 
artery) 
 
 
B. Identification of lumen-intima and media-adventitia borders on far wall 
 
The analyst manually places the markers on the lumen-intima and media-adventitia 
borders. 
lumen-intima interface 
media-adventitia interface 
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C. Automated calculation of intima-media thickness 
 
  
 
Intima-media thickness is then automatically calculated. The value used is the mean 
intima-media thickness along the length of artery wall selected.
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Figure 2.7 Calculation of parameters of arterial stiffness from M-mode image 
of distal common carotid artery 
 
A. Selection of region of interest 
 
 
 
A region of the M-mode image encompassing near and far artery walls over at least two 
cardiac cycles is selected. 
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B. Identification of near and far walls 
 
 
C. Automated identification of near and far walls and calculation of 
parameters of arterial stiffness 
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2.6 Descriptive statistics of study participants (Markers of individual-level 
socioeconomic status)  
 
The characteristics of study participants in terms of markers of individual-level 
socioeconomic status are shown in Table 2.2. 
 
2.6.1 Early life markers of socioeconomic status 
 
The first striking feature of note (Table 2.2) is that height differed by 6cm and leg length 
by over 3cm between most and deprived participants (both p<0.0001). Leg length is 
recognised as a marker of nutritional status during the years of growth,131 hence its 
inclusion as an early life marker of socioeconomic status. Number of people per room at 
age 11 years (as a marker of overcrowding in childhood) was significantly higher in the 
most deprived group. As expected, highly statistically significant differences in father’s 
occupation and total years of education were observed between the most deprived and least 
deprived groups.  
 
2.6.2 Other markers of individual-level socioeconomic status 
 
As can be seen from Table 2.2, participant’s occupation and annual income were 
significantly different (p<0.0001) in participants from most deprived areas compared to 
least deprived. A word of explanation is needed regarding the classification of participant’s 
occupation by Registrar General’s Social Class, and the apparently surprisingly low 
percentage of unemployed participants (0.6%) in the most deprived group. Registrar 
General Social Class was determined by each participant’s current or most recent paid job 
– thus those not currently working were classified according to their last paid employment. 
Consequently, only those who were unemployed and had never been in paid employment 
were classified as unemployed in this analysis. 
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Table 2.2 Markers of individual-level socioeconomic status 
Variable Least deprived 
(n=342) 
Most deprived 
(n=324) 
p 
 (a) Early life markers of individual-level socioeconomic status 
Height (cm) 171.0 (9.4) 165.0 (8.7) <0.0001 
 Data missing 2 1  
Leg length (cm) 81.9 (6.0) 78.7 (5.4) <0.0001 
 Data missing 41 21  
People/room at age 11 yrs 1.2 (0.5) 1.8 (0.9) <0.0001 
 Data missing 0 2  
Father’s occupation: 
0 Data not classifiable 
I Professional 
II Managerial & technical 
IIIN Skilled non-manual 
IIIM Skilled manual  
IV Partly skilled 
V Unskilled 
Unknown to participant 
Unemployed 
 
15 (4%) 
30 (9%) 
130 (38%) 
30 (9%) 
98 (29%) 
22 (7%) 
10 (3%) 
4 (1%) 
1 (0.3%) 
 
17 (5%) 
1 (0.3%) 
27 (8%) 
13 (4%) 
155 (48%) 
43 (13%) 
42 (13%) 
16 (5%) 
10 (3%) 
<0.0001 
 Data missing 2 0  
Total Education (years) 16.1 (3.6) 11.8 (2.5) <0.0001 
 Data missing 0 0  
 
(b) Other markers of individual-level socioeconomic status 
Participant’s occupation: 
0 Data not classifiable 
I Professional 
II Managerial & technical 
IIIN Skilled non-manual 
IIIM Skilled manual  
IV Partly skilled 
V Unskilled 
Unemployed 
 
1 (0.3%) 
58 (17%) 
193 (57%) 
59 (17%) 
16 (5%) 
10 (3%) 
2 (0.6%) 
1 (0.3%) 
 
16 (5%) 
5 (2%) 
57 (18%) 
52 (16%) 
87 (27%) 
70 (22%) 
35 (11%) 
2 (0.6%) 
<0.0001 
 Data missing 2 0  
Annual Income: 
<£15 000 
£16-25 000 
£26-35 000 
£36-45 000 
>£45 000 
 
12 (4%) 
29 (9%) 
40 (12%) 
44 (13%) 
187 (55%) 
 
186 (57%) 
78 (24%) 
21 (7%) 
13 (4%) 
10 (3%) 
<0.0001 
 Data missing 30 16  
 
Values are mean (SD), except for categorical variables for which percentages are shown.  
P values refer to difference between most deprived and least deprived, using analysis of 
covariance, adjusting for age and sex. 
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2.7 Comparison of participants and non-participants 
 
In a population-based study such as this, it is clearly vital that the study group is as closely 
representative as possible of the population from which the subjects are drawn. On 
planning this study, a source of concern was the possibility that those volunteering to 
participate in the study would not be typical of the majority of the population from which 
the subjects were drawn – in particular that the “worried well” and “healthy deprived” 
would preferentially volunteer for the study, thus minimising the differences between the 
most deprived and least deprived groups being studied. To address this concern, and with 
the agreement of the Local Research Ethics Committee and the Greater Glasgow Health 
Board Caldicott Guardian, the characteristics of participants and non-participants were 
compared using anonymised data extracted from the General Practice Administration 
System for Scotland (GPASS),132 which was used by 8 out of 10 of the practices from 
which participants were drawn (4 in the least deprived and 4 in the most deprived areas). 
Data were obtained on smoking status and current prescriptions for statins, aspirin, 
antihypertensives, antidepressants and antidiabetic drugs. Data were collected separately 
for those who attended visit 1 (Group 1, n=700), those who declined to attend (Group 2, 
n=812) and non-respondents to the invitation (Group 3, n=1200). Non-participants (Group 
4, n=2012) were defined as the combination of groups 2 and 3. 
 
In the least deprived group, a higher percentage of non-participants were current smokers 
(11.5%) compared to participants (6.3%); p=0.017, although no such difference was 
observed in the most deprived group (non-participants who were current smokers 50.5%; 
participants who were current smokers 48.8%; p=0.6). Both least and most deprived 
participants were more likely than non-participants to be on statins (least deprived 
participants 8.8%; least deprived non-participants 5.0%; p=0.03; most deprived 
participants 29.7%; most deprived non-participants 15.5%; p<0.0001), antihypertensives 
(least deprived participants 18.2%; least deprived non-participants 13.3%; p=0.05; most 
deprived participants 34.8%; most deprived non-participants 24.5%; p=0.0004), and 
antidiabetic medication (least deprived participants 2.8%; least deprived non-participants 
0.9%; p=0.03; most deprived participants 8.5%; most deprived non-participants 5.0%; 
p=0.02). 
 
Although these data demonstrate differences between participants and non-participants, it 
is plausible that the higher levels of prescriptions for statins, antihypertensives and 
antidiabetic drugs in participants compared to non-participants, especially in the most 
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deprived group, is that those in the most deprived group who participated had a higher 
level of recognised morbidity than those who did not participate, and probably were more 
concerned with their health, or were more used to visiting their General Practitioner. Thus, 
the initial concerns that the “healthy deprived” would preferentially volunteer from the 
most deprived group, do not appear to have materialised. 
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CHAPTER 3 – DEVELOPMENT AND VALIDATION OF CAROTID 
ULTRASOUND PROTOCOL 
 
3.1 Initial training in carotid ultrasound 
 
Carotid ultrasound assessment of intima-media thickness and plaque score had not 
previously been undertaken by the University Department of Vascular Biochemistry at 
Glasgow Royal Infirmary. For the purposes of obtaining the necessary training and 
expertise in carotid ultrasound techniques, I therefore arranged to collaborate with 
Professor John Kastelein, Dr Eric de Groot and colleagues in the Department of Vascular 
Medicine, Academic Medical Centre, Amsterdam, The Netherlands. For the carotid 
ultrasound work, it was preferable that the scans would be analysed by a different person to 
the sonographer, so that the analyst could read the scans blinded to the identity of the study 
participants. It was, therefore, planned that I would be responsible for analysing the 
ultrasound scans, with a research nurse carrying out the ultrasonography. However, it was 
prudent for me to be proficient in carrying out ultrasonography also, so that I could oversee 
training of the research nurse, and also so that I could scan participants if required to 
provide cover for the research nurse on rare occasions. I therefore received training in both 
ultrasonography and carotid ultrasound scan analysis from Dr Eric de Groot – this was 
undertaken at the Lipidklinikken, Rikshospitalet, Oslo, Norway, where Dr de Groot was 
training some research nurses in carotid ultrasound for another study. 
 
3.2 Development of pSoBid carotid ultrasound protocol 
 
Having become competent in carotid ultrasonography and analysis of scans, it was 
necessary to develop a carotid ultrasound protocol which would be suitable for the 
purposes of the pSoBid study. The protocol used is detailed in Chapter 2. The rationale 
behind each component of the protocol is as follows: 
 
Common carotid artery intima-media thickness: One of the sources of difficulty in 
comparing the results of different carotid ultrasound studies is that different studies have 
used a variety of methods to measure intima-media thickness. In this study, mean common 
carotid intima-media thickness measured over as much of the far wall of the distal 1cm of 
the common carotid artery as possible, was the primary outcome; this was consistent both 
with the standards set out in the Mannheim Carotid Intima-Media Thickness consensus,80 
and also with accepted practice in the Department of Vascular Medicine, Academic 
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Medical Centre, Amsterdam, which is an internationally recognised authority on carotid 
intima-media thickness assessment. 
 
Carotid bulb and internal carotid artery intima-media thicknesses: On a practical 
level, it was necessary to image the carotid bulbs and internal carotid arteries for 
assessment of plaque score (discussed in section 3.6, below) in any case. Furthermore, 
early atherosclerotic changes may be seen more commonly in the carotid bulbs and 
proximal internal carotid arteries than in the common carotid artery, so it was appropriate 
also to measure cIMT at these sites. 
 
3.3 Training of research nurse 
 
The vast majority of the carotid ultrasound scans were performed by the same research 
nurse, who had no previous experience of carotid ultrasound. Before the study 
commenced, therefore, she underwent a period of intensive training in carotid ultrasound 
scanning, with assessment of proficiency before the study commenced. Training was 
provided by myself in conjunction with Dr Eric de Groot and Mr Johan Gort of the 
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The 
Netherlands, and took place in part at Glasgow Royal Infirmary and in part at Academic 
Medical Centre, Amsterdam. Throughout this period, the research nurse performed 
practice scans on staff volunteers, leading up to an assessment of her precision as described 
in section 3.4, below. 
 
3.4 Assessment of reproducibility of replicate scans  
 
Towards the end of the period of intensive training in carotid ultrasound described in 
section 3.3, the research nurse performed duplicate carotid ultrasound scans on 10 staff 
volunteers, with the replicate scans being performed on separate days. This allowed 
assessment of the mean absolute difference for mean common carotid artery intima-media 
thickness, as prespecified in the ultrasound training plan for the pSoBid study. The results 
of these replicate scans are shown in Table 3.1, which shows that the mean absolute 
difference for mean common carotid artery IMT was 0.0542mm. This was well within the 
predefined performance requirement for sonographer certification, with the requirement 
having been determined by the Department of Vascular Medicine, Academic Medical 
Centre, Amsterdam, to be a mean absolute difference of <0.15mm, and was also within the 
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more stringent requirements suggested by the American Society of Echocardiography, who 
suggest a certification requirement of a mean absolute difference of <0.055mm.78 
 
Approximately 1 year after commencement of the pSoBid study, assessment of 
reproducibility was repeated using the same procedure as detailed above, except that 5 staff 
volunteers had duplicate scans on separate days on this occasion. Again, reproducibility 
was within acceptable limits using either the Academic Medical Centre or American 
Society of Echocardiography criteria. 
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Table 3.1 Assessment of sonographer reproducibility of common carotid 
artery intima-media thickness measurement 
 
Volunteer RCCA 
IMT 
(mm) – 
1st scan 
LCCA 
IMT 
(mm) – 
1st scan 
Mean 
cIMT  
(mm) – 
1st scan 
RCCA 
IMT 
(mm) – 
2nd scan 
LCCA 
IMT 
(mm) – 
2nd scan 
Mean 
cIMT 
(mm) – 
2nd scan 
Absolute 
Difference 
in cIMT 
(mm) 
1 0.5848 0.4293 0.5071 0.4867 0.4461 0.4664 0.0407 
2 0.5342 0.5983 0.5663 0.4856 0.5028 0.4942 0.0721 
3 U 0.4751 0.4751 0.5324 0.4947 0.5136 0.0385 
4 0.4554 0.4291 0.4423 0.3656 0.3543 0.3600 0.0823 
5 0.4873 0.4896 0.4885 0.6410 0.5199 0.5805 0.0920 
6 0.4255 0.4430 0.4343 0.4189 0.4632 0.4411 0.0068 
7 0.5064 0.4757 0.4911 0.5454 0.5948 0.5701 0.0790 
8 0.6537 U 0.6537 0.6183 0.7803 0.6993 0.0456 
9 0.4225 0.4703 0.4464 0.3548 0.4296 0.3922 0.0542 
10 0.4056 0.4056 0.4056 0.4111 0.4616 0.4364 0.0308 
Mean absolute difference for mean common carotid IMT (mm) 0.0542 
  
RCCA: right common carotid artery 
LCCA: left common carotid artery 
U: scan unable to be analysed 
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 3.5 Assessment of reproducibility of cIMT analysis 
 
In a similar way to assessment of sonographer precision, scan analyst reproducibility was 
also assessed by repeat reading of 5% (n=33) of the pSoBid study scans. Results are shown 
in Table 3.2. The mean absolute difference in cIMT for my reproducibility as a scan 
analyst was 0.0362mm, which is within the predefined limit of satisfactory performance 
which was set by the Department of Vascular Medicine, Academic Medical Centre, 
Amsterdam, as a mean absolute difference <0.05mm, and also within the American 
Society of Echocardiography recommended limit of <0.055mm.78 
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Table 3.2 Assessment of reader reproducibility of common carotid artery 
intima-media thickness analysis 
 
Participant ID 
RCCA 
IMT 
(mm) – 
1st 
reading 
LCCA 
IMT 
(mm) – 
1st 
reading 
Mean 
cIMT  
(mm) – 
1st 
reading 
RCCA 
IMT 
(mm) – 
2nd 
reading 
LCCA 
IMT 
(mm) – 
2nd 
reading 
Mean 
cIMT 
(mm) – 
2nd 
reading 
Absolute 
Difference 
in cIMT 
(mm) 
0002WL 0.6265 0.7403 0.6834 0.6287 0.7890 0.7089 0.0255 
0188MN 0.5380 0.5333 0.5357 0.5051 0.5761 0.5406 0.0050 
0277JM 1.1563 0.8671 1.0117 1.0228 0.8522 0.9375 0.0742 
0367SK 0.5810 0.5940 0.5875 0.5982 0.5419 0.5701 0.0175 
0492TH 0.7415 0.8142 0.7779 0.7220 0.7393 0.7307 0.0472 
0611MD 0.5894 0.5809 0.5852 0.6676 0.5742 0.6209 0.0358 
0704MM 0.7734 0.9227 0.8481 0.8240 0.9619 0.8930 0.0449 
0809PI 0.6436 0.6359 0.6398 0.6173 0.6375 0.6274 0.0124 
0910CC 0.6319 0.6649 0.6484 0.5946 0.7073 0.6510 0.0026 
1064KJ 0.5960 0.6260 0.6110 0.6577 0.5601 0.6089 0.0021 
1222VC 0.5763 0.5840 0.5802 0.5885 0.7863 0.6874 0.1073 
1297AC U U U U U U U 
1407CB 0.6563 0.5098 0.5831 0.5573 0.5597 0.5585 0.0246 
1524CL 0.5590 0.7883 0.6737 0.4923 0.7037 0.5980 0.0757 
1613DD 0.6421 0.4232 0.5327 0.6502 0.4331 0.5417 0.0090 
1761JC 0.5053 0.5582 0.5318 0.5611 0.5073 0.5342 0.0025 
1842JW 0.9560 0.9937 0.9749 0.9764 1.0736 1.0250 0.0502 
1996JH 0.8124 0.7240 0.7682 0.7940 0.6934 0.7437 0.0245 
2135HC 0.7454 1.0696 0.9075 0.8250 1.0868 0.9559 0.0484 
2233MM 0.5883 0.4983 0.5433 0.5464 0.5954 0.5709 0.0276 
2403AD 0.7348 0.7850 0.7599 0.7308 0.8113 0.7711 0.0112 
2630VK 0.8539 0.8793 0.8666 0.8651 0.7849 0.8250 0.0416 
2744MC 0.7225 0.7787 0.7506 0.7224 0.7132 0.7178 0.0328 
2859HW 0.7006 0.7344 0.7175 0.6198 0.5959 0.6079 0.1097 
2984RB 0.6486 0.7586 0.7036 0.5779 0.7709 0.6744 0.0292 
3100JS 0.7194 0.5593 0.6394 0.5965 0.4356 0.5161 0.1233 
3225EB 0.4775 U 0.4775 0.4738 U 0.4738 0.0037 
3349DA U U U U U U U 
3493NM 0.7973 0.7939 0.7956 0.7625 0.7573 0.7599 0.0357 
3610JS 0.8847 0.5468 0.7158 1.0392 0.5072 0.7732 0.0575 
3853WT 0.6900 0.6373 0.6637 0.7467 0.6274 0.6871 0.0234 
4129EM 0.6105 0.5385 0.5745 0.5618 0.5647 0.5633 0.0113 
4450SL 0.5900 0.8186 0.7043 0.5783 0.8180 0.6982 0.0062 
Mean absolute difference (mm) 0.0362 
 
RCCA: right common carotid artery 
LCCA: left common carotid artery 
U: scan unable to be analysed 
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3.6 Plaque score 
   
In order for determination of plaque score to be as objective and reproducible as possible, 
it was necessary to define plaque using objective criteria. The most widely accepted 
definition of plaque is as set out in the Mannheim Carotid Intima-Media Consensus (2004-
2006),80 which defines plaque as:  
“a focal structure encroaching into the arterial lumen of at least 0.5 mm or 50% of the 
surrounding IMT value, or demonstrating a thickness >1.5 mm as measured from the 
media-adventitia interface to the intima-lumen interface.”  
A very similar definition of plaque has been recommended by the American Society of 
Echocardiography.78  
 
Using the above definition of plaque, the six movie images per subject (common carotid 
artery, carotid bulb and internal carotid artery on each side) were examined offline and the 
total number of plaques for each subject was recorded. The movie images were used as it 
was much easier on these images to differentiate plaque from image artefact, which could 
occasionally be difficult to differentiate in some subjects who had been difficult to scan. I 
analysed all scans for plaque number, blinded to the identity of the participants. I did not 
have facilities to assess plaque cross-sectional area, or plaque volume (the assessment of 
which is still very much an emerging technique).133 
 
It was then necessary to adjust plaque count to take account of missing or unreadable 
images, in order to avoid biasing the results by attributing to all unreadable images an 
assumed plaque count of zero. In order to do this, an approach akin to that used in the 
Rotterdam study was derived.81 The plaque number, derived as detailed above, was divided 
by the number of readable image segments for that subject, then multiplied by 6 (the 
maximum number of readable image segments per subject), thus adjusting for any 
unreadable images. 
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CHAPTER 4 – SOCIAL DEPRIVATION AND CARDIOVASCULAR RISK 
MARKERS 
 
4.1 Introduction 
 
As discussed in detail in chapter 1, the currently recognised (classic) cardiovascular risk 
factors include smoking, physical activity, hypercholesterolaemia, diabetes mellitus, 
obesity and hypertension. Although clear socioeconomic gradients exist for many of these 
risk factors, differences in classic risk factors typically explain only part of the excess 
coronary heart disease risk associated with social deprivation (38% of the excess risk in the 
Whitehall II study25 and 39% in the British Regional Heart Study).50 Attention must 
therefore turn to emerging risk factors in an attempt to explain the remainder of the excess 
coronary heart disease risk associated with social deprivation. 
 
Such emerging risk factors include markers of insulin resistance and adiposity (fasting 
insulin, Homeostasis Model Assessment – Insulin Resistance [HOMA-IR], adiponectin 
and leptin), inflammation (e.g. CRP and IL-6), endothelial dysfunction (e.g. sICAM-1) and 
haemostasis (vWF, fibrinogen, D-dimer and tPA antigen). The associations of these factors 
with coronary heart disease risk and with social deprivation have been discussed in chapter 
1. The contribution of these emerging risk factors to the explanation of the socioeconomic 
gradient in coronary heart disease risk has been less extensively studied than that of the 
classic risk factors. However, the Women’s Health Study found that adjusting for CRP, 
sICAM-1, fibrinogen and homocysteine had no impact on the socioeconomic gradient in 
cardiovascular events.71  
 
Other potential risk factors are, of course, constantly emerging, and asymmetric 
dimethylarginine (ADMA) is one of those. ADMA is an inhibitor of nitric oxide synthase, 
the enzyme which synthesises nitric oxide, the major endothelium-derived relaxing factor. 
Nitric oxide also has a number of antiatherogenic properties. Intravenous infusion of 
ADMA raises systemic vascular resistance, impairs the cardiac response to exercise and 
has adverse effects on renal perfusion and sodium excretion. Associations have been noted 
between ADMA concentration and hypercholesterolaemia, insulin resistance, chronic 
kidney disease and hypertension. ADMA concentration is higher in people with coronary 
heart disease than in controls; is associated with severity of lesions at angiography in 
people with established CHD; correlates with cIMT and independently predicts cIMT 
progression. In prospective studies, ADMA has been shown to predict acute coronary 
 94 
events, cardiovascular mortality and all-cause mortality, independent of classic 
cardiovascular risk factors.134 No studies have been identified to date that examined 
ADMA concentrations in relation to social deprivation. 
 
In recent years, much attention has been focussed on associations between low 
concentrations of vitamin D and cardiovascular risk.135 Vitamin D receptors (VDRs) have 
recently been shown to be expressed in various tissues which are aetiologically important 
in the progress of cardiovascular disease, including vascular smooth muscle cells, vascular 
endothelium, cardiomyocytes, and in T-cells, B-cells and dendritic cells.136 Observational 
studies have found low circulating concentrations of 25-hydroxy vitamin D to be prevalent 
in cardiovascular diseases such as coronary heart disease, heart failure and stroke.137-139 
Prospectively, a link between low 25-hydroxy vitamin D concentrations and higher risk for 
incident cardiovascular disease (CVD) events was recently reported, with a hazard ratio of 
1.80 (1.05-3.08) at <10ng/ml in fully adjusted models.140 A similar finding was reported in 
the Health Professionals Study.141 By contrast, a randomised intervention trial of vitamin D 
and calcium supplementation in >36 000 women142 showed no difference in a post hoc 
analysis of risk for incident CVD with combined intakes of vitamin D and calcium versus 
placebo. A possible explanation for this discrepancy is confounding of circulating vitamin 
concentrations by socioeconomic status, which is often inadequately adjusted for in 
epidemiological studies.143 Further data relating vitamin D levels to vascular markers of 
CVD are required, in particular with better assessment of potential confounding factors, 
including social deprivation.  
 
Cortisol has been identified as a potential mediator between chronic stress and CHD risk. 
The Caerphilly study of 2512 men aged 45 to 59 years found a prospective association 
between morning serum cortisol to testosterone ratio and incident ischaemic heart disease 
(age-adjusted odds ratio of 1.22 per z score change in cortisol:testosterone ratio, p=0.003). 
Adjusting for markers of insulin resistance (fasting glucose, insulin and HOMA-IR) 
markedly attenuated this association (adjusted odds ratio 1.10 per z score change in 
cortisol:testosterone ratio, p=0.18). These findings suggested that the association between 
cortisol:testosterone ratio, as a marker of chronic stress, and CHD risk may be mediated 
through insulin resistance.144 Despite the associations between chronic stress and serum 
cortisol, a recent review of the literature found no consistent evidence for an association 
between serum cortisol and socioeconomic status. Although some studies included in the 
review had reported an association between lower socioeconomic status and higher 
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concentrations of cortisol, many studies had found no association, and some had reported 
the opposite relationship.145 
 
Non-alcoholic fatty liver disease (NAFLD), typically (but non-specifically) characterised 
by an elevated alanine aminotransferase (ALT) concentration,146 is now recognised to be 
strongly associated with obesity, insulin resistance, dyslipidaemia and type 2 diabetes 
mellitus, and to be an independent cardiovascular risk factor.147  
 
Chronic kidney disease is now well recognised as being indicative of increased 
cardiovascular risk.148 In routine clinical practice, glomerular filtration rate (GFR) is often 
estimated using the four variable Modification of Diet in Renal Disease (MDRD) equation, 
which uses serum creatinine concentration, age, sex and ethnicity to estimate GFR.149 
Cystatin C, a protein synthesised at a constant rate in all nucleated cells, freely filtered in 
the glomerulus and completely reabsorbed and catabolised in the proximal tubule, has been 
proposed as a more ideal marker of GFR – although it is also influenced by age, BMI, sex 
and smoking status. Importantly, cystatin C concentration has been found to be predictive 
in elderly patients of cardiovascular death from all causes, MI, stroke, incident heart failure 
and death from all causes. In patients with existing CHD, cystatin C is predictive of all-
cause mortality and MI, and in patients with established chronic kidney disease, cystatin C 
predicts all cause mortality. In patients without chronic kidney disease, cystatin C predicts 
hypertension, death (both cardiovascular and non-cardiovascular), heart failure, stroke and 
MI. Furthermore, cystatin C appears to improve identification of individuals at high risk of 
cardiovascular events compared to models which use creatinine or estimated GFR values, 
possibly because of the ability of cystatin C to identify earlier stages of deteriorating renal 
function.150 The association of cystatin C with social deprivation has been examined in a 
study of 736 African Americans aged over 65 years. Renal dysfunction was found to be 
strongly associated with low income (<$8000/year) when renal dysfunction was classified 
by either cystatin C or estimated GFR.151 
 
The aim of the work detailed in this chapter was to enhance current knowledge of the 
associations between social deprivation and the cardiovascular risk markers detailed above. 
Primarily, this was in order to identify potential mediators of the associations between 
social deprivation and cardiovascular risk, with differences in the measured biomarkers 
being analysed to determine if they contribute to the explanation of any differences in 
ultrasound markers of subclinical atherosclerosis – this aspect of the work is detailed in 
chapter 5. 
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4.2 Methods 
 
 4.2.1 Biochemical methods 
 
The plasma samples used for the work described in this chapter were obtained in the 
pSoBid study as detailed in chapter 2. Biochemical methods for lipids, glucose, insulin, 
adiponectin, leptin, CRP, IL-6, sICAM-1, vWF, fibrinogen, D-dimer and tPA antigen are 
described in chapter 2. In addition, the following biochemical analyses were carried out: 
ADMA was measured by High Performance Liquid Chromatography (HPLC) after cation 
exchange extraction and derivatisation.152 25-hydroxy vitamin D was measured using an 
automated solid-phase extraction (SPE) procedure with liquid chromatography-tandem 
mass spectrometry (LC-MS/MS).153 Cortisol was measured by immunoassay on an Abbott 
c8000 analyser (Abbott Diagnostics, Maidenhead, United Kingdom). Creatinine, cystatin 
C, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma 
glutamyl transferase (GGT) were measured on an ILAB 600 clinical chemistry analyser 
(Instrumentation Laboratory UK Ltd., Warrington, United Kingdom). Creatinine was 
measured by kinetic Jaffe reaction (Randox Laboratories, Crumlin, United Kingdom). 
Estimated Glomerular Filtration Rate (eGFR) was calculated by the 4-variable Modified 
Diet in Renal Disease (MDRD) equation.149 Cystatin C was measured 
immunoturbidimetrically (Dako UK Ltd., Ely, United Kingdom). Alanine aminotransferase 
(ALT) was measured by enzymatic reaction with lactate dehydrogenase (Instrumentation 
Laboratory UK Ltd., Warrington, United Kingdom). Aspartate aminotransferase (AST) 
was measured by enzymatic reaction with malate dehydrogenase (Instrumentation 
Laboratory UK Ltd., Warrington, United Kingdom). Gamma glutamyl transferase (GGT) 
was measured enzymatically (Instrumentation Laboratory UK Ltd., Warrington, United 
Kingdom). 
 
4.2.2 Statistical methods 
 
Descriptive statistics are presented as mean (SD) for continuous variables and count (%) 
for categorical outcomes. Variables with positively skewed distributions (triglyceride, 
CRP, IL6 and sICAM-1) are described by geometric means and log-transformation was 
used for regression analysis. For comparisons of population characteristics between 
deprivation groups, analysis of covariance was used for continuous variables, and logistic 
regression analyses for binary responses, with the results presented as p values comparing 
adjusted ‘least’ minus ‘most’ deprived means and odds ratio for least versus most deprived 
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categories respectively, adjusting for age and sex. Alcohol consumption, arginine, 
homoarginine, ADMA, symmetric dimethylarginine (SDMA), ALT, AST, creatinine, 
cystatin C and GGT showed non-parametric distribution and are described as median 
(interquartile range) and comparison of most versus least deprived is by Mann-Whitney 
test. Cortisol was normally distributed and so is described as mean (SD) and comparison 
between most and least deprived is by Student’s T test. Normality of distribution was 
assessed by the Anderson-Darling test. Analyses were conducted in R v2.8 and Minitab 
Release 13.1. 
 
4.3 Results 
 
Differences in classic and emerging cardiovascular risk factors between most and least 
deprived participants are shown in Table 4.1. 
 
4.3.1 Classic risk factors 
 
4.3.1.1 Behavioural risk factors 
 
As expected, there was a highly significant difference in number of participants who had 
ever smoked regularly, and also in percentage of current cigarette smokers, between most 
affluent and most deprived areas. Physical activity was significantly different between least 
and most deprived, with almost half of those in the most deprived areas being physically 
inactive, compared with just under a quarter of those in the least deprived areas (p<0.0001 
for trend). 
 
The findings on alcohol consumption at first seem surprising, with self-reported weekly 
alcohol consumption being significantly higher in the least deprived group (p<0.0001). 
Figure 4.1 gives further detail about the distribution of alcohol consumption in least versus 
most deprived groups. Although the median weekly alcohol consumption was higher in the 
least deprived group, there were a number of outliers in the most deprived group with very 
high weekly alcohol consumption.  
 
4.3.1.2 Physiological risk factors 
 
Total and Low Density Lipoprotein (LDL) cholesterol were significantly different between 
least and most deprived participants, with the difference being the opposite of what might 
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intuitively be expected, in that total cholesterol and LDL were higher in the least deprived 
group. These differences persisted after adjusting for statin use: 69 (21.3%) of the most 
deprived and 18 (5.3%) of the least deprived participants were on statin therapy. If 
participants on statin therapy were excluded, mean (SD) total cholesterol was 5.36 (0.98) 
mmol/L in the least deprived group and 5.13 (1.00) mmol/L in the most deprived; adjusted 
p value=0.049 after adjusting for age, sex and statin use (data not shown). The differences 
in triglycerides and High Density Lipoprotein (HDL) were in the expected directions 
(higher HDL and lower triglycerides in the least deprived group). LDL/HDL ratio did not 
differ between least and most deprived (mean of 2.37 in both; p=0.91). 
 
Fasting glucose was higher in the most deprived group, as was waist/hip ratio. Weight did 
not differ between the two groups, but by virtue of the differences in height, body mass 
index (BMI) was significantly higher in the most deprived group. Blood pressure did not 
differ between the two groups. 
 
4.3.2 Emerging risk factors 
 
4.3.2.1 Markers of insulin resistance / adiposity 
 
Fasting insulin was significantly higher in the most deprived group. As a consequence of 
this and the higher fasting glucose concentration in the most deprived group, Homeostasis 
Model Assessment – Insulin Resistance (HOMA-IR) was higher in the most deprived 
group. Adiponectin did not differ between the two groups. Consistent with the higher body 
mass index and waist/hip ratio, leptin (a marker of adiposity) was higher in the most 
deprived group. 
 
4.3.2.2 Markers of inflammation/endothelial dysfunction 
 
Higher levels of inflammation in the most deprived group are demonstrated by the higher 
concentrations of CRP and IL-6 in this group. Higher levels of endothelial dysfunction in 
the most deprived group are demonstrated by the higher concentrations of sICAM-1. 
 
4.3.2.3 Markers of haemostasis 
 
vWF, fibrinogen and D-dimer were all significantly higher in the most deprived group. tPA 
antigen did not differ between the two groups. 
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Table 4.1 Differences in classic and emerging cardiovascular risk factors  
between most and least deprived participants 
 
Variable Least deprived 
(n=342) 
Most deprived 
(n=324) 
p 
Classical risk factors (behavioural): 
Smoking:  
Ever smoked regularly  
 
121 (35.4%) 
 
241 (74.4%) 
 
<0.0001 
Current cigarette smoker 21 (6.1%) 131 (40.4%)  
 Data missing 0 0  
Physical activity:   <0.0001 
Inactive 82 (24%) 160 (49%)  
Moderately inactive 84 (25%) 37 (11%)  
Moderately active 87 (25%) 71 (22%)  
Active 89 (26%) 56 (17%)  
 Data missing 0 0  
Alcohol consumption 
(units/week) a 
7.8 (2.4, 15.0) 3.5 (0.0, 12.0) <0.0001 
 Data missing 0 0  
 
Classical risk factors (physiological): 
Cholesterol (mmol/L) 5.29 (1.03) 4.95 (1.05) <0.0001 
 Data missing 7 14  
Triglycerides (mmol/L) b 1.19 1.44 <0.0001 
 Data missing 7 14  
LDL cholesterol (mmol/L) 3.16 (0.87) 2.86 (0.88) <0.0001 
 Data missing 7 18  
HDL cholesterol (mmol/L) 1.43 (0.38) 1.30 (0.39) <0.0001 
 Data missing 7 14  
Glucose (mmol/L) 5.15 (0.69) 5.42 (1.90) 0.0088 
 Data missing 19 35  
Weight (kg) 78.7 (15.3) 78.2 (18.4) 0.78 
 Data missing 1 1  
Waist/hip ratio 0.88 (0.08) 0.92 (0.09) <0.0001 
 Data missing 3 4  
Body mass index (kg/m2) 26.9 (4.49) 28.7 (6.34) <0.0001 
 Data missing 2 2  
Blood pressure (mmHg) 135 (17.8)/81.4(10.3) 136 (20.0)/81.1(11.6) 0.58/0.74 
 Data missing 2 2  
 
Emerging risk factors: Insulin resistance / adiposity: 
Insulin (mU/L) 6.62 (4.91) 7.72 (5.97) 0.011 
 Data missing 18 41  
HOMA-IR 1.52 (1.22) 1.81 (1.60) 0.015 
 Data missing 24 49  
Total adiponectin (µg/mL) 5.81 (3.02) 5.54 (3.21) 0.12 
 Data missing 10 15  
HMW adiponectin (µg/mL) 3.02 (2.18) 2.88 (2.27) 0.22 
 Data missing 10 15  
Leptin (ng/mL) 18.7 (16.8) 23.7 (24.0) 0.0017 
 Data missing 14 20  
 
Emerging risk factors: Inflammation / endothelial dysfunction: 
CRP (mg/L) b 1.16 2.07 <0.0001 
 Data missing 11 19  
IL-6 (pg/mL) b 1.36 2.08 <0.0001 
 Data missing 13 24  
sICAM-1 (ng/mL) b 235.8 302.4 <0.0001 
 Data missing 10 20  
 
Emerging risk factors: Haemostasis: 
vWF (IU/dL) 129 (39) 155 (47) <0.0001 
 Data missing 8 23  
Fibrinogen (g/L) 3.23 (0.60) 3.50 (0.80) <0.0001 
 Data missing 10 23  
D-dimer (ng/mL) 130 (97) 155 (102) 0.0018 
 Data missing 8 23  
tPA antigen (ng/mL) 4.89 (4.12) 5.30 (4.32) 0.18 
 Data missing 8 23  
 
a
 results presented as median (IQR) 
b
 indicates use of geometric means
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Figure 4.1 Self-reported weekly alcohol consumption in relation 
to social deprivation 
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Means are indicated by solid circles. Grey boxes represent interquartile ranges, with 
horizontal lines showing medians. 
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4.3.3 Additional biomarkers measured 
 
Differences between most and least deprived groups in additional biomarkers measured are 
shown in Table 4.2. 
 
4.3.3.1 Asymmetric dimethylarginine and associated variables 
 
Asymmetric dimethylarginine was significantly higher in the most deprived group 
compared to the least deprived (p<0.0001). Arginine did not differ between the two groups. 
As a result of the differences in ADMA, Arginine/ADMA ratio was higher in the least 
deprived group. Symmetric dimethylarginine, which is renally excreted, did not differ 
between the two groups. Homoarginine was higher in the least deprived group. 
 
4.3.3.2 Liver “function” tests 
 
Neither ALT nor AST differed between most and least deprived groups. Despite weekly 
alcohol consumption being higher in the least deprived group, GGT was significantly 
higher in the most deprived group (p<0.0001). In order to explore this finding further, 
multivariate models were constructed to examine the ability of deprivation to predict ALT, 
AST and GGT after adjusting for alcohol consumption, age and sex. The results are shown 
in Tables 4.3, 4.4 and 4.5. In the case of ALT (Table 4.3), age, male sex and alcohol 
consumption predicted ALT, but deprivation did not predict ALT in either the model 
which included alcohol consumption or the model in which alcohol consumption was not 
included. The association of age with ALT in both models was an inverse association. For 
AST, only male sex and alcohol consumption predicted AST. There was a non-significant 
trend towards higher AST in the most deprived group in the model including age, sex and 
deprivation and the model including age, sex, deprivation and alcohol consumption. In the 
case of GGT, alcohol consumption, male sex and being in the most deprived group all 
predicted having a higher GGT. For GGT, a further model was constructed to include BMI 
as a covariate in addition to deprivation, age, sex and alcohol consumption (Table 4.6). In 
this model, higher BMI was predictive of higher GGT, but inclusion of BMI in the model 
did not abolish the significance of deprivation as a predictor of GGT.  
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Table 4.2 Differences between most and least deprived participants in 
additional biomarkers measured  
 
Variable Least deprived 
 
Most deprived 
 
p 
Asymmetric dimethylarginine and associated variables: 
 (n=329) (n=306)  
ADMA (umol/L) 0.44 (0.40, 0.50) 0.47 (0.42, 0.52) <0.0001 
SDMA (umol/L) 0.38 (0.34, 0.43) 0.38 (0.33, 0.44) 0.344 
Arginine (umol/L) 65.6 (58.3, 75.9) 66.3 (58.3, 77.6) 0.3701 
Homoarginine (umol/L) 1.67 (1.30, 2.14) 1.57 (1.17, 2.02) 0.0089 
Arginine/ADMA 150.7 (127.5, 171,3) 143.2 (125.1, 165.0) 0.0151 
 
Liver “function” tests: 
 (n=330) (n=308)  
ALT (IU/L) 22.0 (18.0. 31.0) 22.0 (17.0, 31.0) 0.4653 
AST (IU/L) 22.0 (19.0, 27.0) 22.0 (18.0, 28.0) 0.667 
GGT (IU/L) 24.0 (17.0, 35.3) 29.0 (21.0, 49.8) <0.0001 
 
Markers of renal function: 
 (n=330) (n=308)  
Creatinine (umol/L) 83.0 (75.2, 91.4) 80.1 (72.4, 87.8) 0.0023 
MDRD-4 eGFR 
(mL/min/1.73m2) 
82.9 (76.8, 92.5) 88.7 (76.4, 99.6) 0.0007 
Cystatin C (mg/L) 0.92 (0.86, 1.00) 0.96 (0.89, 1.07) <0.0001 
 
Other biomarkers: 
 (n=318) (n=298)  
Cortisol (nmol/L) a 347 (120) 361 (131) 0.183 
25-hydroxy vitamin D 
(nmol/L) b 
45.7 (1.87) 34.2 (2.02) p<0.0001 
 
Values shown are median (IQR) except: 
a
 mean (SD) 
b
 geometric mean 
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Table 4.3 Prediction of ALT from deprivation, age, sex and self-reported 
weekly alcohol consumption 
 
Model not including alcohol consumption Model including alcohol consumption 
 Estimated 
effect 
95% confidence 
interval p 
Estimated 
effect 
95% confidence 
interval p 
Deprivation (most 
deprived) -0.024 (-2.227, 2.179) 0.983  -0.051 (-2.247, 2.145) 0.964 
Age -0.185 (-0.318, -0.051) 0.007 
 
-0.181 (-0.314, -0.048) 0.008 
Sex (male) 10.558 (8.356, 12.760) <0.001 
 
9.699 (7.384, 12.013) 0.001 
Alcohol - - - 
 
0.078 (0.011, 0.145) 0.022 
 
 
Table 4.4 Prediction of AST from deprivation, age, sex and self-reported 
weekly alcohol consumption 
 
Model not including alcohol consumption Model including alcohol consumption 
 Estimated 
effect 
95% confidence 
interval p 
Estimated 
effect 
95% confidence 
interval p 
Deprivation (most 
deprived) 1.373 (-0.115, 2.861) 0.071  1.329 (-0.124, 2.781) 0.073 
Age -0.019 (-0.109, 0.072) 0.685 
 
-0.012 (-0.101, 0.076) 0.781 
Sex (male) 5.776 (4.288, 7.263) <0.001 
 
4.365 (2.834, 5.896) <0.001 
Alcohol - - - 
 
0.129 (0.084, 0.173) <0.001 
 
 
Table 4.5 Prediction of GGT from deprivation, age, sex and self-reported 
weekly alcohol consumption 
  
Model not including alcohol consumption Model including alcohol consumption 
 Estimated 
effect 
95% confidence 
interval p 
Estimated 
effect 
95% confidence 
interval p 
Deprivation (most 
deprived) 18.024 (10.076, 25.971) <0.001  17.748 (10.062, 25.435) <0.001 
Age 0.204 (-0.277, 0.686) 0.405 
 
0.242 (-0.224, 0.708) 0.308 
Sex (male) 20.057 (12.113, 28.001) <0.001 
 
11.278 (3.175, 19.380) 0.006 
Alcohol - - - 
 
0.801 (0.566, 1.035) <0.001 
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Table 4.6 Prediction of GGT from deprivation, age, sex, self-reported weekly 
alcohol consumption and Body Mass Index (BMI) 
 
Estimated effect 95% confidence interval p 
Deprivation (most deprived) 15.691 (7.765, 23.617 <0.001 
Age 0.1729 (-0.2889, 0.6347) 0.454 
Sex (male) 11.080 (2.838, 19.322) 0.007 
Alcohol 0.8578 (0.6168, 1.0988) <0.001 
Body Mass Index (BMI) 1.1512 (0.4232, 1.8792) 0.002 
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4.3.3.3 Markers of renal function 
 
There was a significant difference in plasma creatinine and consequently in eGFR, with 
higher creatinine in the least deprived group. This is further discussed in Section 4.4, in 
which it is recognised that this finding must be interpreted in the context of a 6cm 
difference in muscle mass. Cystatin C was higher in the most deprived group (p<0.0001), 
suggesting poorer renal function in that group. 
 
4.3.3.4 Cortisol 
 
There was no difference in plasma cortisol concentrations between the most and least 
deprived groups. Importantly, all specimens were taken in the morning (between 8am and 
11am). Analysis of cortisol results was repeated excluding participants who were on 
exogenous corticosteroid therapy, whether oral, inhaled or topical. A total of 284 least 
deprived and 263 most deprived participants remained. Mean (SD) plasma cortisol in the 
least deprived group was 350 (119) nmol/L, and in the most deprived group was 366 (127) 
nmol/L; p=0.133 for most versus least deprived (data not shown). 
 
4.3.3.5 Vitamin D 
 
Geometric mean concentrations of 25-hydroxy vitamin D (25-OHD) were higher among 
the least deprived (45.7±1.87 nmol/L) compared to the most deprived (34.2±2.02 nmol/L); 
p<0.0001. A total of 141 participants (22.6%) could be defined as being deficient in 
circulating 25-OHD (<25nmol/L), 49 in the least deprived group and 92 in the most 
deprived group (χ2 p<0.0001). Circulating 25-OHD concentrations were strongly 
associated with month of participation (blood sampling) across all participants; χ2 
p<0.0001. Median 25-OHD concentrations were lowest in February (33.1nmol/L; 
IQR 22.0-49.9nmol/L, n=103) and highest in June (70.8nmol/L; IQR 44.7-103.5nmol/L, 
n=40). When examining seasonal effects on 25-OHD concentrations by deprivation status 
(Figure 4.2), there was some evidence that the least deprived group had higher 25-OHD 
than the most deprived group at the onset of winter (Oct-Dec, p<0.05 in comparison of 
levels). Least deprived groups appeared to have higher 25-OHD concentrations for much 
of the year. There was no evidence of a trend towards month of participation in the study 
being different by deprivation group (χ2 p=0.69). 
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Figure 4.2 Variation in 25-OHD concentrations by month of participation in 
the two deprivation groups 
 
 
Point estimates are geometric means; error bars are 95% CI. Difference in 25-OHD 
between the least and most deprived groups is seen in March (p<0.01), October (p<0.05), 
November (p<0.01), and December (p<0.05). 
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4.4 Discussion 
 
4.4.1 Differences in cardiovascular risk factors between most and 
least deprived 
 
The finding that a significantly higher proportion of most deprived participants are current 
smokers compared to most affluent participants is entirely consistent with what would be 
expected from previously published statistics.3 In this current study, proportion of current 
cigarette smokers varied from 6.1% to 40.4%. The Let Glasgow Flourish report3 cites 
smoking prevalence varying from 16% in the least deprived areas to 63% in the most 
deprived areas. Although the ages of the survey populations are not directly comparable 
(16-74 years in Let Glasgow Flourish compared with 35 to 64 years in this study) the most 
striking difference is the date of sampling: 2001 in the case of Let Glasgow Flourish, and 
December 2005 to May 2007 in the case of this study. In March 2006, a ban on smoking in 
enclosed public places was introduced in Scotland, so the majority of participant visits in 
this study were conducted once the ban was in place. Previous data have shown an 
association between introduction of the public smoking ban and an increase in the rate of 
smoking cessation.20 
 
In this study, there was a significant difference in physical activity between least and most 
deprived participants, with just under half of most deprived participants being classed as 
inactive, compared with a quarter of least deprived participants. This classification is based 
on an assessment of both work and leisure time activity.154 This finding is in contrast to 
data from the NHS Greater Glasgow Health/Well-Being Survey 2002, which found that 
53% of most affluent subjects took at least 20 minutes of vigorous exercise at least 3 times 
per week or 30 minutes of moderate exercise at least 5 times per week, compared with 
59% of most deprived subjects.3 The differences between the findings of these two studies 
may be because of different methods of assessing physical activity, with the assessment in 
this study being more extensive, and including assessment of occupational and leisure 
activity. Another study which used similar methodology in assessing physical activity 
yielded similar results to this study.34  
 
The figures for self-reported alcohol consumption (7.8 units/week in the least deprived 
group; 3.5 units/week in most deprived) seem, at first glance, surprisingly low. As a point 
of comparison, the 2003 Scottish Health Survey found that in adults (age 16 years or older) 
living in Greater Glasgow, 32% of males and 17% of females were exceeding 
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recommended safe weekly limits of alcohol consumption (21 units for males and 14 units 
for females).3 Using these cut-offs, 26% of males and 10% of females in the pSoBid study 
were exceeding recommended limits (data not shown). Given the different ages of the two 
study populations (all aged 16 years or over in the case of the Scottish Health Survey and 
35 to 64 year olds in the pSoBid study) it is reasonable to expect a lower proportion of 
people to exceed recommended limits in the pSoBid study. While acknowledging the 
difficulties in obtaining accurate data on alcohol consumption, and the inherent potential 
inaccuracies when using self-reported alcohol consumption, the figures obtained in the 
pSoBid study therefore appear plausible.  
 
The results of the lipid analyses were very interesting. Total and LDL cholesterol were 
higher in the least deprived group. Findings from previous studies are conflicting. The 
Whitehall II study (which studied civil servants based in London)25 and the European 
Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk)26 found no 
consistent associations between socioeconomic status and total cholesterol concentration. 
In contrast, a study of 2063 adults aged 23 to 25 years in Brazil yielded similar results to 
this study, with lower total and LDL cholesterol concentrations being found in more 
deprived individuals.27 One message that can be taken from this finding is that if 
LDL/HDL ratio is used as an indicator of the contribution to cardiovascular risk from lipid 
parameters, this is unlikely to explain the deprivation-based difference in cardiovascular 
risk, as the LDL/HDL ratio was identical in the least and most deprived groups in this 
study (2.37 in both groups, p=0.91; data not shown). 
 
The observations of higher serum triglyceride concentration, lower HDL cholesterol 
concentration, higher fasting glucose and insulin concentrations, higher HOMA-IR index 
and higher waist/hip ratio in the most deprived group are easier to explain. There is a well 
documented higher risk of developing type 2 diabetes mellitus 3 25 43 44 155 and metabolic 
syndrome156 157 in more deprived individuals when compared with more affluent 
individuals. Abdominal obesity, fasting serum triglycerides >1.7mmol/L, HDL cholesterol 
<1.04mmol/L in men or <1.30mmol/L in women and fasting plasma glucose >6.1mmol/L 
are, of course, four of the five components used to diagnose metabolic syndrome (with 
blood pressure >130/85mmHg being the fifth component, and three or more providing a 
diagnosis of metabolic syndrome).10 Adiponectin concentrations are also known to be 
reduced in obesity and insulin resistance,158 so lower concentrations might have been 
expected in more deprived subjects, although this was not observed in this study. Leptin 
concentration is known to show a significant correlation with percentage fat mass,125 so it 
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is not surprising to find higher leptin concentrations in the most deprived group which had 
higher waist/hip ratio and, by virtue of having smaller height, a higher Body Mass Index 
(BMI). The height difference between the most deprived and most affluent group (a 
difference of 6cm) is, in itself, striking, and presumably related to significant differences in 
childhood nutrition.159 
 
The finding of higher levels of inflammation in the most deprived group, as demonstrated 
by higher CRP and IL-6 concentrations, is in keeping with previous data from the West of 
Scotland Coronary Prevention Study (WOSCOPS) and the Midspan Study, in which 
associations noted between CRP and social deprivation were not fully explained by 
smoking and body mass index.63 Soluble intercellular adhesion molecule (sICAM-1) has 
been implicated in inflammatory processes and in endothelial dysfunction.70 Associations 
have been noted between increasing concentrations of sICAM-1 and risk of future 
myocardial infarction160 so the finding of increased concentrations of sICAM-1 in the most 
deprived group is of interest, although not unexpected. 
 
The associations between social deprivation and markers of haemostasis have previously 
been investigated. An analysis of the 1958 British Birth Cohort found higher 
concentrations of fibrinogen, von Willebrand Factor antigen and tissue Plasminogen 
Activator antigen in individuals with higher cumulative levels of social deprivation. After 
adjustment for body mass index, smoking and physical activity, the trend for fibrinogen 
remained significant.77 Similarly, the British Regional Heart Study found that in British 
men aged 60 to 79 years with no diagnosis of cardiovascular disease, diabetes or 
musculoskeletal disease requiring anti-inflammatory medication, social deprivation was 
associated with higher concentrations of fibrinogen, von Willebrand Factor and fibrin D-
dimer, but not tissue Plasminogen Activator antigen. The association with von Willebrand 
Factor persisted after adjustment for behavioural risk factors.67 Remarkably similar 
findings are demonstrated in this study which involved males and females in a younger age 
group, but again demonstrated a socioeconomic gradient in vWF, fibrinogen and D-dimer, 
but not tPA antigen. 
 
The finding of higher concentrations of ADMA in the most deprived group is interesting, 
and – to the best of my knowledge – novel. This finding is not surprising, though, in view 
of the known associations of ADMA with insulin resistance, and the evidence of higher 
levels of insulin resistance in the most deprived group in this study. ADMA is a biomarker 
around which there is considerable current interest, and there is significant potential for 
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further work exploring the extent to which ADMA is a mediator, as opposed to simply a 
marker, of processes leading to atherosclerosis. Similarly, the finding of higher 
homoarginine concentrations in the least deprived group is novel. Homoarginine has been 
less extensively studied than ADMA. However, it is known that homoarginine competes 
with arginine for binding sites on nitric oxide synthase. Unlike ADMA, which directly 
inhibits nitric oxide synthase, homoarginine is simply a less efficient substrate than 
arginine for nitric oxide synthase.161 Interestingly, homoarginine is increased during the 
second and third trimesters of pregnancy, and it has been suggested that this may 
contribute to the enhanced endothelial function seen in pregnancy.162 Thus, the finding of 
higher concentrations of homoarginine in the least deprived may be suggestive of superior 
endothelial function in this group, which is in turn consistent with lower concentrations of 
sICAM-1 being found in the least deprived group. 
 
Of the three markers of liver damage measured, only GGT differed between the most and 
least deprived groups. It is striking that this difference (higher GGT in the most deprived 
group) was seen despite weekly self-reported alcohol consumption being higher in the least 
deprived group, and the effect of deprivation in predicting GGT being independent of age, 
sex and alcohol consumption. Although ALT is the most commonly recognised marker of 
non-alcoholic fatty liver disease, GGT is also elevated in many cases of fatty liver, and its 
elevation is indicative of increased mortality in men, especially those with ultrasound 
evidence of hepatic steatosis.163 It is, therefore, unsurprising that higher BMI was 
significantly associated with higher GGT in a model adjusted for age, sex, deprivation and 
self-reported alcohol intake (Table 4.6). However, deprivation remained a significant 
predictor of GGT, even after this additional adjustment for BMI.  
 
The finding of higher creatinine concentrations in the least deprived group might at first 
seem surprising. However, there was a difference of 6cm in height between the most and 
least deprived groups, so it is likely that the differences in creatinine concentration are a 
result of differences in muscle mass. Furthermore, MDRD 4 variable eGFR uses 
creatinine, age, sex and ethnicity to estimate GFR. Since the participants were selected in a 
way to include approximately equal numbers of males and females in each group, and 
equal numbers from each age tertile, it is not surprising that eGFR has been estimated to be 
higher in the most deprived group: again, this is likely to be a consequence of lower 
creatinine in this group as a results of lower muscle mass. Cystatin C, whose concentration 
is not specifically related to muscle mass, is likely to be a more appropriate marker of renal 
function in this context. The finding of higher cystatin C concentration, i.e. lower GFR, in 
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the most deprived group, is consistent with previous findings in an African American 
population,151 and may be indicative of higher cardiovascular risk in the most deprived 
group.150 
 
No difference was noted in plasma cortisol concentrations between the most and least 
deprived groups. This is in contrast to the findings from the Caerphilly study, although that 
study examined cortisol to testosterone ratios on the basis that the response to stress in 
males involves a rise in cortisol concentrations and a fall in testosterone, the ratio therefore 
incorporating both of these features. In addition, the pSoBid study had some variation in 
time of sampling between 8 and 11am, although all samples were still morning plasma 
samples, and the timing was less variable than in the Caerphilly study, in which samples 
were taken between 3 and 11am, although the majority were between 7 and 8am.144 
 
Circulating 25-hydroxy vitamin D concentrations were “suboptimal” in a sizeable 
proportion (22.6%) of the urban population of Glasgow, particularly in socially deprived 
communities. The observation that social deprivation is an important determinant of 25-
OHD status significantly extends a prior study suggesting 25-OHD concentrations are 
lower among UK state benefit recipients.164 Association of 25-OHD with social 
deprivation may be one explanation for the discrepancy between epidemiological findings 
of associations between 25OHD and CVD risk, and lack of efficacy of vitamin D 
supplementation in randomised controlled trials,143 although of course, dose of 
supplementation may be relevant.  
 
In summary, the work described in this chapter has shown deprivation-based differences in 
cigarette smoking, physical activity, self-reported alcohol consumption (higher in least 
deprived), total and LDL cholesterol (higher in least deprived), markers of insulin 
resistance/adiposity, inflammation, endothelial dysfunction, haemostasis, renal function 
and vitamin D status. The next question to be addressed, therefore, is which – if any – of 
these factors contribute to the deprivation-based difference in cardiovascular risk, and this 
issue is addressed in Chapter 5. 
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CHAPTER 5 – SOCIAL DEPRIVATION AND ULTRASOUND MARKERS OF 
ATHEROSCLEROSIS 
 
5.1 Introduction  
 
As discussed in Chapter 1, the socioeconomic gradient in coronary heart disease is only 
partly explained by classic cardiovascular risk factors39 165 and it remains to be seen to 
what extent emerging risk factors contribute to this gradient.  
 
Carotid ultrasound is recognised as an efficient and validated tool for assessing the degree 
of atherosclerosis in an individual. Measurement of the artery wall intima-media thickness 
(cIMT) is a commonly employed index. As discussed in Chapter 1, the age-and-sex-
adjusted relative risk for myocardial infarction is 1.15 (95% confidence intervals 1.12 to 
1.17) for every 0.10mm increase in cIMT. For stroke, the age-and-sex-adjusted relative 
risk is 1.18 (95% confidence intervals 1.16 to 1.21) for every 0.10mm increase in cIMT.79 
Ultrasound detection of carotid plaque is also highly informative,80 plaque score having 
been shown to be associated with risk of myocardial infarction81-83 and stroke.84 In the 
Rotterdam study, hazard ratio for myocardial infarction was 1.83 (95% confidence 
intervals 1.27 to 2.62) for plaque score of >3 versus 081 and age-and-sex-adjusted relative 
risk for stroke was 1.61 (95% confidence interval 1.16–2.23) for highest to lowest tertile of 
plaque score.84 The American Society of Echocardiography has recognised a clinical role 
for carotid intima-media thickness (cIMT) measurement and plaque detection in refining 
cardiovascular risk assessment in asymptomatic patients assessed as being at intermediate 
cardiovascular risk.78 Previous studies have found associations between area-based 
indicators of social deprivation and both cIMT and plaque presence.92 93 
 
The aim of the work described in this chapter was to enhance current understanding of the 
factors underlying associations between deprivation and atherosclerosis. The hypothesis 
was that social deprivation would be associated with higher cIMT and / or plaque score but 
that adjustment for emerging risk factors, especially inflammatory markers, would account 
for such differences. 
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5.2 Methods 
 
 5.2.1 Carotid ultrasound 
 
Carotid ultrasound was performed during the second study visit as described in Chapter 2.   
The pre-specified primary outcome was mean common carotid intima-media thickness, 
measured on the far wall of each arterial segment, averaged along a 1cm length, or as much 
of this as was able to be read. The secondary outcome was plaque score,81 determined by 
counting the number of plaques, dividing by the number of readable images present and 
multiplying by 6 (the maximum possible number of images per subject),81 thus adjusting 
for unreadable images.  
 
5.2.2 Statistical analysis 
 
For cIMT an analysis was performed of thickness versus age for males and females in each 
deprivation category. Since the slopes and intercepts differed in least versus most deprived 
groups a 2-degree of freedom test was employed. For analysis of plaque score, negative 
binomial regression was carried out with additional adjustment for the number of missing 
scans. For multivariate models involving plaque, plaque presence was used as the 
dependent variable and logistic regression was used for modelling. In multivariate 
analyses, missing values were removed from the relevant analyses. 
 
Carotid intima-media thickness data are presented in tertile of age for each deprivation 
group using "box-and-whisker" plots. Plaque score in age tertiles and deprivation groups is 
presented as a bar plot.  
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5.3 Results 
 
Differences in ultrasound markers of atherosclerosis are shown in Table 5.1. For mean 
cIMT, the age and sex-adjusted difference for most versus least deprived was +0.02mm 
(p=0.015). When analysing males and females separately, mean cIMT showed a 
statistically significant difference between most and least deprived for males (p=0.044) but 
not for females (p=0.77) (data not shown). Figure 5.1 shows the differences in cIMT and 
plaque score for each gender, separately split by age tertile. The ages stated for each age 
tertile are the ages of the participants at the time of carotid ultrasound scan, by which point 
the participants were slightly older than they were at the time of original selection for the 
study. The expected increase in cIMT with age was observed and the difference in cIMT 
between most and least deprived only reached statistical significance in the highest age 
tertile (56.3-66.5 years) in males and did not achieve statistical significance in females at 
any age. By contrast, plaque score showed highly significant differences (all p<0.01) in 
males in the two highest age tertiles (46.8-56.2 years and 56.3-66.5 years) and in females 
in the highest age tertile (56.3-66.5 years). 
 
5.3.1 Area-level deprivation difference in cIMT: potential explanatory 
variables 
 
As planned in the study protocol,166 analyses were carried out to uncover potential 
explanations for the area-level deprivation difference in cIMT. Since this difference was 
significant only in males when analysing the genders separately, only males were included 
in these analyses. For age-adjusted carotid intima-media thickness cIMT, the following 
variables of the list in Table 4.1 were significant correlates: log triglycerides showed a 
positive association (p=0.0092); HDL cholesterol was negatively associated (p=0.044) and 
systolic blood pressure was positively associated (p=0.028). Of note, 25-hydroxy vitamin 
D concentration was not associated with cIMT (p=0.99). A number of multivariate models 
were then constructed, with potential explanatory variables grouped according to category 
of risk marker (e.g. classical risk factors; markers of insulin resistance; inflammatory 
markers; markers of haemostasis). On plotting cIMT versus age, both gradients and 
intercepts differed between most and least deprived males. Table 5.2 shows the mean 
difference in gradient between most and least deprived males, adjusted as described for 
each model. Model 2, which included classic risk factors (age, triglycerides, low density 
lipoprotein cholesterol, high density lipoprotein cholesterol, systolic blood pressure, 
diastolic blood pressure, history of regular smoking and history of hypertension) 
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Table 5.1 Differences in ultrasound markers of atherosclerosis between 
most and least deprived groups 
 
 
 
 
 
 
 
 
a
 difference between least deprived and most deprived after adjusting for age and sex
Variable Least deprived 
(n=342) 
Most deprived 
(n=324) 
p 
Mean carotid intima-media 
thickness (cIMT) (mm) 
 
0.68 (0.12) 
 
0.70 (0.16) 
 
0.015a 
 Data missing 23 29  
 
Plaque score: 
0 plaques 193 (56.9%) 130 (41.7%) 
1-2 plaques 101 (29.8%) 89 (28.5%) 
>2 plaques 45 (13.3%) 93 (29.8%) 
 
 
 
<0.0001  
for trend 
 Data missing 3 12  
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Figure 5.1 Severity of atherosclerosis by tertile of age and deprivation 
category 
LD: Least Deprived; MD: Most Deprived. Numbers refer to tertiles of age in years – e.g. “LD 35-46.7” refers 
to the Least Deprived youngest age tertile (35 to 46.7 years old). Grey and white box-and-whisker plots show 
cIMT in mm; coloured (red, amber and green) bars indicate the percentage of subjects in each group with      
0 (green), 1-2 (amber) or more than 2 (red) plaques.
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Table 5.2 Difference between men from the least deprived areas and those 
from the most deprived areas in gradient of mean common carotid intima-
media thickness (cIMT) plotted against age  
 
Mean difference 
(95% CI) 
F-test p value  
Model 1 -0.07 (-0.11 to -0.02), p=0.0059 0.0011 
Model 2  
(classic) 
-0.06 (-0.11 to -0.01), 
p=0.021 0.031 
Model 3  
(classic+insulin resistance)  
-0.07 (-0.12 to -0.02), 
p=0.008 0.017 
Model 4  
(classic+inflammatory)  
-0.06 (-0.11 to -0.01), 
p=0.021 0.018 
Model 5  
(classic+haemostasis)  
-0.06 (-0.11 to -0.01), 
p=0.02 0.037 
Model 6  
(classic+physical activity) 
-0.06 (-0.11 to -0.01), 
p=0.018 0.026 
Model 7 
(classic+all emerging+ 
physical activity) 
-0.08 (-0.13 to -0.02), 
p=0.0075 0.010 
Model 8 
(classic+individual 
socioeconomic status – early 
life) 
-0.06 (-0.11 to -0.01), 
p=0.024 0.053 
Model 9 
(classic+individual 
socioeconomic status –  
all factors) 
-0.07 (-0.12 to -0.02), 
p=0.01 0.03 
Model 10 
(classic+all)  
-0.1 (-0.16 to -0.03), 
p=0.0025 0.010 
 
Model 1 – not adjusted for other factors 
Model 2 (classic markers) – adjusted for: triglycerides, LDL cholesterol, HDL cholesterol, systolic blood 
pressure, diastolic blood pressure, smoking, history of hypertension 
Model 3 (classic+insulin resistance markers) – as Model 2+waist circumference, glucose, HOMA-IR, 
adiponectin, leptin, history of diabetes 
Model 4 (classic+inflammatory) - as Model 2+CRP, IL-6, sICAM-1 
Model 5 (classic+haemostasis) - as Model 2+fibrinogen, D-dimer, vWF 
Model 6 (classic+physical activity) – as Model 2+physical activity 
Model 7 (classic+all emerging + physical activity) – as Model 2+ waist circumference, glucose, HOMA-IR, 
adiponectin, leptin, history of diabetes, CRP, IL-6, sICAM-1, fibrinogen, D-dimer, vWF, physical activity 
Model 8 (classic+individual socioeconomic status – early life) – as Model 2+height, leg length, people/room 
at age 11 years, father’s Registrar General Social Class, total years of education 
Model 9 (classic+individual socioeconomic status – all factors) – as Model 8+participant’s Registrar General 
Social Class, annual household income 
Model 10 (classic+all) – as Model 2+waist circumference, glucose, HOMA-IR, adiponectin, leptin, history of 
diabetes, CRP, IL-6, sICAM-1, fibrinogen, D-dimer, vWF, physical activity, height, leg length, people/room 
at age 11 years, father’s Registrar General social class, participant’s Registrar General social class, annual 
household income, total years of education 
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failed to attenuate the cIMT difference in most versus least deprived men. In further 
models, emerging risk markers were added in groups representing insulin resistance, 
inflammatory factors and haemostasis. Further models incorporating physical activity and 
individual-level markers of socioeconomic status were constructed. Finally, all variables 
were added simultaneously to the model. With all classic and emerging risk factors added, 
and individual level markers of socioeconomic status included, the difference in cIMT 
between most and least deprived males remained significant (Model 10).  
 
5.3.2 Area-level deprivation difference in plaque score: potential explanatory 
variables 
 
On age and sex adjusted analyses, the following were significant predictors of plaque 
presence: log triglycerides (p=0.0016), systolic blood pressure (p=0.0079), diastolic blood 
pressure (p=0.049), current smoking (p<0.0001), log sICAM-1 (p=0.00028) and fibrinogen 
(p=0.023). Height (p=0.00013) and hip circumference (p=0.00014) were negatively 
associated with plaque presence. 25-hydroxy vitamin D concentration was not associated 
with plaque presence (p=0.36). 
 
Similar models to those used for cIMT were constructed using presence of plaque as the 
dependent variable, with the analyses being run in all subjects (as plaque score 
demonstrated significant differences between most and least deprived in both males and 
females). Plaque presence was used as the dependent variable in these analyses (rather than 
plaque score) because plaque score did not fit conventional distributions that might be used 
for regression analyses and it was decided that the binary approach transformation would 
contain most of the information in the data. The results are shown in Table 5.3. With all 
classic and emerging risk factors and physical activity included in a model predicting 
plaque presence (Model 7), the area-level deprivation-based differences in plaque presence 
remained significant (adjusted odds ratio of 1.73 [95% confidence intervals 1.07 to 2.82] 
for plaque presence in most deprived versus least; p=0.026). In general terms, individuals 
from most deprived areas had around a 1.6 to 2-fold higher risk for presence of carotid 
plaque compared to those from least deprived areas.  
 
In contrast to the effect on cIMT, however, inclusion of early life individual markers of 
socioeconomic status (height, leg length, people/room at age 11 years, father’s Registrar 
General Social Class and total years of education) in an age-and sex-adjusted model 
(Model 8) abolished the area-level deprivation-based difference in plaque presence 
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(adjusted odds ratio for plaque presence = 0.94 [0.54 to 1.65]; p=0.84). When the 
individual level markers of socioeconomic status (height, leg length, people/room at age 11 
years, father’s Registrar General Social Class, participant’s Registrar General Social Class, 
annual income, total years of education) were each added in turn to an age-and-sex 
adjusted model, none of the individual-level markers of socioeconomic status on their own 
abolished the area-level deprivation-based difference in plaque presence (data not shown). 
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Table 5.3 Odds ratio for presence of plaque in most deprived versus least 
deprived individuals with adjustment for classic risk factors without and 
with addition of emerging risk factors  
 
Odds ratio for plaque 
presence (95% CI) 
Model 1 2.05 (1.45 to 2.89) p<0.0001 
Model 2  
(classic) 
1.71 (1.14 to 2.55) 
p=0.009 
Model 3  
(classic+insulin resistance)  
1.82 (1.18 to 2.80) 
p=0.0066 
Model 4  
(classic+inflammatory)  
1.71 (1.11 to 2.65) 
p=0.015 
Model 5  
(classic+haemostasis)  
1.77 (1.16 to 2.69) 
p=0.0075 
Model 6  
(classic+physical activity) 
1.60 (1.05 to 2.41) 
p=0.027 
Model 7 
(classic+all emerging+ 
physical activity) 
1.73 (1.07 to 2.82) 
p=0.026 
Model 8 
(classic+individual 
socioeconomic status – early 
life) 
0.94 (0.54 to 1.65) 
p=0.84 
Model 9 
(classic+individual 
socioeconomic status –  
all factors) 
1.12 (0.53 to 2.37) 
p=0.76 
Model 10 
(classic+all)  
1.05 (0.45 to 2.44) 
p=0.91 
Model 1 – adjusted for age, sex and scans present 
Model 2 (classic markers) – adjusted for: age, sex, scans present, triglycerides, LDL cholesterol, HDL 
cholesterol, systolic blood pressure, diastolic blood pressure, smoking, history of hypertension 
Model 3 (classic+insulin resistance markers) – as Model 2+waist circumference, glucose, HOMA-IR, 
adiponectin, leptin, history of diabetes 
Model 4 (classic+inflammatory) - as Model 2+ CRP, IL-6, sICAM-1 
Model 5 (classic+haemostasis) - as Model 2+fibrinogen, D-dimer, vWF 
Model 6 (classic+physical activity) – as Model 2+physical activity 
Model 7 (classic+all emerging + physical activity) – as Model 2+ waist circumference, glucose, HOMA-IR, 
adiponectin, leptin, history of diabetes, CRP, IL-6, sICAM-1, fibrinogen, D-dimer, vWF, physical activity 
Model 8 (classic+individual socioeconomic status – early life) – as Model 2+height, leg length, people/room 
at age 11 years, father’s Registrar General social class, total years of education 
Model 9 (classic+individual socioeconomic status – all factors) – as Model 8+participant’s Registrar General 
social class, annual household income 
Model 10 (classic+all) – as Model 2+waist circumference, glucose, HOMA-IR, adiponectin, leptin, history of 
diabetes, CRP, IL-6, sICAM-1, fibrinogen, D-dimer, vWF, physical activity, height, leg length, people/room 
at age 11 years, father’s Registrar General social class, participant’s Registrar General social class, annual 
household income, total years of education 
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5.4 Discussion 
 
The work described in this chapter examined prevalence of carotid atherosclerosis in 
subjects at extremes of the socio-economic gradient in Glasgow, a city with well 
documented health issues associated with social deprivation. Plaque score and cIMT were 
significantly worse in the more deprived group. Although there were clear differences in 
biomarkers of chronic inflammation between most and least deprived groups (see Chapter 
4), neither these nor classic risk factors satisfactorily explained the increased 
atherosclerosis burden in the lower socio-economic group. Only adjusting for individual-
level markers of socioeconomic status explained the area-level difference in carotid plaque 
presence, and even this adjustment did not explain the area-level difference in cIMT. 
 
A striking finding is that plaque score showed differences between the two groups at an 
earlier age than cIMT, although the trends in cIMT are in the expected direction (rising 
with age; greater in males). It is not surprising that the difference in cIMT between least 
and most deprived did not reach statistical significance in females in any age tertile studied 
given that the difference in males only reached statistical significance in the highest age 
tertile, and the fact that atherosclerosis tends to develop around a decade later in females. 
In contrast to cIMT, differences in plaque score were highly statistically significant, 
reaching significance in the two highest age tertiles in males, and the highest age tertile in 
females. This observation suggests that plaque score measured in a standardised, objective 
and blinded way could be more useful than cIMT when studying differences in severity of 
atherosclerosis as in this study. 
 
5.4.1 Factors underlying the area-level deprivation difference in 
atherosclerosis 
 
On multivariate analysis, classic risk factors reduced but did not abolish the area-level 
deprivation difference in plaque presence and cIMT, strongly suggesting that classic risk 
factors do not fully explain the difference in ultrasound markers of atherosclerosis between 
most and least deprived subjects. Given the involvement of inflammatory pathways in 
atherosclerosis,167 and the significant differences in inflammatory markers noted between 
deprivation categories in this and other studies,63 it might have been expected that 
inclusion of markers of inflammation and/or endothelial dysfunction would have reduced 
or abolished the significant difference in plaque score, and this was indeed my hypothesis. 
However, none of the measured markers of inflammation, insulin resistance or haemostasis 
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had a significant impact on the ability of area-level deprivation to predict plaque presence, 
with area-level deprivation remaining a significant predictor even once all classic and 
emerging risk factors were included in the model. These findings are consistent with those 
from the Women’s Health Study, in which the inverse association between educational 
attainment and risk of cardiovascular events was not reduced by adjusting for CRP, 
sICAM-1, fibrinogen or homocysteine.71 Only by adjusting for individual-level early life 
markers of socioeconomic status was the area-level deprivation-based difference in plaque 
presence abolished, and it is of interest that even this adjustment did not explain the area-
level deprivation-based difference in cIMT in males. Given the fact that area-level and 
individual-level markers of socioeconomic status are likely to be highly correlated, it is 
clearly highly plausible that the abolition of the area-level deprivation difference in plaque 
presence on adjusting for individual-level markers of socioeconomic status may be due to 
overadjustment. It would have been of further interest to know if assessment of plaque 
volume would have yielded further useful information,133 although the technology 
allowing such assessment is not yet widely available. 
 
This work demonstrates the great significance of area level deprivation as a predictor of 
atherosclerosis. Classic cardiovascular risk factors did not fully explain the difference in 
plaque presence between most and least deprived participants, suggesting that current 
public health messages directed at classic risk factors (diet, blood pressure, smoking) may 
not adequately address the problem of the continuing socioeconomic gradient in 
cardiovascular disease. The findings add weight to the case for inclusion of social 
deprivation in cardiovascular risk assessment, as has been done in the ASSIGN 
(ASSessing cardiovascular risk using SIGN) scoring system.168 
 
Although the deprivation-based difference in atherosclerosis was not explained by the 
classic risk factors examined, neither (and somewhat surprisingly) was it explained by the 
range of emerging markers measured in this study. Health status is a reflection not only of 
features of the individual but also of wider social and economic influences, health and 
social services, early life experience and environmental factors. The analyses reported in 
this chapter have focused on biological pathways. Further analyses focusing on the relative 
strengths of different pathways in explaining the health gap seen between the most and 
least deprived groups may help in unravelling the multifactorial nature of health 
inequalities. 
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CHAPTER 6 – RELATIONSHIP BETWEEN CARDIOVASCULAR RISK 
MARKERS AND ULTRASOUND MARKERS OF ATHEROSCLEROSIS 
 
6.1 Introduction 
 
In Chapter 5, differences were observed between the information that could be gleaned 
from cIMT and that obtainable from plaque score. More marked differences between the 
deprivation groups were noted for plaque score than for cIMT, and the differences became 
significant at a younger age for plaque score than for cIMT. Furthermore, while individual-
level early life markers of socioeconomic status explained the deprivation-based difference 
in plaque score, adjustment for individual-level markers of socioeconomic status did not 
explain the differences in cIMT. These observations prompt a closer examination of the 
relationship between the measured cardiovascular risk markers and cIMT and plaque. 
 
cIMT is thought to represent hypertrophy of intimal and medial cells in response to lipid 
infiltration or hypertension, while plaque formation is thought to represent a later stage of 
atherogenesis involving inflammation, oxidation, endothelial dysfunction and/or smooth 
muscle cell proliferation.169 The Cardiovascular Health Study of 5201 men and women 
aged 65 years and older found that increasing age, male sex, systolic blood pressure, LDL 
cholesterol concentration, history of smoking, hypertension, diabetes mellitus and presence 
of any major ECG abnormality were associated with increased cIMT. HDL cholesterol and 
diastolic blood pressure were negatively associated with cIMT.170 A study by Spence and 
Hegele found age, male sex, smoking, diabetes mellitus, systolic blood pressure, total 
cholesterol, plasma homocysteine and treatment with lipid-lowering or antihypertensive 
therapy to be associated with total carotid plaque area.169 A more recent study involving 
the same investigators found that cIMT was significantly associated with hypertension, 
total plaque area with smoking and plasma cholesterol and total plaque volume with 
diabetes mellitus.171 
 
The wide range of biomarkers analysed in the pSoBid study provides an ideal opportunity 
for further investigation of the biomarkers associated with cIMT and those associated with 
plaque score. The aim of the work described in this chapter was to further understanding of 
the biomarkers associated with variation in cIMT and those associated with plaque score. 
Emerging biomarkers have been much less extensively studied than classic risk factors, so 
a particular aim was to expand knowledge of the role of emerging biomarkers. The 
hypothesis was that hypertension and cholesterol would explain much of the variation in 
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cIMT, while emerging biomarkers, especially markers of inflammation, would contribute 
to the explanation of variation in plaque score. 
 
6.2 Methods 
 
The cIMT and plaque results used for the analysis described in this chapter are those 
detailed in Chapter 5. The biomarkers used as covariates are those detailed in Table 4.1. 
 
Multivariate models were constructed using log transformed cIMT as the dependent 
variable. For these analyses, all participants were included (i.e. the analysis was not 
restricted to males only as it had been in Chapter 5). An initial model (Model 1) was 
adjusted for age, sex and deprivation. In subsequent models, covariates were added in 
groups representing: classic risk factors (Model 2), inflammation (Model 3), insulin 
resistance (Model 4), haemostasis (Model 5) and early life socioeconomic factors (Model 
6). In each case, after construction of the full model, a backward selected model was used 
to identify those variables retaining a significant association with cIMT. Finally (Model 7) 
bootstrap variable selection was used. A sample of the data (of the same size, where 
individuals can appear more than once in the sample) was taken and variables identified 
which had a significant association with cIMT, from those variables identified in the 
individual backward selected models (Models 1 to 6). This was repeated 1000 times and 
the confidence interval and p-value derived from these 1000 values. A forward stepwise 
selection was then carried out on those variables that had been selected in at least 50% of 
the models in order to identify those variables retaining a significant association with 
cIMT. This bootstrap model selection was then repeated in only those subjects with no 
history of CVD, in those not on statin therapy, in those not on antihypertensive treatment 
and in those not on statin or antihypertensive treatment. 
 
This procedure was repeated with plaque presence (as a binary variable) as the dependent 
variable, using logistic regression analysis. 
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6.3 Results 
 
 6.3.1 Predictors of cIMT 
 
Table 6.1 shows the effect of age, male sex and being in the most deprived group on 
cIMT. As expected (and as observed in Chapter 5), cIMT increased with age, and was 
higher in males than in females. The effect on cIMT of being in the most versus least 
deprived group has already been extensively discussed in Chapter 5. The purpose of Model 
1 was to provide an age, sex and deprivation-adjusted baseline model to which classic and 
emerging cardiovascular risk factors could be added in groups, in order to identify which 
factors were associated with and might underlie increases in cIMT. 
 
The associations of classic risk factors with cIMT are shown in Table 6.2. Of the classic 
risk factors, HDL cholesterol had a negative association with cIMT (p<0.001 in backward 
selected model). Systolic blood pressure was positively associated with cIMT (p<0.001) 
and diastolic blood pressure had an inverse association (p = 0.014). 
 
The associations of inflammatory markers with cIMT are shown in Table 6.3. In the full 
model, CRP was positively associated with cIMT. However, none of the markers of 
inflammation were associated with cIMT in the backward selected model. 
 
The associations with cIMT of markers associated with insulin resistance are shown in 
Table 6.4. The only significant association was a negative effect of adiponectin on cIMT. 
Lower concentrations of adiponectin indicate a higher degree of insulin resistance, so this 
finding is consistent with higher levels of insulin resistance being associated with thicker 
cIMT. None of the markers of haemostasis were associated with cIMT (Table 6.5). 
 
In Table 6.6, the associations of early life individual-level markers of socioeconomic 
status with cIMT are shown. Leg length, a marker of childhood nutrition, showed a 
negative association with cIMT, i.e. shorter leg length (and, by association, poorer 
childhood nutritional status) was associated with thicker cIMT. Paradoxically, the 
association of height with cIMT was positive: taller height was associated (albeit less 
strongly than leg length) with thicker cIMT. 
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Table 6.1 Effect of age, sex and deprivation on cIMT (Model 1) 
 
Variable Effect 95% confidence interval p 
Age 0.010 (0.009, 0.012) <0.001 
Sex (male) 0.059 (0.033, 0.085) <0.001 
Deprivation (most deprived) 0.029 (0.003, 0.055) 0.028 
 
 
 
Table 6.2 Associations of classic cardiovascular risk factors with cIMT 
(Model 2) 
 
Full model Backward selected model 
 
 Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.008 (0.006, 0.010) <0.001 
 
0.009 (0.007, 0.011) <0.001 
Sex (male) 0.019 (-0.011, 0.048) 0.210 
 
0.027 (-0.001, 0.055) 0.062 
Deprivation (most deprived) 0.001 (-0.030, 0.032) 0.947 
 
0.013 (-0.013, 0.040) 0.321 
Triglycerides * 0.011 (-0.019, 0.042) 0.458 
 
- - - 
LDL cholesterol 0.016 (0.000, 0.032) 0.055 
 
- - - 
HDL cholesterol -0.071 (-0.113, -0.030) 0.001 
 
-0.066 (-0.103, -0.030) <0.001 
Systolic blood pressure 0.003 (0.002, 0.004) <0.001 
 
0.003 (0.002, 0.004) <0.001 
Diastolic blood pressure -0.003 (-0.004, -0.001) 0.005 
 
-0.002 (-0.004, 0.000) 0.014 
Smoking (current) 0.031 (-0.005, 0.066) 0.088 
 
- - - 
History of hypertension -0.001 (-0.038, 0.036) 0.958 
 
- - - 
 
*
 log-transformed 
 
 
 
Table 6.3 Associations of inflammatory markers with cIMT (Model 3) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.010 (0.009, 0.012) <0.001 
 
0.010 (0.009, 0.012) <0.001 
Sex (male) 0.063 (0.036, 0.090) <0.001 
 
0.059 (0.033, 0.085) <0.001 
Deprivation (most deprived) 0.027 (-0.003, 0.058) 0.081 
 
0.029 (0.003, 0.055) 0.028 
CRP * 0.020 (0.005, 0.035) 0.009 
 
- - - 
IL-6 -0.010 (-0.021, 0.002) 0.091 
 
- - - 
sICAM-1 * 0.001 (-0.058, 0.059) 0.978 
 
- - - 
 
*
 log-transformed 
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Table 6.4 Associations of markers of insulin resistance with cIMT (Model 4) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.011 (0.009, 0.013) <0.001 
 
0.011 (0.009, 0.012) <0.001 
Sex (male) 0.042 (-0.009, 0.092) 0.104 
 
0.037 (0.008, 0.066) 0.012 
Deprivation (most deprived) 0.025 (-0.003, 0.053) 0.075 
 
0.023 (-0.004, 0.050) 0.093 
Waist circumference 0.000 (-0.001, 0.002) 0.684 
 
- - - 
Glucose -0.011 (-0.033, 0.011) 0.313 
 
- - - 
HOMA-IR * 0.001 (-0.026, 0.028) 0.941 
 
- - - 
Adiponectin * -0.055 (-0.087, -0.023) 0.001 
 
-0.051 (-0.079, -0.022) 0.001 
Leptin * 0.007 (-0.023, 0.037) 0.651 
 
- - - 
Diabetes -0.059 (-0.250, 0.132) 0.543 
 
- - - 
 
*
 log-transformed 
 
 
 
Table 6.5 Associations of markers of haemostasis with cIMT (Model 5) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.011 (0.009, 0.012) <0.001 
 
0.010 (0.009, 0.012) <0.001 
Sex (male) 0.058 (0.030, 0.085) <0.001 
 
0.059 (0.033, 0.085) <0.001 
Deprivation (most deprived) 0.032 (0.004, 0.061) 0.026 
 
0.029 (0.003, 0.055) 0.028 
Fibrinogen 0.015 (-0.007, 0.038) 0.173 
 
- - - 
D-dimer * -0.018 (-0.045, 0.008) 0.176 
 
- - - 
von Willebrand factor 0.000 (-0.001, 0.000) 0.367 
 
- - - 
 
*
 log-transformed 
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Table 6.6 Associations of early life socioeconomic factors with cIMT  
(Model 6) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 
95% confidence 
interval p 
Age 0.010 (0.008, 0.012) <0.001 
 
0.010 (0.009, 0.012) <0.001 
Sex (male) 0.061 (0.016, 0.105) 0.007 
 
0.061 (0.019, 0.104) 0.005 
Deprivation (most deprived) 0.011 (-0.031, 0.054) 0.597 
 
0.026 (-0.005, 0.057) 0.104 
Height 0.004 (0.000, 0.008) 0.029 
 
0.004 (0.000, 0.007) 0.046 
Leg length -0.008 (-0.013, -0.003) 0.002 
 
-0.008 (-0.012, -0.003) 0.002 
People per room at age 11 years * -0.002 (-0.040, 0.036) 0.923 
 
- - - 
Father's social class (Non-
manual) -0.019 (-0.054, 0.016) 0.287  - - - 
Years of education * -0.038 (-0.112, 0.036) 0.310 
 
- - - 
 
*
 log-transformed 
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As described in Section 6.2, bootstrap variable selection was then used to identify, from all 
variables identified in the previous backward selected models (Models 1 to 6), those 
associated with cIMT. The results are shown in Table 6.7. HDL cholesterol had a negative 
association with cIMT; systolic blood pressure had a positive association, and diastolic 
blood pressure had a negative association. Leg length had a negative association with 
cIMT.  
 
In order to determine if the associations identified in Model 7 were consistent throughout 
the study subjects, the same procedure of bootstrap variable selection was used: in only 
those subjects with no history of CVD (Table 6.8); in only those subjects not on statin 
therapy (Table 6.9); in only those subjects not on antihypertensive therapy (Table 6.10) 
and in only those subjects on neither statin nor antihypertensive therapy (Table 6.11). The 
findings in each subgroup were generally consistent: in subjects with no history of 
cardiovascular disease (Table 6.8), significant associations with cIMT were found for 
HDL cholesterol (negative association), systolic blood pressure (positive association) and 
diastolic blood pressure (negative association). Adiponectin showed a negative association 
with cIMT, i.e. lower adiponectin concentrations (associated with higher levels of insulin 
resistance) were associated with thicker cIMT.  
 
When the same analyses were run only in subjects not on: statin therapy (Table 6.9); 
antihypertensive therapy (Table 6.10) or either statin or antihypertensive therapy (Table 
6.11), the associations of systolic blood pressure, diastolic blood pressure (negative 
association), leg length (negative association) and HDL cholesterol (negative association) 
with cIMT were again present.  
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Table 6.7 Associations of co-factor variables with cIMT (Model 7) 
 
 
Estimated effect 95% confidence interval p 
Age 0.009 (0.007, 0.010) <0.001 
Sex (male) 0.050 (0.014, 0.087) 0.007 
Deprivation (most deprived) -0.002 (-0.032, 0.028) 0.895 
HDL cholesterol -0.071 (-0.110, -0.032) <0.001 
Systolic Blood Pressure 0.003 (0.002, 0.004) <0.001 
Diastolic Blood Pressure -0.003 (-0.005, -0.001) 0.002 
Leg length -0.004 (-0.007, -0.001) 0.014 
 
Variables were selected by bootstrap selection from all variables selected in the previous 
backward selected models (Models 1 to 6). 
 
 
Table 6.8 Associations of co-factor variables with cIMT – only subjects 
without history of CVD 
 
 
Estimated 
effect 
95% confidence 
interval p 
Age 0.009 (0.007, 0.011) <0.001 
Sex (male) 0.007 (-0.024, 0.039) 0.649 
Deprivation (most deprived) 0.010 (-0.018, 0.038) 0.492 
HDL cholesterol -0.057 (-0.100, -0.014) 0.009 
Systolic Blood Pressure 0.003 (0.002, 0.004) <0.001 
Diastolic Blood Pressure -0.002 (-0.004, 0.000) 0.025 
Adiponectin * -0.049 (-0.082, -0.016) 0.004 
 
*
 log-transformed  
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Table 6.9 Associations of co-factor variables with cIMT – only subjects not 
on statin therapy 
 
 
Estimated effect 95% confidence interval p 
Age 0.009 (0.007, 0.010) <0.001 
Sex (male) 0.044 (0.006, 0.082) 0.025 
Deprivation (most deprived) -0.005 (-0.035, 0.026) 0.763 
HDL cholesterol -0.070 (-0.111, -0.029) 0.001 
Systolic Blood Pressure 0.003 (0.002, 0.005) <0.001 
Diastolic Blood Pressure -0.003 (-0.005, -0.001) 0.002 
Leg length -0.004 (-0.007, -0.001) 0.014 
 
 
 
Table 6.10 Associations of co-factor variables with cIMT – only subjects not 
on antihypertensive therapy 
 
 
Estimated effect 95% confidence interval p 
Age 0.009 (0.007, 0.011) <0.001 
Sex (male) 0.045 (0.006, 0.085) 0.025 
Deprivation (most deprived) -0.007 (-0.039, 0.025) 0.668 
HDL cholesterol -0.071 (-0.114, -0.028) 0.001 
Systolic Blood Pressure 0.003 (0.002, 0.005) <0.001 
Diastolic Blood Pressure -0.003 (-0.005, -0.001) 0.005 
Leg length -0.004 (-0.008, -0.001) 0.011 
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Table 6.11 Associations of co-factor variables with cIMT – only subjects not 
on statin or antihypertensive therapy 
 
 
Estimated effect 95% confidence interval p 
Age 0.009 (0.007, 0.011) <0.001 
Sex (male) 0.054 (0.014, 0.094) 0.008 
Deprivation (most deprived) -0.011 (-0.043, 0.021) 0.509 
HDL cholesterol -0.064 (-0.107, -0.020) 0.004 
Systolic Blood Pressure 0.003 (0.002, 0.005) <0.001 
Diastolic Blood Pressure -0.003 (-0.005, -0.001) 0.007 
Leg length -0.005 (-0.008, -0.001) 0.007 
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6.3.2 Predictors of plaque score 
 
As described in Section 6.2, similar models to those reported in Section 6.3.1 for cIMT 
were run with plaque presence (as a binary variable) being the dependent variable. Table 
6.12 shows the contribution of age, sex and deprivation to plaque presence. Consistent with 
the findings reported in detail in Chapter 5, increasing age, male sex and being in the most 
deprived group were associated with greater risk of having one or more carotid plaques. 
 
The associations of classic cardiovascular risk factors with plaque presence are shown in 
Table 6.13. When all classic risk factors were included in the model, only current smoking 
was associated with plaque presence. 
 
Table 6.14 shows a model containing markers of inflammation/endothelial dysfunction 
along with age, sex and deprivation. None of the markers measured (CRP, IL-6 and 
sICAM-1) were associated with plaque presence. 
 
Of the markers of insulin resistance / adiposity (Table 6.15), only waist circumference 
predicted plaque presence – although paradoxically, the association was negative, i.e. 
greater waist circumference was associated with lower likelihood of plaque presence. In 
order to explore this finding further, the contribution of waist circumference to the 
deprivation effect on plaque presence was assessed by determining the difference in 
deprivation effect between Model 4 (which included markers of insulin 
resistance/adiposity) and Model 1 (which included only age, sex and deprivation). In 
Model 4, the deprivation effect was actually strengthened (estimated difference -0.093; 
95% bootstrap confidence interval -0.195 to -0.024; p=0.006, data not shown). This 
indicates that, consistent with the findings reported in Chapter 5, waist circumference did 
not contribute to the explanation of the difference in plaque presence, and suggests that 
once deprivation was adjusted for, there was an apparent negative association between 
waist circumference and plaque presence. 
 
The associations of markers of haemostasis with plaque presence are shown in Table 6.16. 
There were no associations between plaque presence and any of the markers of 
haemostasis (fibrinogen, D-dimer and vWF). 
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Table 6.12 Associations of age, sex and area-level deprivation with plaque 
presence (Model 1) 
 
 
Effect 95% confidence interval p 
Age 0.084 (0.063, 0.105) <0.001 
Sex (male) 0.523 (0.194, 0.857) 0.002 
Deprivation (most deprived) 0.743 (0.411, 1.079) <0.001 
 
 
Table 6.13 Associations of classic cardiovascular risk factors with plaque 
presence (Model 2) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.073 (0.048, 0.098) <0.001 
 
0.082 (0.061, 0.105) <0.001 
Sex (male) 0.535 (0.147, 0.928) 0.007 
 
0.516 (0.175, 0.861) 0.003 
Deprivation (most deprived) 0.483 (0.076, 0.891) 0.020 
 
0.459 (0.079, 0.840) 0.018 
Triglycerides * 0.335 (-0.065, 0.739) 0.102 
 
- - - 
LDL cholesterol 0.156 (-0.052, 0.366) 0.143 
 
- - - 
HDL cholesterol 0.348 (-0.208, 0.915) 0.223 
 
- - - 
Systolic blood pressure 0.003 (-0.012, 0.018) 0.675 
 
- - - 
Diastolic blood pressure -0.006 (-0.030, 0.019) 0.643 
 
- - - 
Smoking (current) 0.738 (0.273, 1.213) 0.002 
 
0.727 (0.280, 1.182) 0.002 
History of hypertension 0.231 (-0.259, 0.725) 0.357 
 
- - - 
 
*
 log-transformed 
 
 
Table 6.14 Associations of markers of inflammation/endothelial dysfunction 
with plaque presence (Model 3) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p-value 
Age 0.081 (0.059, 0.104) <0.001 
 
0.084 (0.063, 0.105) <0.001 
Sex (male) 0.584 (0.239, 0.933) 0.001 
 
0.084 (0.063, 0.105) <0.001 
Deprivation (most deprived) 0.736 (0.351, 1.128) <0.001 
 
0.743 (0.411, 1.079) <0.001 
CRP * -0.047 (-0.237, 0.142) 0.626 
 
- - - 
IL-6 -0.011 (-0.156, 0.135) 0.883 
 
- - - 
sICAM-1 * 0.366 (-0.373, 1.110) 0.332 
 
- - - 
 
*
 log-transformed 
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Table 6.15 Associations of markers of insulin resistance/adiposity with 
plaque presence (Model 4) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.083 (0.059, 0.108) <0.001 
 
0.087 (0.065, 0.109) <0.001 
Sex (male) 0.575 (-0.081, 1.238) 0.087 
 
0.669 (0.321, 1.022) <0.001 
Deprivation (most deprived) 0.843 (0.475, 1.218) <0.001 
 
0.838 (0.498, 1.185) <0.001 
Waist circumference -0.027 (-0.049, -0.006) 0.014 
 
-0.018 (-0.031, -0.005) 0.005 
Glucose 0.092 (-0.207, 0.435) 0.573 
 
- - - 
HOMA-IR * 0.011 (-0.345, 0.365) 0.953 
 
- - - 
Adiponectin * -0.403 (-0.829, 0.017) 0.061 
 
- - - 
Leptin * -0.036 (-0.422, 0.350) 0.854 
 
- - - 
Diabetes 13.572 (-52.146, NA) 0.979 
 
- - - 
 
*
 log-transformed 
 
 
Table 6.16 Associations of markers of haemostasis with plaque presence 
(Model 5) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.083 (0.060, 0.107) <0.001 
 
0.084 (0.063, 0.105) <0.001 
Sex (male) 0.511 (0.167, 0.858) 0.004 
 
0.523 (0.194, 0.857) 0.002 
Deprivation (most deprived) 0.841 (0.482, 1.207) <0.001 
 
0.743 (0.411, 1.079) <0.001 
Fibrinogen 0.028 (-0.252, 0.308) 0.845 
 
- - - 
D-dimer * -0.120 (-0.459, 0.217) 0.485 
 
- - - 
von Willebrand factor -0.001 (-0.006, 0.003) 0.586 
 
- - - 
 
*
 log-transformed 
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Of the early life individual-level markers of socioeconomic status, father’s social class was 
associated with plaque presence, with participants whose father was in the non-manual 
social classes being less likely to have a plaque than those whose father had a manual 
social class (Table 6.17). 
 
Using similar bootstrap selection procedures to those used for cIMT, variables were 
selected from those identified on backward selection in Models 1 to 6. The results are 
shown in Table 6.18. The variables associated with plaque presence using these 
procedures were current smoking, waist circumference (negative association as previously 
observed) and father’s social class, with non-manual father’s social class being identified 
with less likelihood of plaque presence than manual father’s social class. 
 
When carrying out the above model selection process in only those subjects with no history 
of CVD (Table 6.19), the negative association of waist circumference with plaque 
presence was again present, as was the association of father’s social class with plaque 
presence. Smoking was not associated with plaque presence when only those subjects with 
no history of CVD were included – this may be because smoking and CVD are strongly 
associated. 
 
When including only subjects not on statin therapy (Table 6.20), smoking, waist 
circumference (negative association) and father’s social class were the significant 
associations with plaque presence as in the analysis of the whole study population. 
 
In subjects not on antihypertensive treatment (Table 6.21) and in subjects on neither 
antihypertensive nor statin therapy (Table 6.22), the associations with plaque presence 
were waist circumference and father’s social class.
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Table 6.17 Associations of early life socioeconomic factors with plaque 
presence (Model 6) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 
95% confidence 
interval p 
Age 0.083 (0.058, 0.109) <0.001 
 
0.089 (0.066, 0.112) <0.001 
Sex (male) 1.051 (0.467, 1.647) <0.001 
 
0.640 (0.288, 0.995) <0.001 
Deprivation (most deprived) 0.074 (-0.474, 0.617) 0.790 
 
0.573 (0.181, 0.969) 0.004 
Height -0.030 (-0.080, 0.020) 0.245 
 
- - - 
Leg length 0.017 (-0.049, 0.083) 0.611 
 
- - - 
People per room at age 11 years * 0.099 (-0.399, 0.600) 0.697 
 
- - - 
Father's social class (Non-
manual) -0.451 (-0.905, 0.000) 0.050  -0.443 (-0.844, -0.044) 0.030 
Years of education * -1.062 (-2.045, -0.102) 0.032 
 
- - - 
 
*
 log-transformed 
 
Table 6.18 Associations of co-factor variables with plaque presence  
 
 
Estimated effect 95% confidence interval p 
Age 0.089 (0.066, 0.114) <0.001 
Sex (male) 0.738 (0.356, 1.128) <0.001 
Deprivation (most deprived) 0.445 (-0.016, 0.908) 0.059 
Current smoking 0.554 (0.065, 1.050) 0.027 
Waist circumference -0.015 (-0.030, -0.001) 0.033 
Father's social class (non-manual) -0.464 (-0.876, -0.055) 0.027 
 
 
Table 6.19 Associations of co-factor variables with plaque presence – only 
subjects with no history of CVD 
 
 
Estimated effect 95% confidence interval p 
Age 0.084 (0.060, 0.109) <0.001 
Sex (male) 0.834 (0.440, 1.235) <0.001 
Deprivation (most deprived) 0.565 (0.135, 1.000) 0.010 
Waist circumference -0.020 (-0.035, -0.006) 0.007 
Father's social class (non-manual) -0.451 (-0.877, -0.028) 0.037 
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Table 6.20 Associations of co-factor variables with plaque presence – only 
subjects not on statin therapy 
 
 
 
Estimated effect 95% confidence interval p 
Age 0.080 (0.055, 0.106) <0.001 
Sex (male) 0.794 (0.391, 1.205) <0.001 
Deprivation (most deprived) 0.295 (-0.197, 0.787) 0.239 
Current smoking 0.595 (0.071, 1.125) 0.026 
Waist circumference -0.021 (-0.036, -0.006) 0.007 
Father's social class (non-manual) -0.444 (-0.881, -0.010) 0.046 
 
 
 
Table 6.21 Associations of co-factor variables with plaque presence – only 
subjects not on antihypertensive treatment 
 
 
 
Estimated effect 95% confidence interval p 
Age 0.083 (0.057, 0.111) <0.001 
Sex (male) 0.819 (0.409, 1.238) <0.001 
Deprivation (most deprived) 0.511 (0.061, 0.966) 0.027 
Waist circumference -0.021 (-0.037, -0.005) 0.010 
Father's social class (non-manual) -0.626 (-1.077, -0.179) 0.006 
 
 
 
Table 6.22 Associations of variables with plaque presence – only subjects 
not on antihypertensive or statin therapy 
 
 
Estimated effect 95% confidence interval p 
Age 0.081 (0.054, 0.108) <0.001 
Sex (male) 0.847 (0.432, 1.271) <0.001 
Deprivation (most deprived) 0.433 (-0.028, 0.897) 0.066 
Waist circumference -0.022 (-0.039, -0.006) 0.008 
Father's social class (non-manual) -0.583 (-1.043, -0.129) 0.012 
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6.4 Discussion 
 
The aim of the work described in this chapter was to examine the co-factors associated 
with cIMT and those associated with plaque, with the hypothesis that lipid parameters and 
blood pressure would explain much of the variability in cIMT, while plaque would be 
explained by other variables – possibly some of the lesser studied emerging biomarkers, 
and specifically markers of inflammation. 
 
In the case of cIMT, the consistent associations noted were a negative association with 
HDL cholesterol, a positive association with systolic blood pressure and a negative 
association with diastolic blood pressure. A negative association between adiponectin and 
cIMT was seen in the model incorporating markers of insulin resistance/adiposity (Model 
4), which may imply an association between insulin resistance and cIMT, but no 
significant association between adiponectin and cIMT was identified once other variables 
were included (Table 6.7). The early life socioeconomic factors analysed as covariates are 
clearly much more ‘upstream’ markers than the biomarkers analysed. Leg length, a marker 
of nutritional status during the years of growth,131 was inversely associated with cIMT. The 
possible significance of early life factors in influencing health outcomes in later life is 
further explored in Chapter 8. The positive association between height and cIMT appears 
at first unexpected, and is the opposite of what would be expected from previous studies in 
which height and leg length were found to be inversely associated with CHD.172 However, 
in the model reported here (Table 6.6), height and leg length were both included in the 
model, and it is in the context of a highly significant inverse association between leg length 
and cIMT that a weaker positive association was seen between height and cIMT. If the 
association between cIMT and height per se were to be assessed, a model would need to be 
constructed in which height was included without leg length, given the obvious co-linearity 
between height and leg length. 
 
The inverse association between HDL cholesterol and cIMT, and the direct association 
between systolic blood pressure and cIMT are consistent with findings from previous 
work. Given that IMT is thought to represent hypertrophy of intimal and medial cells in 
response to lipid infiltration or hypertension,169 and given that previous work has shown 
associations between cIMT and both lipid parameters and hypertension,170 the findings 
reported here are consistent with previous findings. The negative association between 
diastolic blood pressure and cIMT (after adjusting for systolic blood pressure) might at 
first seem counter-intuitive, in view of the positive association between systolic blood 
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pressure and cIMT. However, a similar finding was reported in the Cardiovascular Health 
Study, and the investigators in that study hypothesised that this might be due to the fact 
that lower diastolic blood pressure may reflect decreased arterial compliance leading to 
increased pulse pressure.170 
 
In contrast to cIMT, in the case of plaque presence the consistent associations were with 
current cigarette smoking, waist circumference (negative association) and father’s social 
class. Contrary to my prior hypothesis, no associations were demonstrated between any 
emerging biomarkers and plaque presence. This was particularly surprising in the case of 
markers of inflammation/endothelial dysfunction, with no associations noted between 
CRP, IL-6 or sICAM-1 and plaque presence. Given the growing body of evidence for the 
role of inflammation in atherogenesis,60 a worthy area for future extension of this work 
would be to expand the repertoire of inflammatory markers measured on stored plasma 
from the pSoBid study. 
 
The association between cigarette smoking and plaque presence is, of course, unsurprising, 
given the overwhelming body of evidence for the relationship between smoking and 
atherosclerosis.13 Model 2, which examined the associations between classic risk factors 
and plaque presence (Table 6.13) powerfully demonstrates that when smoking is in the 
model predicting plaque presence, no other classic risk factor  (other than age and sex) 
adds to the ability to predict plaque presence. 
 
Father’s social class, which was also associated with plaque presence, is a much more 
‘upstream’ marker than the biomarkers measured in this study. It is likely that there is a 
degree of co-linearity between father’s social class and area-level deprivation (which was 
demonstrated in Chapter 5 to be strongly associated with carotid plaque). However, the 
demonstration of the association between father’s social class and carotid plaque presence 
may suggest a role for early life socioeconomic factors. The role of early life factors in 
general is explored more fully in Chapter 8. 
 
The negative association between waist circumference and plaque presence is interesting, 
and at first glance surprising. However, it must be remembered that this effect was seen in 
models which already adjusted for age, sex and deprivation. This might suggest a 
differential effect of abdominal obesity on plaque presence in the two deprivation groups, 
although such a suggestion can only be speculative. In any case, the fact that the 
deprivation effect on plaque presence was strengthened rather than weakened after 
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adjusting for waist circumference indicates that, whatever the relationship between waist 
circumference and plaque presence, differences in waist circumference do not contribute to 
the explanation of the difference in plaque presence between the most and least deprived 
groups. 
 
In summary, the work described in this chapter shows clearly differential associations of 
risk factors with cIMT compared to plaque. The main associations for cIMT are HDL 
cholesterol (negative association), systolic blood pressure and leg length (negative 
association). In the case of plaque presence, the main predictors are cigarette smoking, 
father’s social class and the paradoxical inverse association with waist circumference. 
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CHAPTER 7 – SOCIAL DEPRIVATION AND ARTERIAL STIFFNESS 
 
7.1 Introduction 
 
As discussed in Chapter 1, carotid ultrasound also allows for assessment to be made of 
parameters of arterial stiffness, using M-(movement) mode. Associations have been 
reported between ultrasound-derived parameters of arterial stiffness and cIMT and carotid 
plaque severity.100 Furthermore, arterial stiffness parameters have been shown to be 
predictive of mortality in patients with end-stage renal failure and of cardiovascular events 
after renal transplantation.95 
 
Some previous studies have examined associations between parameters of arterial stiffness 
and some individual-level markers of social deprivation. Associations between educational 
attainment and lower arterial stiffness were reported in 45-64 year-old men in the 
Atherosclerosis Risk in Communities study.104 A study of adolescents living in the USA 
found inverse associations between PWV and both parental educational attainment and 
family income, despite no associations being found between these markers of 
socioeconomic status and cIMT,106 leading some to suggest that changes in arterial 
stiffness might precede development of atherosclerosis in individuals. 
 
The work described in this chapter had three aims. The first aim was to expand on previous 
work by others who have examined the association between individual-level markers of 
socioeconomic status and parameters of arterial stiffness, by assessing whether differences 
can be identified in parameters of arterial stiffness between participants selected from the 
two extremes of social deprivation as determined by area-level markers of deprivation. The 
second aim was to identify which classic and emerging cardiovascular risk factors are 
associated with parameters of arterial stiffness. Finally, I sought to identify any 
associations between ultrasound parameters of arterial stiffness and ultrasound markers of 
atherosclerosis, namely cIMT and carotid plaque. 
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7.2 Methods 
 
At the same time as participants in the pSoBid study were having carotid ultrasound 
assessment of cIMT and plaque presence, M-mode ultrasound analysis of parameters of 
arterial stiffness was undertaken as detailed in Section 2.5.8, with blood pressure being 
recorded immediately before and after acquisition of the M-mode image. Calculation of 
parameters of arterial stiffness was carried out offline later by myself, blinded to the 
identities of the participants. The details of the semi-automated procedure for analysis of 
M-mode images, and the algorithms used by the eTrack reader software to calculate the 
parameters of arterial stiffness are to be found in Section 2.5.8. 
 
Statistical analysis was performed using Minitab release 13.1 and R version 2.9. Normality 
of distribution was assessed by the Anderson-Darling test. All of the arterial stiffness 
parameters were non-parametrically distributed, and so are described as median 
(interquartile range). P values for differences in parameters of arterial stiffness between 
most and least deprived groups are shown adjusted for age and sex. 
 
For assessment of associations between cardiovascular risk factors and parameters of 
arterial stiffness (only stiffness and distensibility were used as dependent variables in this 
analysis), multivariate models were constructed using log transformed stiffness or log 
transformed distensibility as the dependent variable. Similar models to those used in 
chapter 6 for cIMT were then constructed. An initial model (Model 1) was adjusted for 
age, sex and deprivation. In subsequent models, covariates were added in groups 
representing: classic risk factors (Model 2), inflammation (Model 3), insulin resistance 
(Model 4), haemostasis (Model 5) and early life socioeconomic factors (Model 6). In each 
case, after construction of the full model, a backward selected model was used to identify 
those variables retaining a significant association with the dependent variable. Finally 
(Model 7) bootstrap variable selection was used. A sample of the data (of the same size, 
where individuals can appear more than once in the sample) was taken and variables 
identified (from those which were significant on backward selection in Models 1 to 6) 
which had a significant association with the dependent variable. This was repeated 1000 
times and the confidence interval and p-value derived from these 1000 values. A forward 
stepwise selection was then carried out on those variables that had been selected in at least 
50% of the models in order to identify those variables retaining a significant association 
with the dependent variable. This bootstrap model selection was then repeated in only 
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those subjects with no history of CVD, in those not on statin therapy, in those not on 
antihypertensive treatment and in those not on statin or antihypertensive treatment. 
 
For the analysis of associations of stiffness and distensibility with cIMT and plaque 
presence, similar models were constructed to those described in Chapter 6, with cIMT or 
plaque as the dependent variable, and the parameters of arterial stiffness as covariates.  
 
7.3 Results 
 
7.3.1 Comparison of parameters of arterial stiffness between most and 
least deprived groups 
 
The distribution of parameters of arterial stiffness in most and least deprived groups is 
shown in Table 7.1, demonstrating that there were no differences in any of the arterial 
stiffness variables between most and least deprived groups. 
 
7.3.2 Association of stiffness (β) with classic and emerging 
cardiovascular risk factors 
 
Table 7.2 shows the effect of age, sex and deprivation on stiffness. As expected, stiffness 
increased with age and was higher in males than females. To this age, sex and deprivation-
adjusted model, co-factor variables were then added in groups as described in Section 7.2 
in order to examine the associations of these co-factors with stiffness (β). 
 
When classic risk factors were added to the age, sex and deprivation adjusted model 
(Table 7.3), significant associations were observed for systolic blood pressure and current 
smoking – although the effect of smoking was a negative effect. 
 
When the associations of markers of inflammation/endothelial dysfunction with stiffness 
were modelled (Table 7.4), there was a significant association between CRP and stiffness 
– although paradoxically the association was in a negative direction. 
 
No significant associations were evident with stiffness for markers of insulin 
resistance/adiposity (Table 7.5), haemostasis (Table 7.6) or early life socioeconomic 
factors (Table 7.7). 
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Table 7.1 Comparison of parameters of arterial stiffness between most and 
least deprived groups 
 
Parameter Least deprived 
(n=325) 
Most deprived 
(n=293) 
p * 
Distensibility  
(10-3/kPa) 
32.4 (25.0, 39.8) 34.2 (26.5, 44.0) 0.067 
Distensibility_Tf 
(10-3/kPa) 
34.5 (26.4, 43.2) 36.7 (28.0, 47.5) 0.062 
Compliance 
(mm2/kPa) 
0.82 (0.65, 1.00) 0.89 (0.68, 1.04) 0.060 
Compliance_Tf 
(mm2/kPa) 
0.87 (0.69, 1.07) 0.94 (0.71, 1.13) 0.051 
Stiffness (β) 4.58 (3.68, 5.61) 4.53 (3.47, 5.65) 0.12 
Elasticity (Petersen) 
(kPa) 
60.7 (47.4, 78.3) 59.5 (45.8, 77.5) 0.73 
 
* p value refers to difference between most and least deprived groups, adjusted for age 
and sex. 
 
  
Table 7.2 Association of age, sex and deprivation with stiffness (β) (Model 1) 
 
 
Effect 95% confidence interval p 
Age 0.014 (0.011, 0.017) <0.001 
Sex (male) 0.123 (0.078, 0.169) <0.001 
Deprivation (most deprived) -0.037 (-0.082, 0.009) 0.116 
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Table 7.3 Association of classic cardiovascular risk factors with stiffness (β) 
(Model 2) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.013 (0.009, 0.016) <0.001 
 
0.013 (0.010, 0.016) <0.001 
Sex (male) 0.115 (0.062, 0.168) <0.001 
 
0.110 (0.062, 0.159) <0.001 
Deprivation (most deprived) -0.021 (-0.077, 0.035) 0.460 
 
-0.016 (-0.069, 0.036) 0.544 
Triglycerides * -0.004 (-0.058, 0.051) 0.898 
 
- - - 
LDL cholesterol 0.005 (-0.024, 0.034) 0.727 
 
- - - 
HDL cholesterol 0.027 (-0.048, 0.102) 0.480 
 
- - - 
Systolic blood pressure 0.002 (0.000, 0.004) 0.057 
 
0.002 (0.000, 0.003) 0.009 
Diastolic blood pressure -0.001 (-0.004, 0.002) 0.559 
 
- - - 
Smoking (current) -0.062 (-0.125, 0.001) 0.055 
 
-0.068 (-0.130, -0.007) 0.030 
History of hypertension 0.028 (-0.041, 0.096) 0.429 
 
- - - 
 
*
 log-transformed 
 
 
Table 7.4 Association of markers of inflammation/endothelial dysfunction 
with stiffness (β) (Model 3) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.015 (0.012, 0.018) <0.001 
 
0.015 (0.012, 0.018) <0.001 
Sex (male) 0.116 (0.069, 0.164) <0.001 
 
0.119 (0.073, 0.165) <0.001 
Deprivation (most deprived) -0.022 (-0.075, 0.031) 0.412 
 
-0.026 (-0.073, 0.022) 0.293 
CRP * -0.025 (-0.051, 0.001) 0.057 
 
-0.023 (-0.044, -0.001) 0.040 
IL-6 0.011 (-0.010, 0.032) 0.303 
 
- - - 
sICAM-1 * -0.057 (-0.160, 0.045) 0.273 
 
- - - 
 
*
 log-transformed 
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Table 7.5 Association of markers of insulin resistance/adiposity with 
stiffness (β) (Model 4) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.014 (0.011, 0.017) <0.001 
 
0.014 (0.011, 0.017) <0.001 
Sex (male) 0.071 (-0.019, 0.161) 0.121 
 
0.123 (0.078, 0.169) <0.001 
Deprivation (most deprived) -0.047 (-0.096, 0.003) 0.064 
 
-0.037 (-0.082, 0.009) 0.116 
Waist 0.000 (-0.003, 0.003) 0.832 
 
- - - 
Glucose 0.012 (-0.027, 0.052) 0.541 
 
- - - 
HOMA-IR * 0.009 (-0.038, 0.057) 0.696 
 
- - - 
Adiponectin * -0.045 (-0.102, 0.012) 0.125 
 
- - - 
Leptin * -0.030 (-0.082, 0.022) 0.258 
 
- - - 
Diabetes 0.199 (-0.140, 0.538) 0.249 
 
- - - 
 
*
 log-transformed 
 
 
 
Table 7.6 Association of markers of haemostasis with stiffness (β) (Model 5) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.015 (0.012, 0.018) <0.001 
 
0.014 (0.011, 0.017) <0.001 
Sex (male) 0.120 (0.072, 0.168) <0.001 
 
0.123 (0.078, 0.169) <0.001 
Deprivation (most deprived) -0.028 (-0.077, 0.021) 0.267 
 
-0.037 (-0.082, 0.009) 0.116 
Fibrinogen -0.016 (-0.055, 0.023) 0.412 
 
- - - 
D-dimer * 0.024 (-0.023, 0.070) 0.315 
 
- - - 
von Willebrand factor 0.000 (-0.001, 0.000) 0.172 
 
- - - 
 
*
 log-transformed 
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Table 7.7 Association of early life socioeconomic factors with stiffness (β) 
(Model 6) 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 
95% confidence 
interval p 
Age 0.016 (0.012, 0.019) <0.001 
 
0.014 (0.011, 0.017) <0.001 
Sex 0.121 (0.045, 0.197) 0.002 
 
0.123 (0.078, 0.169) <0.001 
Deprivation (deprived) -0.008 (-0.080, 0.064) 0.826 
 
-0.037 (-0.082, 0.009) 0.116 
Height 0.004 (-0.002, 0.011) 0.188 
 
- - - 
Leg length -0.007 (-0.015, 0.002) 0.133 
 
- - - 
People per room at age 11 * -0.020 (-0.085, 0.045) 0.537 
 
- - - 
Father's social class (Non-
manual) -0.019 (-0.080, 0.042) 0.547  - - - 
Years of education * 0.094 (-0.035, 0.223) 0.154 
 
- - - 
 
*
 log-transformed 
 
 
 
Table 7.8 Association of co-factor variables with stiffness (β) 
 
 
Estimated effect 95% confidence interval p 
Age 0.014 (0.011, 0.017) <0.001 
Sex (male) 0.108 (0.059, 0.157) <0.001 
Deprivation (most deprived) -0.003 (-0.057, 0.052) 0.923 
Systolic blood pressure 0.002 (0.001, 0.003) 0.007 
Current smoking -0.065 (-0.127, -0.002) 0.043 
CRP * -0.026 (-0.049, -0.004) 0.022 
 
*
 log-transformed 
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On carrying out bootstrap selection from the variables that were significant in Models 1 to 
6, the same variables were significantly associated with stiffness as had been identified in 
the individual models, namely systolic blood pressure, CRP (negative association) and 
smoking (negative association) (Table 7.8). 
 
 
When only subjects with no history of cardiovascular disease were included in the analysis, 
the associations with systolic blood pressure and CRP remained, although the inverse 
association of smoking with arterial stiffness was no longer present, most likely because of 
the strong association of smoking with CVD meaning that relatively few smokers remained 
in this analysis (Table 7.9). Including only subjects not on statin or antihypertensive 
therapy did not significantly change the results (data not shown).  
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Table 7.9 Association of co-factor variables with stiffness (β) – only subjects 
with no history of CVD 
 
 
 
Estimated effect 95% confidence interval p 
Age 0.013 (0.010, 0.016) <0.001 
Sex (male) 0.106 (0.055, 0.156) <0.001 
Deprivation (most deprived) -0.039 (-0.090, 0.012) 0.131 
Systolic blood pressure 0.002 (0.001, 0.004) 0.004 
CRP * -0.025 (-0.048, -0.002) 0.033 
 
*
 log-transformed 
 
 
 
 
Table 7.10 Association of co-factor variables with distensibility 
 
 
 
Estimated effect 95% confidence interval p 
Age -0.014 (-0.017, -0.011) <0.001 
Sex (male) -0.143 (-0.193, -0.093) <0.001 
Deprivation (most deprived) 0.046 (-0.003, 0.095) 0.068 
Systolic blood pressure -0.004 (-0.006, -0.002) <0.001 
Diastolic blood pressure -0.004 (-0.007, 0.000) 0.035 
 151 
The same set of models was then constructed with distensibility as the dependent variable. 
Of the classic risk factors, both systolic blood pressure (effect estimate -0.004; 95% CI  
-0.006 to -0.002; p<0.001) and diastolic blood pressure (effect estimate -0.004; 95% CI  
-0.007 to 0.000; p=0.035) were inversely associated with distensibility, i.e. lower blood 
pressure was associated with higher distensibility (data not shown). None of the markers of 
inflammation/endothelial dysfunction showed significant association with distensibility. In 
the model which included markers of insulin resistance/adiposity, HOMA-IR was 
inversely associated with distensibility (effect estimate -0.056; 95% CI -0.094 to -0.018; 
p=0.004), i.e. lower levels of insulin resistance were associated with higher distensibility. 
No markers of haemostasis or early life socioeconomic status were associated with 
distensibility. On bootstrap variable selection, significant negative associations were 
observed for systolic and diastolic blood pressure (Table 7.10), and this was also the case 
when only participants with no history of CVD, those not on statin therapy, or those not on 
antihypertensive therapy were included in the analysis (data not shown). 
 
7.3.3 Associations of parameters of arterial stiffness with cIMT and plaque 
 
In order to identify any associations of arterial stiffness or distensibility with cIMT, an age, 
sex and deprivation-adjusted model was constructed with cIMT as the dependent variable 
and stiffness and distensibility as covariates. Neither stiffness nor distensibility was 
associated with cIMT in this model (Table 7.11). Similarly, when plaque presence was the 
dependent variable in a similar model, there were no associations between stiffness or 
distensibility and plaque presence (Table 7.12) 
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Table 7.11 Association of parameters of arterial stiffness with cIMT 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.011 (0.009, 0.013) <0.001 
 
0.010 (0.009, 0.012) <0.001 
Sex 0.066 (0.039, 0.093) <0.001 
 
0.059 (0.033, 0.085) <0.001 
Deprivation (most deprived) 0.023 (-0.003, 0.049) 0.081 
 
0.029 (0.003, 0.055) 0.028 
Stiffness * -0.050 (-0.127, 0.027) 0.206 
 
- - - 
Distensibility * -0.007 (-0.075, 0.061) 0.841 
 
- - - 
  
*
 log-transformed  
 
 
Table 7.12 Association of parameters of arterial stiffness with carotid plaque 
presence 
 
Full model Backward selected model 
 
Effect 95% confidence interval p Effect 95% confidence interval p 
Age 0.082 (0.058, 0.106) <0.001 
 
0.084 (0.063, 0.105) <0.001 
Sex 0.589 (0.236, 0.946) 0.001 
 
0.084 (0.063, 0.105) <0.001 
Deprivation (most deprived) 0.763 (0.422, 1.110) <0.001 
 
0.743 (0.411, 1.079) <0.001 
Stiffness * -0.556 (-1.583, 0.443) 0.280 
 
- - - 
Distensibility * -0.436 (-1.349, 0.451) 0.341 
 
- - - 
 
*
 log-transformed 
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7.4 Discussion 
 
Of the three aims of the work described in this chapter, the first was to determine if any 
parameters of arterial stiffness were different in the two area-level deprivation groups. It is 
quite clear that no deprivation-based differences in arterial stiffness parameters were 
evident in the pSoBid study population. This is in contrast to the findings in some previous 
studies, the Atherosclerosis Risk in Communities Study having reported in 45 to 64 year 
olds an association between educational attainment and arterial diameter change,104 and a 
study in adolescents having found associations between pulse wave velocity and both 
parental educational attainment and family income.106 However, both of these studies were 
examining associations between arterial stiffness and individual-level markers of 
socioeconomic status, so the finding reported in this chapter of no associations between 
arterial stiffness and area-level deprivation is not in direct conflict with the above findings. 
Furthermore, the methods used in the various studies differ, making the results not directly 
comparable. In the Atherosclerosis Risk in Communities study, the parameter used was B-
mode ultrasound echo-tracked pulsatile arterial diameter change,104 which does not involve 
derivation of the range of parameters of arterial stiffness examined in this study. Thurston 
et al’s study of adolescents used carotid-femoral pulse wave velocity,106 rather than M-
mode carotid ultrasound as was done in this study. The findings in this study indicate that, 
in this study population, B-mode ultrasound assessment of cIMT and plaque score is a 
more useful tool for studying differences between the deprivation groups than is M-mode 
ultrasound assessment of arterial stiffness. 
 
The second aim of this part of the work was to determine which cardiovascular risk factors 
are associated with parameters of arterial stiffness. Not surprisingly, the most consistent 
associations were for blood pressure (systolic blood pressure in the case of stiffness, and 
both systolic and diastolic blood pressure in the case of distensibility). The fact that 
associations with cardiovascular risk factors were very similar for both stiffness and 
distensibility is not surprising, given that stiffness and distensibility are essentially 
variations on a theme, both being calculated from systolic and diastolic blood pressure and 
strain.  
 
Of the other associations identified, the association of smoking with stiffness is certainly 
counterintuitive, in that it was a negative association. However, in the set of models 
constructed, smoking was only analysed in models which also contained blood pressure, 
which is clearly the main determinant of arterial stiffness. If the effect of smoking on 
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arterial stiffness were to be explored further, models would be required which do not 
include blood pressure. The fact that no association was observed between smoking and 
stiffness when only subjects with no history of CVD were analysed is probably due to the 
strong association between CVD and smoking, meaning that relatively few smokers 
remained in the analysis after removing those with CVD. A recent systematic review found 
that acute smoking causes an acute increase in arterial stiffness, passive smoking increases 
arterial stiffness acutely and chronically and most studies have found chronic smoking to 
be a risk factor for increased arterial stiffness.173 
 
The negative association of CRP with arterial stiffness is also surprising. A possible 
explanation is that all the models reported in this chapter were already adjusted for 
deprivation. Although arterial stiffness was not associated with deprivation in this study, 
CRP was significantly associated with deprivation, so by adjusting for deprivation and 
CRP simultaneously, there may be the possibility of overadjustment. In general, studies 
which have set out to investigate the association of inflammation with arterial stiffness a 
priori  have found a positive association of inflammation with arterial stiffness, with some 
evidence that even acute systemic inflammation leads to increased arterial stiffness.174 
 
The inverse relationship between HOMA-IR and distensibility is interesting – although this 
association was only significant in the model containing markers of insulin resistance, and 
not in the full model containing all significant variables (Table 7.10). This may be because 
the full model also adjusted for blood pressure, with the strong associations of blood 
pressure with distensibility masking any other associations present. The observation of 
higher HOMA-IR (i.e. higher levels of insulin resistance) being associated with lower 
distensibility is consistent with recent findings by Webb et al, in which HOMA-IR was 
found to be a powerful predictor of arterial stiffness.175 
 
In this study population, no evidence was found of any associations between parameters of 
arterial stiffness and either cIMT (Table 7.11) or plaque (Table 7.12). This is in contrast to 
findings from the Rotterdam study, in which significant increases in carotid-femoral PWV 
were noted with increasing quartiles of cIMT and with increasing categories of carotid or 
aortic plaque, and common carotid distensibility decreased with increasing quartiles of 
cIMT and with increasing categories of carotid or aortic plaque – although the Rotterdam 
study population was significantly older (age 60 to 101 years) than this study population.100  
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In conclusion, the work described in this chapter has shown carotid ultrasound-derived 
parameters of arterial stiffness to be no different between those in most versus least 
deprived areas. Consequently, of the ultrasound markers assessed in this study, carotid 
plaque score has been shown to be the most discriminant marker, followed by mean 
common carotid intima-media thickness. 
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CHAPTER 8 – SOCIAL DEPRIVATION AND EARLY LIFE, BIOLOGICAL 
FACTORS AND PSYCHOLOGY 
 
8.1 Introduction 
 
The work described so far in this thesis has focused on the associations of social 
deprivation with classic and emerging cardiovascular risk factors and ultrasound markers 
of atherosclerosis and arterial stiffness, these being the areas of the pSoBid study for which 
I was responsible. However, the pSoBid study was a collaborative study, involving 
investigators from many fields such as epidemiology, public health, psychology and 
biostatistics. This chapter, therefore, seeks to set in context the work described in the 
preceding chapters, by giving a brief overview of some of the other aspects of the pSoBid 
study – work which I undertook in collaboration with other members of the pSoBid study 
team. This chapter will principally explore the relevance of early life experiences, and the 
role of personality, in the relationships between social deprivation and ill health. 
 
8.2 Associations between early life socioeconomic adversity and chronic 
inflammation, carotid atherosclerosis, lung function and cognitive 
performance in adult life 
 
8.2.1 Introduction 
 
Increasing evidence indicates that socioeconomic circumstances during the early years of 
life are important determinants of later health outcomes and disease risk in adult and older 
life, with the propensity for poor health in adulthood being greatest among those from 
disadvantaged backgrounds. Risk of mortality accumulates during the life course176 177 with 
exposure to risk factors occurring many years before the development of an outcome.178 
Adverse childhood socioeconomic position has been reported to be associated with a 
poorer health profile in mid adulthood (45 years of age), independent of adult social 
position and across diverse measures of disease risk and physical and mental 
functioning.176 At mid adulthood associations with childhood social class were identified 
for blood pressure, body mass index, high density lipoprotein, triglycerides, lung function, 
depressive symptoms and chronic widespread pain. Increased risk of ill-health was related 
to participants’ father’s occupation i.e. from class I (professional occupations) to V 
(unskilled occupations).  
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Whether increased morbidity and mortality in adulthood are the result of biological 
programming due to critical events in utero, the accumulation and interaction of harmful 
exposures along the pathway between infancy and adulthood, or a combination of both 
remains unclear for most diseases. It follows that better understanding of the antecedents of 
the greater burden of chronic disease and disability in relatively deprived populations 
gained from an exploration of life course effects from pre-birth179 through childhood131 178 
180
 to adult life is essential to tackle the growing “health divide.” 
 
The research question investigated in this section was whether adverse early life conditions 
give rise to intermediary phenotypes such as a persistent chronic inflammatory state, 
increased insulin resistance and endothelial activation (possibly as a response to repeated 
infection or poor nutrition), and whether these in turn are associated with adverse effects 
on a range of health outcomes in adulthood (atherosclerosis, lung function and cognitive 
impairment), which may share common aetiological determinants.181-183  
 
8.2.2 Methods 
 
8.2.2.1 Early life and adult individual level socioeconomic status 
 
A number of indices based on participant recall were used to assess childhood conditions at 
age 11 years. These were number of siblings, whether or not their parents owned their 
home, father’s occupational category, whether or not they reported being bullied as a child, 
whether or not their parents owned a car, overcrowding (number of occupants in house 
divided by number of rooms), leg length and trunk length. Father’s occupational category 
was classified using the Registrar General’s Social Classification (that is: I – professional 
occupations; II – managerial and technical occupations; IIINM – skilled occupations (non-
manual); IIIM – skilled occupations (manual); IV – partly skilled occupations; and V – 
unskilled occupations). For the purposes of analysis, non-manual social classes (I, II and 
IIINM) were merged and compared with merged manual social classes (IIIM, IV and V). 
Current (i.e. adult) socioeconomic status was assessed from income (average household 
income in GB Pounds Sterling), educational achievement (years in education), and home 
ownership (owner occupier, tenant – local authority, tenant – private, living with parents, 
other). 
 
Methods for analysis of biomarkers, carotid ultrasound and assessment of cognitive 
function are detailed in Chapter 2. 
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8.2.2.2 Statistical methods 
 
For comparisons of population characteristics between deprivation groups, linear 
regression was used for continuous variables and logistic regression for binary responses, 
from which p-values for differences or odds ratios between deprivation groups were 
calculated for all variables with adjustment for age and sex. Analyses were conducted in 
SAS v9.1 and R v2.8. 
 
A multivariate model (Model 1) was used to investigate the impact of adverse early life 
conditions on (a) biomarkers of chronic inflammation and endothelial dysfunction and (b) 
adult lung function, cognitive performance and carotid atherosclerosis. A second model 
(Model 2) explored the extent to which variables reflecting chronic 
inflammation/endothelial activation explained the associations. The values provided in 
Table 8.3 are regression (beta) coefficients with associated significance levels. 
 
8.2.3 Results 
 
Table 8.1 provides summary statistics by area level deprivation for variables related to 
early life conditions and individual socioeconomic status (SES) as adults, lung function 
and cognitive performance. There were significant differences between groups in early life 
variables, i.e. the number of siblings in the family, a measure of habitation overcrowding at 
age 11 years (number of occupants in house divided by the number of rooms), father’s 
occupational category, and whether or not parents owned the family home or a car. There 
was no significant difference between groups in relation to being bullied as a child. 
Individual level indices of socioeconomic status as an adult (household income, home 
ownership and years in education) varied as expected. 
 
Subjects recruited from deprived areas performed less well in tests of memory recall 
(Auditory Verbal Learning Test [AVLT]) and executive cognitive function (Stroop test; 
Choice Reaction Time thinking time [CRT]). Their lung function (FEV1) was also poorer. 
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Table 8.1 Early life conditions, biomarkers of chronic disease and cognitive 
function by area level deprivation 
 
 
Least Deprived (n=342) Most Deprived (n=324) p a 
Early life conditions 
   
Number of siblings 2.6 (1.2) b 3.6 (1.8) <0.0001 
People/room 1.2 (0.5) 1.8 (0.9) <0.0001 
Parents owned home 49.4% 5.9% <0.0001 
Parents owned car 57.6% 19.6% <0.0001 
Reported being bullied 24.6% 28.7% 0.24 
Father’s occupational category c 
(non-manual/manual) 
55.8% / 38.2% 12.6% / 74.1% <0.0001 
Adult socioeconomic status    
Average household income £41,699 £16,461 <0.0001 
Age left school (years) 16.6 (1.0) 15.5 (0.9) <0.0001 
Current home status (owner-
occupier/tenant) 
97.7% / 2.3% 
 
29.9% / 70.1% <0.0001 
Cognitive Function    
Stroop test (s) 8.3 (12.6) 18.7 (19.1) <0.0001 
Choice Reaction Time (ms) d 531 (101) e 630 (185) <0.0001 
AVLT (words recalled) 12.4 (1.9) 10.9 (2.4) <0.0001 
Lung Function    
FEV1 (L) 3.2 (0.8) 2.7 (0.7) <0.0001 
 
a
 p-values from linear or logistic regression models, adjusted for age and sex; 
b
 Values given are mean with 1 Standard Deviation in parenthesis for continuous variables;  
c
 Father’s occupational category for Least Deprived was unemployed for n=1 (0.3%) and unknown/unclassifiable for 
n=19 (5.6%); Father’s occupational category for Most Deprived was unemployed for n=10 (3.1%) and 
unknown/unclassifiable for n=33 (10.1%); P value derived by Chi squared across the distribution; 
d Choice Reaction Time (CRT), data for the thinking time element of test presented; Auditory Verbal Learning Test 
(AVLT); Forced Expiratory Volume (FEV1). 
e
 Indicates use of geometric means 
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8.2.3.1 Early life conditions and biomarkers of chronic disease 
 
The possibility was explored that variation in inflammatory status, endothelial activation 
and insulin resistance in adults was related to early life conditions. Thereafter, associations 
were sought between the selected health outcomes and early life adversity, and putative 
intermediary phenotypes (increased chronic inflammation, enhanced endothelial activation 
and increased insulin resistance) identified. 
 
Relationships (adjusted only for age and sex) between childhood conditions and indicators 
of potential ill health in adulthood were explored by examining the statistical associations 
of leg length, number of siblings, people/room in the parental home, parental home status 
and father’s occupational category (grouped as non-manual or manual) with phenotypes of 
increased chronic inflammation, poorer cognitive performance, decreased lung function, 
prevalence of classical CHD risk factors and carotid atherosclerosis (Table 8.2). 
Biomarkers of inflammation and endothelial activation appeared to be influenced little by 
the number of siblings, moderately by leg length and strongly by early life home 
conditions and father’s occupational category. Likewise, lung function and cognitive 
performance in adults also appeared to be influenced significantly by father’s occupation, 
whether the parents/guardians were owner-occupiers or tenants, and by degree of 
overcrowding. Cognitive performance was associated also with the number of siblings. 
Insulin resistance was linked to father’s occupational category and whether the 
participant’s parents owned their own home. cIMT was modestly related to father’s 
occupation but not to home conditions or number of siblings whereas the presence of 
carotid plaque was related strongly to father’s occupation and parental home status, and 
moderately to the number of people per room and the number of siblings. 
 
Table 8.2 Association of early life conditions with biomarkers of intermediary phenotypes and health outcomes in adulthood 
 
 
 
Quartile of leg lengthc 
(shortest to longest) 
Number of siblingsd 
<1, >1 to 2, >2 to 3, >4 
People/roome 
<1, >1 to 2, >2 
Parents owned homef 
Yes/No 
Fathers occupationg 
Non-manual/Manual  
 
A. Inflammatory & CHD Biomarkers 
CRP (mg/L)b 2.03, 1.61, 1.30, 1.28** 1.52, 1.32, 1.56, 1.70 1.23 , 1.63, 2.30*** 1.13/1.73*** 1.14/1.88*** 
IL-6 (pg/ml)b 1.78, 1.72, 1.67, 1.49 1.91, 1.55, 1.59, 1.71 1.46, 1.72, 2.11* 1.32/1.82*** 1.35/1.87*** 
ICAM (ng/ml)b 269, 269, 258, 254* 260, 249, 261, 274** 247, 266, 292*** 239/272*** 245/273*** 
vWF (IU/dl)a 143, 139, 146, 138*  140, 135, 143, 145 132, 145, 141** 129/146*** 131/148*** 
LDL Cholesterol (mmol/l)a 2.97, 3.05, 3.01, 3.00 3.00, 3.04, 3.10, 2.94 3.09, 3.00, 2.86 * 3.13/2.97* 3.08/3.02 
BP systolic (mmHg)a,h 136, 134, 135, 138* 139, 136, 135, 135 135, 136, 137 132/137* 134/136 
HOMA-IRa,h  1.54, 1.63, 1.72, 1.71 1.79, 1.63, 1.60, 1.69 1.63, 1.68, 1.70 1.45/1.76* 1.48/1.79* 
 
 
B. Adult Health Outcomes 
Stroop test (s)a 14.5, 14.3, 11.7, 13.2 12.1, 10.8, 12.9. 16.3** 9.4, 14.4, 20.9*** 7.7/15.7*** 8.6/15.6*** 
Choice Reaction Time (ms)b 584, 572, 561, 554 569, 530, 569, 582*** 523, 572, 562*** 518/582*** 529/583*** 
AVLT (words recalled)a,h  11.7, 11.8,11.5, 11.8* 11.7, 12.1, 11.5, 11.4** 12.3, 11.4, 11.2*** 12.3/11.4*** 12.3/11.2*** 
FEV1 (L)a,h 2.36, 2.75, 3.04, 3.52* 2.90, 3.03, 2.98, 2.81* 3.14, 2.89, 2.43*** 3.28/2.7*** 3.18/2.78* 
Carotid IMT (mm)a 0.69, 0.69,0.72, 0.69* 0.70, 0.68, 0.38, 0.70 0.68, 0.69, 0.74 0.67/0.70 0.68/0.70* 
Plaque present (%)a 45.3, 45.1, 54.7, 48.1 47.9, 42.6, 48.5, 55.5* 43.6, 49.7, 64.2* 38.3/49.2** 40.7/55.4** 
  
    
 
Table 8.2 (continued) 
 
a
 Mean values for continuous variables adjusted for age and sex;  
b Geometric means adjusted for age and sex; 
c
 Entire group of 666 subjects was divided by quartile of leg length (mean length in quartiles 1 through to 4 was 66.1, 76.0, 84.5, to 97.4 cm respectively);  
d
 In a similar manner the entire population were divided by number of siblings, for category <1 n=94; for >1 to 2 n= 123, for >2 to 3, n=223 and for  >4 n=227; 
e
 Number of people per room was calculated by dividing the total number of people in the house (adults and children) by the number of rooms; 241 subjects were in the category people/room  <1, 337  in 
the 1 to 2 category, and 81 were in the category people/room >2; 
f
 The number of participants at age 11 whose parents who owned their own home was 188, the number of participants at age 11 whose parents who rented or were tenants was 476;  
g
 The number of participants whose fathers had a non-manual occupation was 231; the number of participants whose fathers had a manual occupation was n=381; the number of participants whose father 
was unemployed was n=11; the number of participants whose father’s occupation was unclassifiable or unknown was n=43; 
h
 Auditory Verbal Learning Test (AVLT); Forced Expiratory Volume in 1 second (FEV1); Homeostasis Model Assessment of Insulin Resistance (HOMA-IR); Blood Pressure (BP) 
*, **, ***
 P value relates to the significance of the trend for the variable’s association on early life conditions in the range of  * <0.05 – 0.01; ** 0.01- 0.001; *** <0.0001. 
Figure 8.1 presents the association of overcrowding in the childhood home with 
biomarkers of chronic disease in adult life. It can be seen that indices of inflammation and 
endothelial activation (CRP, sICAM-1) in adulthood were related significantly in an 
apparently linear fashion to overcrowding in childhood, as were lung function (FEV1) and 
cognitive function (as assessed by Choice Reaction Time). LDL cholesterol, insulin 
resistance and blood pressure (data not shown) on the other hand were not.  
 
Table 8.3 explores in multivariate models the independent associations of early life 
variables with a range of health outcomes related to lung function, cognitive performance 
and carotid atherosclerosis. It can be seen that father’s occupational category and 
overcrowding were related in Model 1 to FEV1, and overcrowding to Choice Reaction 
Time. Father’s occupational category was also related to Stroop and AVLT. Trunk length 
was related independently to FEV1 and measures of cognitive performance. In these age 
and sex adjusted models early life variables explained 13% to 65% of the variation in the 
health outcomes. Again, in models where father’s occupational category was omitted 
parental home status became a significant predicator of FEV1 and cognitive function. 
 
Model 2 in Table 8.3 included key biomarkers of the putative intermediary phenotypes 
(sICAM-1 and IL-6) in the ‘early life model’ and it can be seen that for FEV1, Choice 
Reaction Time and AVLT, early life variables were no longer independent predictors of 
performance. Father’s occupational category continued to be a predictor of Stroop test 
performance.
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Figure 8.1 Influence of early life overcrowding on inflammation, lung function and cognitive performance in adulthood 
(continued) 
 
The entire group of 666 participants was divided into categories dependent on the number of people (adults and children) in the home when the subject was aged 11 years divided by the number of rooms in 
the home. 241 participants were in the category people/room <1, 205 participants were in the category people/room 1.0-1.5, 137 participants were in the category people/room 1.5-2.0, and 81 participants 
were in the category people/room >2. 2 participants did not report the number of rooms in the childhood home. P value is the significance of number of people per room as a predictor of CRP, sICAM-1, 
FEV1 and Choice Reaction Time in age and sex adjusted regression models. The height of the bar represents the geometric mean within each category of people/room.  
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Table 8.3 Multivariate analyses of early life determinants of lung function, cognitive performance and atherosclerosis 
 
 
 FEV1 
β-coefficient 
Choice Reaction Time 
β-coefficient 
Stroop test 
β-coefficient 
AVLT 
β-coefficient 
Plaque present 
β-coefficient 
Model 1 
Agea -0.153*** 0.047*** 2.70*** -0.207*** 1.46*** 
Sex -0.268*** -0.040 -3.16 1.24*** 0.391*** 
Parental home status -0.094 0.033 2.10 -0.254 1.21 
Father’s occupational category 0.160*** -0.042 -4.75** 0.614** 0.650 
People/room -0.065 * 0.027* 0.162 -0.106 1.05 
Number of siblings -0.015 0.003 0.967 -0.070 1.09 
Leg length 0.034*** -0.001 0.178 0.025 0.995 
Trunk length 0.058*** -0.007** -0.608** 0.072** 0.964 
Overall R2 65% 21% 16% 13% 19% 
Model 2 
Age -0.140*** 0.048*** 2.77*** -0.213*** 1.43*** 
Sex -0.314 -0.021 -3.73 1.21*** 0.368*** 
Parental home status -0.040 0.024 2.20 -0.204 1.12 
Father’s occupational category 0.118 -0.028 -4.12* 0.446 0.623* 
People/room -0.063 0.013 -0.994 0.002 1.20 
Number of siblings 0.012 0.005 0.878 -0.051 1.06 
Leg length 0.033 0.000 0.195 0.024 0.990 
Trunk length 0.055 -0.006** -0.665*** 0.069** 0.960 
sICAM-1 -0.292*** 0.075 7.82* -1.28** 1.51 
IL-6 -0.092*** 0.030 -0.131 -0.013 0.823 
Overall R2 68% 25% 18% 15% 19% 
 
Table 8.3 Multivariate analyses of early life determinants of lung function, cognitive performance and atherosclerosis (continued) 
 
 
Model 1 examined the influence of the early life variables identified as most strongly linked to inflammation and tested their independence; 
Model 2 included not only early life variables but also markers of inflammation (IL-6 and sICAM-1); 
a
 Regression coefficient calculated as per 5 years for age; 
*,**,***
 Relate to the significance of the P value associated with the regression coefficient in the range of  * <0.05-0.001; ** 0.001-0.0001; *** <0.0001. 
 
 
 
8.2.4 Discussion 
 
Chronic inflammation is considered to be a ‘common soil’ in the aetiology of a number of 
diseases and disorders including cardiovascular disease and type 2 diabetes.184 It also 
appears to be related to cognitive decline in older people.183 This work explored possible 
links between early life adversity, intermediary phenotypes, and a range of poorer health 
outcomes in deprived communities. By examining the statistical associations between 
variables, evidence emerged that childhood living conditions may impact on the state of 
activation of the innate immune system and on endothelial activation in adult life. Notably, 
father’s occupational category, whether or not the subject’s parents owned the family 
home, and a measure of overcrowding in the home (number of occupants divided by 
number of rooms) showed significant associations with biomarkers of inflammation and 
endothelial dysfunction. These findings add weight to the postulate that the social and 
family environment in early life influences through biological pathways the propensity to 
develop common, chronic diseases in later life. Emerging data also suggest that the 
duration of childhood spent in poverty or in a household of low socioeconomic status 
accumulates over time to affect adversely morbidity and mortality in later adulthood.185 186  
 
Indices of lung function, cognitive performance and carotid artery plaque presence appear 
to be likewise affected by adverse early life conditions. This finding is in line with earlier 
work showing a prospective association between the duration of childhood poverty and 
adult working memory, an association which in part appears to be explained by elevated 
chronic stress during childhood.187 The observation that inclusion of IL-6 and sICAM-1 in 
multivariate models (Model 2) reduced the importance of father’s occupation/parental 
home conditions (owner-occupier status and overcrowding) as potential predictors suggests 
that chronic inflammation and endothelial activation may be intermediary phenotypes in 
the relationship between adverse childhood home conditions and poorer lung function and 
cognitive performance. The results of the present analysis are in line with a recent report of 
associations between socioeconomic status, inflammatory markers and psychometric 
performance.188 Early life socioeconomic status has also been shown recently to be 
significantly associated with CRP levels, independent of later life socioeconomic status, 
with adiposity accounting for the majority of this association between life-course 
socioeconomic indicators and CRP levels.189 Similarly, it has been reported that adolescent 
females who spent their early life in a family owned, as opposed to a rented, home had 
lower levels of expression of specific inflammatory genes in peripheral blood 
monocytes.190 In a systematic review of population based studies examining CRP levels 
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and indicators of socioeconomic position, race and ethnicity, elevated CRP levels were 
associated with increasing poverty and non-white race.189 Similarly, an investigation of the 
life course association between childhood maltreatment and adult inflammation in a birth 
cohort as part of the Dunedin Multidisciplinary Health and Development Study, maltreated 
children showed a significant and graded increase in CRP levels in adulthood,191 providing 
evidence of a causal association between childhood maltreatment and adult inflammation 
and evidence of a dose-response relation between severity of maltreatment and 
inflammation. Low birth weight and infection in childhood are also related to endothelial 
dysfunction192 and these may be additional mechanisms by which childhood 
socioeconomic circumstances relate to these adult biomarkers of chronic disease. However, 
these association studies cannot eliminate the impact of unmeasured potential confounders 
on the outcome of interest. Thus, while chronic inflammation is plausible as a mechanistic 
application, further work needs to be done to establish cause and effect. 
 
The influence of early life conditions on cognitive executive function is consistent with 
earlier reports of executive dysfunction in children living in deprived circumstances.193 194 
The aetiological links underlying these associations are likely to be complex and include 
the increased likelihood of childhood illness (and missed education) in overcrowded 
homes, as well as an increased risk of compromised lung function.  
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8.3 Interaction of personality traits with social deprivation in determining 
mental well-being and health behaviours 
 
8.3.1 Introduction 
 
The association between personality factors and a range of both positive and maladaptive 
health behaviours is now well established, and is known to influence morbidity and 
mortality. The work described in this section addresses the question as to whether these 
relationships between personality and behaviour differ according to socioeconomic status. 
 
Extraverted and neurotic characteristics have both been shown to be associated with 
mortality.  In a large longitudinal study (N = 2359) involving 50-year follow-up, those 
participants who scored 1 SD above the mean on characteristics of emotional stability (low 
neuroticism), general activity (a sub-trait of extraversion) and conscientiousness survived 
some 2 to 3 years longer than did those who scored 1 SD below the mean. The effect was 
independent of smoking and obesity.195 Higher levels of neuroticism have also been shown 
to be predictive of shorter survival in an elderly North American male sample,196 while 
neurotic hostility, allied to Coronary Heart Disease (CHD)-prone personality features and 
anti-social personality, have predicted mortality in a large French cohort (N = 14,445).197 
Personality is linked also to subjective and objective morbidity. For example, high 
neuroticism is associated with poor subjective health status and also predicts clinically-
defined chronic illness.198   
 
Interactions between personality and health behaviours are seen to influence morbidity and 
subjective well-being.  Smokers have been shown to score more highly on the personality 
factor of neuroticism, and lower on characteristics of agreeableness and conscientiousness 
than those who have never smoked.199 Openness to experience (a facet of extraversion) and 
low neuroticism have been associated with a more active decision-making style with 
respect to self-health care,200 while high extraversion predicts a greater propensity to 
access health care resources which in turn may have significant implications for morbidity, 
mortality and health costs.201  
 
The evidence that personality factors are associated with health-related behaviours that 
influence health status may have important implications for understanding why certain 
sub-groups within the population experience significantly better, or worse, health than 
others. The marked gradient in health as a function of socio-economic status is a case in 
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point: people living in deprived circumstances are significantly more prone than their 
affluent peers to health conditions that are often a product of maladaptive and harmful 
health behaviours. Given the evidence above that neuroticism is associated with harmful 
health behaviours, it would be important to establish whether neuroticism tends to 
exacerbate the health problems of those living in deprivation while extraversion may offer 
a protective function. Moreover, given the greater prevalence of affective disorder in 
socially-disadvantaged groups, and the association between affective disorder and neurotic 
traits, it would be important to consider whether the latter traits are also more prevalent in 
deprived groups. 
 
The work reported in this section examines the association between socioeconomic status, 
personality, mental well-being and health behaviours. The research question posed was 
whether personality traits interacted with measures of social deprivation in determining a 
subject’s mental wellbeing and the ability to adopt healthy living advice. 
 
8.3.2 Methods 
8.3.2.1 Indices of health behaviours  
A score for the consumption of fruit and vegetables was calculated from self-reported food 
frequency questionnaire participant responses. Participants were asked on average how 
often they consumed of a range of food categories (20 food categories listed). Responses 
for each question ranged from daily consumption (number of portions per day) to weekly 
and monthly consumption. Participants selected one response per food category. For the 
purposes of the present analysis responses to four questions from the food frequency 
questionnaire relating to fruit and vegetable intake were aggregated to give an overall 
indicative diet score (i.e. frequency of intake of fresh fruit, cooked green vegetables (fresh 
or frozen), cooked root vegetables (fresh or frozen) and raw vegetables or salad (including 
tomatoes)). Monthly diet scores were calculated on the basis of a 28 day month.  
The number of hours per month each study participant undertook vigorous exercise was 
also calculated. In the participant lifestyle questionnaire ‘vigorous physical activity’ was 
defined as the undertaking of activities vigorously enough to cause sweating or a faster 
heartbeat. The number of hours of activity per month was based on a 28 day month.  
Participants’ smoking behaviours were also assessed. As part of the participant lifestyle 
questionnaire, participants were asked whether they ever smoked regularly (at least one 
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cigarette a day for 12 months of more), what they smoked, what age they started and 
stopped smoking if applicable, and if their parents smoked. 
Details of the assessments of psychological profile and mental wellbeing can be found in 
Chapter 2. 
 
8.3.2.2 Statistical analysis 
 
Analysis of covariance (Rosenberg Self-Esteem Scale, Sense of Coherence, Generalised 
Self-Efficacy Scale) and ordinal logistic regression (Beck Hopelessness Scale, Eysenck 
Personality Questionnaire) analyses were used, with the results presented as point 
estimates, 95% confidence intervals and p-values. Binary logistic regression was used for 
the components of the Eysenck Personality Questionnaire. Quality of the models was 
compared by R2. Analyses were conducted in SAS v9.1 and R v2.8. 
 
8.3.3 Results 
Table 8.4 provides summary statistics by area level deprivation (as defined by SIMD) for 
variables related to health behaviours, psychological profile and mental wellbeing as 
assessed by a panel of validated questionnaires. Clear differences can be seen, as predicted, 
between the most and least deprived groups in health behaviours (cigarette smoking, 
exercise and diet indices), and in indicators of mental well-being (Sense of Coherence, Self 
Esteem, Hopelessness and Self-Efficacy, General Health Questionnaire-28). (Due to the 
design of the Rosenberg Self-Esteem Scale, a higher score on this scale indicates a lower 
degree of self-esteem.) From the personality trait evaluation it was observed that subjects 
from the deprived communities showed higher levels of neuroticism (the tendency to 
experience negative emotions including anxiety, anger and guilt) and psychoticism (the 
predisposition to become sociopathic and tendency to be hostile, manipulative and 
impulsive) compared to those from affluent areas. In contrast the mean score for 
extraversion (the tendency to enjoy positive events and human interaction) and tendency to 
portray themselves favourably (lie scale) was the same in the two groups.  
Table 8.4 Mean differences by area deprivation category of indices of health behaviour, personality and mental wellbeing 
 
 
 
Least Deprived 
(n=342, all ages) 
 
Most Deprived  
(n=324, all ages) 
 
P  
 
Indices of Health Behaviour 
Cigarette smoker (never/former/current) 64.6%/29.3%/6.1% 25.6%/34.0%/40.4% <0.0001 
Regular aerobics physical activity 
(inactive/mod inactive/mod active/active) 
 
23.9%/24.6%/25.4%/26% 
 
49.4%/11.4%/21.9%/17.3% 
 
<0.0001 
Fruit & vegetable diet score  
(portions per month) 
 
95.7(51.5) 
 
59.9(50.4) 
 
<0.0001 
 
Eysenck Personality Trait (EPR) 
Neuroticism 4.06(3.19) 5.96(3.79) <0.0001 
Extraversion 7.49(3.41) 7.34(3.61) 0.58 
Psychoticism 1.26(1.30) 2.58(2.02) <0.0001 
Lie 5.35(2.68) 5.34(2.78) 0.95 
 
Mental Wellbeing Scores 
Beck Hopelessness  
   (Missing data n=38) 
2.82(3.24) 5.12(4.81) <0.0001 
Sense of Coherence 
   (Missing data n=12)  
70.31(11.34) 59.63(15.33) <0.0001 
Rosenberg Self-Esteem  
   (Missing data n=17) 
17.49(4.48) 20.78(5.32) <0.0001 
Generalised Self-Efficacy  
   (Missing data n=7) 
32.74(4.42) 30.08(6.14) <0.0001 
GHQ Total 
   (Missing data n=27) 
 
2.53(4.06) 5.19(6.87) <0.0001 
 
 
 
Values are presented as Mean (SD) for all participants; or as percentages for categorical variables 
 
 
8.3.3.1 Personality, deprivation and mental well-being 
 
Personality traits are expected to influence mental wellbeing. However the question asked 
was whether this association was the same in those who lived in least versus most deprived 
areas. Figure 8.2 models the impact of neuroticism, extraversion and psychoticism on 
mental wellbeing. Increased levels of neuroticism were linked strongly to hopelessness, a 
reduced sense of coherence, reduced self-esteem and generalised self-efficacy in a similar 
manner in the 2 groups.  
 
Variation in the personality trait of extraversion appeared to have a different impact in the 
2 groups. Subjects exhibiting a higher degree of extraversion had similar low levels of 
hopelessness, a high sense of coherence and high levels of self-esteem and self-efficacy, 
regardless of socioeconomic status. However, lower scores for extraversion had a 
significantly greater impact on mental wellbeing in the deprived versus affluent group. The 
models of psychoticism gave broader confidence ranges and similar ranges and similar 
trends with mental wellbeing in the two groups.  
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Figure 8.2 Interaction of personality traits with deprivation in determining  
mental wellbeing 
 
 
 
P value refers to interaction effect. 
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8.3.3.2 Mental well-being, deprivation and uptake of health advice  
 
In an attempt to understand the potential impact of personality and mental well-being on 
the physical health of deprived populations, an analysis was undertaken of the association 
between parameters of mental well-being and responses to current public health messages, 
that is the consumption of fruit and vegetables in the diet and giving up smoking.  
 
Subjects in the most deprived group ate on average about a third fewer portions of fruit and 
vegetables on a monthly basis compared to those in the least deprived (Table 8.4). 
 
Figure 8.3 shows the relationship between mental wellbeing and monthly fruit and 
vegetable consumption in the two groups. It can be seen that the number of portions of 
fruit and vegetables consumed in a month decreased with increasing hopelessness and 
decreasing self-esteem (higher RSES score) and increased with higher degrees of sense of 
coherence and self-efficacy.  
Extraversion was related significantly to fruit and vegetable consumption in the Most 
deprived group (p=0.002) but not in the Least Deprived group, although the p value for the 
interaction was not significant (p=0.237).  
 
Figure 8.3 Relationship between mental wellbeing, personality and monthly consumption of fruit and vegetables 
 
 
 
 
Adjusted for age, sex and years in education. P value refers to interaction effect. 
Smoking differed markedly between the least and most deprived groups (Table 8.4). The 
former was characterised by a high number of ‘never smokers’ (64.6%) while 74.4% of 
subjects in the latter had smoked at some time and 40.4% were current smokers. The 
relationship between personality, mental wellbeing and smoking cessation was examined 
(Figure 8.4). Sense of coherence and self-efficacy had an impact on smoking cessation, 
and for the former there was a significant interaction (p=0.034) with deprivation category. 
Figure 8.4 Relationship between mental wellbeing, personality and probability of being a former smoker (smoking cessation) 
 
Adjusted for age, sex and years in education.  P value refers to interaction effect.                 
8.3.4 Discussion 
 
The work reported in this section demonstrates that not only are there differences in health 
behaviours and mental wellbeing between the most deprived and least deprived groups, but 
also the impact of personality on mental wellbeing is significantly greater in the most 
deprived group, especially in the case of extraversion. Uptake of good health behaviours 
(high fruit and vegetable consumption, stopping smoking and participation in aerobic 
exercise) was higher in the least deprived group and there was evidence that mental 
wellbeing and personality traits had an impact on the uptake of good health behaviours in 
the most deprived but not least deprived group. A possible limitation of this study is the 
possibility that participants might over-report desirable health behaviours, and it was not 
possible to explore whether this was the case and if so, whether there was any difference 
between most deprived and least deprived groups in such over-reporting. 
 
However, these findings suggest that in order to address deprivation-based differences in 
uptake of health promotion messages, more attention should be paid to the effects of 
personality traits and parameters of mental wellbeing in determining the uptake of health 
promoting advice. Those who are of high extraversion, low neuroticism and high sense of 
coherence appear to adopt a healthier lifestyle, but this outcome may be more difficult to 
achieve in deprived populations where low extraversion, high hopelessness and a low 
sense of coherence are more common personality traits. Health messages designed to 
reduce the socioeconomic gradient in health may need to be tailored to personality type 
and address mental wellbeing as well as the adoption of good health behaviours. 
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CHAPTER 9 – DISCUSSION 
 
The work reported in this thesis has examined the associations of social deprivation with a 
variety of health measures, and measured a wide range of co-factors with a view to 
enhancing our understanding of the relationships between social deprivation and ill health. 
In this chapter, the most significant findings will be drawn together in order to build up a 
picture of the factors mediating the socioeconomic gradient in ill health. Thereafter, the 
‘bigger picture’ will be discussed: what implications do the findings from this work have 
for public policy in terms of attempts to improve the health of the whole population while 
narrowing the gap in health between most and least deprived? Suggestions for future 
research will be considered, before finally drawing some conclusions. 
 
The stated aims of this study were: to enhance understanding of the factors underlying the 
socioeconomic gradient in ill health, focussing especially on the association between social 
deprivation and risk of coronary heart disease; to determine the extent to which emerging 
cardiovascular risk factors – especially markers of inflammation – contribute to the 
explanation of the socioeconomic gradient in coronary heart disease, and to further current 
understanding of the associations between social deprivation and markers of cognitive 
function and personality. The main findings from this work will now be drawn together to 
demonstrate the extent to which these aims have been achieved. 
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9.1 Principal findings and their significance 
 
Comparison of classic and emerging cardiovascular risk factors between the most and least 
deprived groups (Chapter 4) revealed clear differences between the two groups in: cigarette 
smoking, physical activity, BMI (by virtue of differences in height), waist/hip ratio, 
triglyceride concentration, HDL concentration and fasting plasma glucose concentration 
(all p<0.01). Total and LDL cholesterol concentrations were higher in the least deprived 
group (p<0.0001) and this difference persisted after adjusting for statin therapy (adjusted p 
value = 0.049). Self-reported weekly alcohol consumption was higher in the least deprived 
group (p<0.0001). Of the emerging risk factors, there were significant differences between 
most deprived and least deprived groups in markers of: insulin resistance/adiposity (fasting 
insulin, HOMA-IR, leptin concentration); inflammation/endothelial dysfunction (CRP, IL-
6 and sICAM-1) and haemostasis (vWF, fibrinogen and D-dimer). Of additional 
biomarkers measured, deprivation-based differences were evident in ADMA (a marker 
associated with insulin resistance) and GGT (but not ALT or AST). The deprivation 
difference in GGT persisted after adjusting for age, sex and alcohol consumption, 
suggesting that the deprivation difference in GGT may reflect an alternative aetiology such 
as non-alcoholic fatty liver disease. Of the markers of renal function analysed, plasma 
creatinine was higher in the least deprived group, and consequently MDRD-4 eGFR was 
lower in this group. However, cystatin C was higher in the most deprived group, indicative 
of poorer renal function in the most deprived group. It is likely that the higher serum 
creatinine concentrations in the least deprived group were due to the 6cm height difference 
between least and most deprived, and consequently differences in muscle mass. There was 
a significant difference between most and least deprived groups in vitamin D status as 
assessed by 25-hydroxy vitamin D concentration (p<0.0001). 
 
Having identified significant differences in many classic and novel cardiovascular markers, 
the next question to address was to what extent these markers explain the deprivation gap 
in cardiovascular risk. There were significant differences between most deprived and least 
deprived groups in both cIMT and plaque score. Plaque score was the more discriminant 
marker, with more highly statistically significant differences between the deprivation 
groups as a whole, and on age tertile subgroup analysis, differences between most and least 
deprived being evident at a younger age for plaque score than for cIMT. Classic 
cardiovascular risk factors explained around 30% of the difference in plaque presence 
between most and least deprived – this was broadly consistent with what would be 
expected from previous studies exploring aspects of cardiovascular risk in relation to social 
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deprivation.25 26 50-52 Surprisingly, none of the emerging risk factors included in the 
multivariate models for plaque presence added anything further to the explanation of the 
deprivation-based difference in plaque presence – this included markers of inflammation 
and endothelial function (CRP, IL-6 and sICAM-1). The range of emerging risk factors 
examined in this study is much more extensive than that examined in the earlier Women’s 
Health Study, in which CRP, sICAM-1 and fibrinogen failed to add to the ability to predict 
cardiovascular events based on classic risk factors alone.71 Given current understanding of 
the role of inflammatory pathways in atherosclerosis,60 a prespecified hypothesis at the 
outset of my work was that inflammatory markers would contribute to the explanation of 
the deprivation-based difference in plaque presence. It was also surprising that when the 
associations of co-factors with plaque presence were modelled after adjusting for age, sex 
and deprivation, no associations were evident for CRP, IL-6 or sICAM-1 with plaque 
presence. A worthy extension to this work would be to expand the repertoire of 
inflammatory markers analysed in order to determine if there is, indeed, evidence of 
genuine associations of inflammation with plaque presence once a fuller assessment of 
inflammatory pathways is undertaken. 
 
As it stands, it was only when early life individual-level markers of socioeconomic status 
were added as covariates in multivariate models of the area-level deprivation effect on 
plaque presence that the deprivation difference in plaque presence was abolished. When 
the role of early life factors was further studied in relation to selected health outcomes 
(cIMT and plaque presence), FEV1 and parameters of cognitive function (Chapter 8), lung 
function and cognitive performance appeared to be influenced by father’s occupation, 
whether the parents/guardians were owner-occupiers or tenants, and by degree of 
overcrowding; cIMT was modestly related to father’s occupation but not to home 
conditions or number of siblings, and carotid plaque was related strongly to father’s 
occupation and parental home status, and moderately to number of people per room and 
number of siblings. Interestingly, when sICAM and IL-6 were incorporated into early life 
models, in the case of FEV1, Choice Reaction Time and AVLT early life variables were no 
longer independent predictors of outcome (although father’s occupational category 
remained a predictor of Stroop test performance). These findings suggest a possible role 
for inflammation as an intermediary phenotype in the relationship between early life 
variables and adult health outcomes, and provide valuable information about possible 
mechanisms by which previously observed associations between early life adversity and 
adult morbidity and mortality may be mediated.185 190 As this was a cross-sectional study, 
caution must be exerted in drawing firm conclusions about lifecourse effects such as these, 
 184 
but the findings are certainly hypothesis-generating and worthy of further study in a 
longitudinal study. 
 
Finally, the associations of deprivation, mental wellbeing and health behaviours were 
examined. As expected, there were clear differences in indices of health behaviour 
(cigarette smoking, physical activity and fruit and vegetable consumption) between the 
most deprived and least deprived groups (all p<0.0001), as well as differences in the 
personality traits of neuroticism and psychoticism, and indices of mental wellbeing (Beck 
Hopelessness, Sense of Coherence, Rosenberg Self-Esteem, Generalised Self-Efficacy and 
General Health Questionnaire) (all p<0.0001). The most interesting findings, however, 
were in relation to deprivation-based differences in the mediating effect of extraversion on 
mental wellbeing. Lower scores for extraversion had a significantly greater impact on 
mental wellbeing (higher levels of hopelessness and lower sense of coherence, self-esteem 
and self-efficacy) in the most deprived group than in the least deprived group. 
Furthermore, extraversion was related significantly to fruit and vegetable consumption in 
the most deprived group but not in the least deprived group. Similarly, sense of coherence 
and self-efficacy had an impact on smoking cessation, and there was a significant 
interaction with deprivation in the case of the association between sense of coherence and 
smoking cessation. These findings may help to explain differential uptake of health 
promotion messages by different sections of the population, and why despite sustained 
efforts to provide healthy living advice, the deprivation gap in health is widening. The 
potential implications of these observations for public policy are discussed further in 
Section 9.3. 
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9.2 Generalisability of study findings to the Greater Glasgow population as a 
whole, and to populations beyond Glasgow 
 
A concern from the planning stages of this study onwards was whether the recruited 
participants would be typical of the population of Greater Glasgow as a whole. Clearly, 
participants would be those who volunteered to participate (after receiving a letter of 
invitation to participate via the General Practice with which they were registered). In 
particular, there was the concern that from the most deprived group, those who volunteered 
would be those most motivated to pay attention to their health, and that from the least 
deprived group, those most concerned about their health would volunteer, resulting in the 
“healthy deprived” and “worried well” participating, with the potential that differences 
between the two groups would be minimised. One step that was taken in order to make the 
study group as representative as possible of the population as a whole was to identify 
potential participants from the practice lists of the ten General Practices through which 
participants were recruited, thus ensuring that potential participants would be invited 
regardless of whether or not they actually visited their General Practitioner. Thereafter, it 
was invaluable to be able to compare anonymised data on drug prescriptions and smoking 
habit for participants and non-participants. As detailed in Section 2.7, there were 
differences between participants and non-participants in levels of prescriptions, with higher 
levels of prescriptions for statins, antihypertensives and antidiabetic drugs in participants 
compared to non-participants, especially in the most deprived group. This may suggest that 
those in the most deprived group who participated had a higher level of recognised 
morbidity than those who did not participate, and do not appear to represent the “healthy 
deprived.”   
 
Having taken steps to ensure that the study population was as representative as possible of 
the general population of Greater Glasgow, the next question is whether the Greater 
Glasgow story is unique, or to what extent the findings from this study are generalisable to 
other cities in the United Kingdom and beyond. Certainly, as detailed in Section 1.1.2, the 
two extremes of deprivation and associated health outcomes are seen in Glasgow. 
However, ongoing work by the Glasgow Centre for Population Health suggests that current 
levels (and distributions) of socioeconomic deprivation in Glasgow are almost identical to 
those seen in Liverpool and in Manchester (when based on up-to-date and spatially 
sensitive measures of deprivation) (Glasgow Centre for Population Health, unpublished 
observations). Thus, the deprivation profile of Glasgow is not unique in the context of 
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other UK post-industrial cities. It is reasonable, therefore, to expect that the findings from 
this study are applicable to other similar (post-industrial) cities in the UK. 
 
9.3 Implications for public policy 
 
The work reported in this thesis has provided significant insights into the interplay between 
early life, classic and emerging biomarkers, cardiovascular risk, personality, cognitive 
function and health behaviour. How can these findings be used in attempts to reverse the 
ongoing widening of the deprivation gap in health and life expectancy? These questions 
were discussed in session 9 of Glasgow’s Healthier Future Forum, an event on 25 February 
2010 at which the initial findings of the pSoBid study were presented to an audience 
composed of approximately 120 representatives from universities, the NHS, Public Health, 
local councils, Scottish Government, voluntary sector organisations and other groups. 
After the main study findings were presented, a panel discussion was convened, during 
which a number of themes emerged. One was the recognition of the complex nature of the 
issue of social deprivation and health outcomes, and the fact that there is no ‘easy answer’ 
to these issues. Tackling these problems requires a multidisciplinary approach, in which 
the interplay of biological and sociological factors is recognised. The importance of early 
life experiences in determining health in later life was a recurring theme. 
 
Looking beyond the UK, the American Heart Association has recently produced a report 
setting out their “Strategic Impact Goal Through 2020 and Beyond,” in which they detail 
their goal of improving the cardiovascular health of all Americans by 20% by 2020 while 
reducing deaths from cardiovascular diseases and stroke by 20%. In order to achieve this 
goal, they introduce the concept of “cardiovascular health,” defined by the presence of 
both ideal health behaviours (non-smoking, BMI<25 kg/m2, physical activity at goal 
levels, and pursuit of a diet consistent with current guideline recommendations) and ideal 
health factors (untreated total cholesterol <200mg/dL [5.18mmol/L], untreated blood 
pressure <120/80mmHg, and fasting plasma glucose <100 mg/dL [5.55mmol/L]). In 
considering how to achieve this, they consider the issue of primordial prevention, i.e. 
preventing the development of risk factors in the first place (as opposed to primary 
prevention, in which individuals with adverse risk factors are treated with a view to 
preventing the first occurrence of a clinical event). They then discuss the high-risk 
(focussing interventions on individuals at highest risk) and population-wide (addressing the 
distribution of risk in the whole population) approaches to prevention, noting that as the 
majority of CVD and stroke events occur in individuals without markedly elevated levels 
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of risk factors, that if the entire distribution of cardiovascular risk is to be shifted, 
population strategies are required in addition to the high-risk approach that addresses risk 
reduction for those individuals with markedly elevated levels of risk factors. They propose 
that to achieve improvements in cardiovascular health across the entire population, the 
seven parameters listed above (smoking, BMI, physical activity, healthy diet score, total 
cholesterol, blood pressure and fasting plasma glucose) are monitored across the 
population and classified as ideal, intermediate or poor. In their Impact Goal statement, 
they highlight the fact that attention should be focussed on underserved minority 
populations in order to achieve the 2020 Impact Goal in these groups as well.202  
 
What principles can we take from the American Heart Association Strategic Impact Goal 
that could be applied in the UK? One of the founding principles of the UK National Health 
Service is that of universal access for all, which should place the UK in a strong position to 
address the health of the whole population. The Quality and Outcomes Framework (QOF) 
for General Practice provides a framework within which practices are rewarded for 
providing good quality care to their patients, and has indicators in areas such as, for 
patients with coronary heart disease, the percentage of patients whose last measured total 
cholesterol is 5 mmol/L or less, or for smoking, the percentage of patients with coronary 
heart disease, stroke or transient ischaemic attack, hypertension, diabetes, chronic 
obstructive pulmonary disease or asthma who smoke whose notes contain a record that 
smoking cessation advice or referral to a specialist service, where available, has been 
offered within the previous 15 months.203 While this approach provides a framework for 
addressing reduction of risk factors in those in whom those factors have been identified 
(mainly in a secondary prevention context), it remains likely that the socioeconomic 
differential in uptake of healthy lifestyle advice will remain unless strategies are developed 
which recognise the interaction of deprivation and personality in likelihood of adopting 
healthier behaviour. Furthermore, the concept of primordial prevention raised by the 
American Heart Association echoes the findings presented in this thesis regarding the 
importance of early life experiences in influencing adult health. Further work is needed to 
delineate further which early life factors influence which adult health outcomes, so that 
strategies can be developed to address these factors. 
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9.4 Limitations of this study 
 
There are limitations inherent in the design of this study. First the sample was selected 
from the ends of the Scottish Index of Multiple Deprivation (SIMD) gradient. In 2004 at 
the time of sampling, 31.4% of the population of Glasgow fell into the bottom of the SIMD 
classification, while only 6% fell into the top 20% of the SIMD. Thus the study reflects the 
particular socioeconomic make up of the city at the start of the study but does not provide 
information on the nature of the gradient of outcome indicators across all SIMD categories, 
nor is it representative of the Scottish population as a whole. Furthermore, the cross-
sectional design of this study means that it is not possible to identify temporal relationships 
between variables (although these are of course inherent in the relationship between early 
life and adulthood) and only associations can be reported.  
 
9.5 Future work  
 
The work reported in this thesis has provided a vast range of data, but it is inevitable that in 
so doing, many new questions will also be raised, and so there is significant potential for 
further work to be done in this subject area. There is potential for further analysis of the 
existing dataset. For example, the associations of further biomarkers (e.g. ADMA, liver 
‘function’ tests and markers of renal function) could be examined in relation to the 
deprivation-based differences in cIMT and plaque score to determine if any such markers 
help to explain the difference in subclinical atherosclerosis between the most and least 
deprived groups. Furthermore, there remains a significant biobank of frozen plasma from 
study participants, and work is already planned to extend the repertoire of biomarkers 
measured on these samples, focussing particularly on a fuller assessment of mediators of 
inflammatory pathways, and also on some other recently emerging cardiovascular risk 
markers. As discussed in Section 9.4, the cross-sectional design of this study means that 
while hypotheses can be generated about possible relationships between early life factors 
and adult health outcomes, and suggestions made about putative intermediary phenotypes, 
a longitudinal study would be required in order to confirm temporal relationships – 
preferably starting at a stage at which it is possible to study early life variables directly, 
rather than by later adult recall. Such a study would clearly be a long-term project. Finally, 
thought should be given to studying the effect of current or novel population health 
interventions (e.g. housing interventions or early life intervention programmes) on lifestyle 
parameters, biomarkers and health outcomes. 
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9.6 Conclusions 
 
The work reported in this thesis has underlined the complex and multifactorial nature of 
socioeconomic inequalities in health. It would appear that the relationship between social 
deprivation and health represents the interplay of, in many cases, early life factors, 
mediators such as inflammatory pathways, psychological parameters such as personality 
and cognitive function, affecting health behaviours and subsequently outcomes such as 
atherosclerosis. The apparently complex nature of these relationships suggests that answers 
to the problem of the widening deprivation gap in health are also likely to be complex, and 
will have to take into account factors such as early life experiences and personality, as well 
as the more classically recognised factors such as smoking, cholesterol and blood pressure, 
if they are to stand a chance of succeeding in narrowing the health gap by improving the 
health of those most in need. 
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